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ABSTRACT
An assessment was made of the role of insulin-like growth factor-I (IGF-I) in
the growth of granulosa and thecal cells of the pre-ovulatory follicles in the ovary of the
domestic hen (Gallus domesticus).
The presence of IGF-I in granulosa and thecal tissues was demonstrated by
radioimmunoassay (RIA) of tissue extracts and by immunocytochemical analysis of
cultured cells. Both studies showed that immunoreactive IGF-I was present in
granulosa and thecal tissues. Reverse-transcription, polymerase chain reaction and
Southern blotting analysis showed that IGF-I mRNA was present in total RNA
extracted from granulosa and thecal tissue of the four largest follicles in the follicular
hierarchy.
Cell culture systems for chicken granulosa and thecal cells were established and
used to determine the effects of IGF-I alone, and with gonadotrophins, on DNA
synthesis using the incorporation of [3H]-thymidine into the cell as an index. The
results of these studies showed that IGF-I stimulated DNA synthesis in both cell types
in a dose-dependent manner. FSH and LH were shown to stimulate steroidogenesis, as
measured by RIA, in thecal and granulosa cells respectively, but neither gonadotrophin
stimulated DNA synthesis in thecal cells. LH, but not FSH, was shown to have a dose-
dependent stimulatory effect on DNA synthesis in granulosa cells; when IGF-I and LH
treatments were combined their stimulatory effects were synergistic. Serum factors
were also shown to act synergistically with IGF-I in this respect. The effects of IGF-I
were found to depend on follicle size, as did the effects of LH on granulosa cells. The
synergistic actions of IGF-I and LH with respect to DNA synthesis in granulosa cells
were independent of follicular size.
The production of IGF binding proteins (IGFBP) by granulosa and thecal cell
cultures was demonstrated using Western ligand blotting. A range IGFBPs were
shown to be produced by both cell types; when the patterns were compared, both were
found to produce four proteins of the same size, but granulosa cells produced an
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additional protein not detected in thecal cell conditioned medium. The stimulation of
cultures with IGF-I resulted in increased production of IGFBPs by granulosa but not
by thecal cells; stimulation with LH had no effect on IGFBPs by granulosa cells.
Receptor binding studies were performed on granulosa and thecal cell cultures,
both cell types were shown to posses IGF-I binding sites from which the peptide was
displaceable by insulin and the IGF peptides in a potency order of IGF-I > IGF-II»
insulin. This is a well documented characteristic of an IGF type I receptor. Treatment of
granulosa cell cultures with LH had no significant effect on the affinity of IGF-I for
these binding sites, or on the number of sites.
In conclusion, IGF-I is produced by, and has significant effects on DNA
synthesis and binding protein production in the cells of pre-ovulatory ovarian follicles.
Further, these cells have IGF-I binding sites. These observations are consistent with an
autocrine or paracrine role for IGF-I in the ovary of the domestic hen.
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PREFACE
The process of ovarian growth and development has been extensively studied.
The developmental events preceding ovulation have an important bearing on
reproductive success and have consequently been the focus of attention for research in
reproduction in man and animals. Despite extensive study, the endocrine and cellular
interactions involved are still not completely understood. In poultry, the ovary differs
from its mammalian counterpart in anatomy, development, control of ovulation and
endocrine interactions. An understanding of ovarian development in poultry is of
particular significance because of the economic importance of egg production.
Insulin-like growth factor-I (IGF-I) is present in the blood of many animals
(Daughaday et al., 1985; Daughaday and Rotwein, 1989) and in many other body
fluids and tissues. It has been shown to regulate the development of cells prior to
ovulation in several mammalian species.
The importance of IGF-I in the growth of chickens has been suggested by the
work of Huybrechts et al. (1985) and Goddard et al. (1988) who showed that IGF-I in
serum increases during chicken growth. The involvement of IGFs in the physiology of
avian reproduction has received little attention in comparison with the mammalian
work. The aims of this study were to elucidate the expression of IGF-I, its receptors




1.1 The Anatomy and Development of The Avian Ovary.
1.1.1. Anatomy of the ovary and early development of follicles
The domestic hen has a single functional ovary which is located in the anterior
of the body cavity, ventral to the aorta, caudal to the vena cava and adjacent to the
cranial extremity of the left kidney and the caudal part of the left lung (King and
McLelland, 1975; Gilbert, 1979; Bahr and Johnson, 1991).
Early in embryogenesis the distribution of germ cells between the right and left
ovary is unequal, with more colonising the left which then becomes larger than the right
one (Gilbert, 1979). From hatching to 4 months the left ovary grows slowly and at this
stage all its oocytes are microscopic in size. As hens become sexually active the ovary
grows enormously from 0.5 to 60 g (Romanoff and Romanoff, 1949; Amin and
Gilbert, 1970). The surface of the left ovary of the laying hen is covered with many
large follicles (shown in Figure 1.1). The avian primary oocyte is the largest single cell
in the animal kingdom (final weight of 20 g in domestic hen) and the avian ovarian
follicle is one of the most rapidly growing structures found in higher vertebrates (King
and McLelland, 1975).
At 8 days of embryonic age, the primordial germ cells begin rapid
multiplication, at this stage they are referred to as oogonia (Romanoff, 1960). Once
these cells reach the prophase of their first meiotic division they become primary
oocytes (Franchi et al., 1962; Baker, 1972), this occurs around the time of hatching.
The granulosa cells, which are derived from the embryonic ovarian epithelium, align
themselves around oocytes between the 4th and 6th day after hatching (Brambell, 1956;
Romanoff, 1960; Franchi et al., 1962; Callebaut, 1976). Other cells, probably derived
from mesenchymal elements, later add to this structure giving rise to the theca
(Brambell, 1956). Within a few weeks of hatch,recognisable follicles about 1 mm in
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Figure 1.1 A photograph of an isolated ovary from a domestic laying hen showing
the five largest pre-ovulatory follicles (F1 - F5).
Figure 1.2 A simplified diagram showing the section through a yellow yolky pre¬
ovulatory follicle in the developing hierarchy. The various cell layers
are labelled.
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diameter have been produced. Each ovary contains several million follicles (Hutt,
1949).
1.1.2. Follicular structure
Follicles provide physical support for oocytes which grow within them: the
structure of the follicular wall is shown in Figure 1.2. The walls of the follicle consist
of a single cell layer of granulosa cells immediately surrounding the plasma membrane
of the yolky oocyte. The granulosa layer is in turn is surrounded by the basal lamina
(which provides physical support and acts as a coarse filter for fluid in the thecal
cavity), then by the theca interna layer which consists of large fibroblasts and terminal
capillaries. In follicles larger than 5 mm diameter steroidogenic interstitial cells are
found in the theca interna, close to the boundary of the two thecal layers (Perry et al.,
1978a). The theca interna is surrounded by the theca externa in which the cells are more
closely packed and consist of spindle shaped fibroblasts interspersed with considerable
quantities of collagen. The thecal layer is surrounded by connective tissue and a
superficial epithelium (King and McLelland, 1975). The thecal layers are well
vascularised, with capillaries extending as far as the border with the granulosa layer
(Rothwell and Solomon, 1977).
1.1.3. Follicular growth
Growth of follicles from 3 to 5 mm takes 3 days, from 5-8 mm, 2 days and
from 8 mm to an ovulable size (35-40 mm) 6 days (Gilbert et al., 1985). There are
between 4 and 7 yellow-yolky follicles with diameters greater than 8 mm in a
developmental hierarchy which are named Fl, the next follicle to ovulate, to Fx, the
smallest (where x is the total number of follicles in the hierarchy). These follicles are
said to be in the "rapid growth" phase
Gilbert et al. (1985) analysed the follicular composition of the ovaries of laying
hens at the peak of lay. They found that in addition to the largest Fl-Fx yellow -yolky
follicles, ovaries contained 30-100 small yolky follicles with diameters in the range 1 to
3
8 mm, 5-25 of these follicles were atretic. In general there were 20 follicles of 1-2 mm
diameter and a single follicle of 7-8 mm and between these groups the numbers of
follicles in other groups were inversely related to their size. This study revealed that
follicular growth is a continuous process which is regulated by differential atresia (see
Section 1.1.5. below). Waddington and Walker (1988) found that the follicles which
grew larger than 8 mm in diameter were most likely to be located in the anterior portion
of the ovary.
As the follicle grows from 1 mm to maturity there is an increase in the oocyte
surface area of about 1000 fold; during the final rapid growth phase (9 mm to 35 mm
diameter) there is a 15-fold increase (Gilbert et al., 1980). The granulosa layer
accommodates this by increasing its own surface area in two ways: an increase in
granulosa cell number of approximately 5-fold and an increase in the surface area of
each cell by approx 3-fold. Within follicles of 1 mm diameter the granulosa cells are
columnar in shape and have the appearance of a pseudostratified epithelium (Bellairs,
1965). As follicles increase in size the granulosa cells change shape to a more flattened
pavement type with a larger surface area (Gilbert et al., 1980). During the rapid growth
phase, adhesion between granulosa cells is reduced, facilitating the transport of yolk
precursors from blood vessels in the theca into the yolk. These changes in the shape of
granulosa cells enable them to maintain a uniform covering of the mature oocyte (Perry
etal., 1978b).
1.1.4. Yolk deposition
Yolk is formed in the liver under the influence of oestrogen and transported to
the ovary as lipoproteins in the blood (Redshaw and Follett, 1972). Yolk deposition
occurs in three phases. The first phase covers the period when the follicle grows from
2.5 to 4 mm in diameter, during this phase the yolk is predominantly white in colour.
The next phase covers growth from 4 to 8 mm diameter, this is a transition where yolk
deposited changes from white to yellow. Most yolk accumulates during growth from 8
mm diameter to ovulation, yellow yolk is deposited in this phase (Griffin et al., 1983).
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The composition of white yolk is high in protein and that of yellow yolk is high in lipid;
yellow yolk is typified by three fractions which contain phosphoproteins, triglyceride-
rich lipoproteins and water soluble proteins (Mackenzie and Martin, 1967; Griffin et
al., 1983). The developmentally-related differences in yolk composition are reflected in
the change in colour of the follicle from white to yellow as the follicle grows to 8 mm
diameter.
1.1.5. Atresia
Atresia is a degenerative process which occurs when a follicle stops growing
prior to ovulation. Gupta et al. (1988) showed that in follicles smaller than 1 mm in
diameter atresia is characterised by resorbtion and that in follicles larger than 1 mm
atresia is accompanied by bursting of the follicle. In the same study it was shown that
in all atretic follicles examined the oocyte nucleus had degenerated, leading them to
suggest that the oocyte is the site at which atretic changes first occur.
The high rate of atresia in follicles between 1 and 8 mm in diameter and the
virtual absence of atresia in follicles greater than 8 mm diameter (Gilbert et al., 1983;
1985) suggests that this process controls the numbers of follicles in the smaller
population thus constraining the numbers of follicles which may develop to a size
greater than 8 mm diameter to one per day; in this way differential atresia creates the
hierarchy. Recent work by Tilly et al. (1991) has shown that DNA fragmentation
occurs in the cells of atretic but not healthy pre-ovulatory follicles. This is a feature of
apoptosis or programmed cell death, caused by Ca2+/Mg2+-dependent endonuclease
(Wyllie, 1980), thus suggesting that atresia is an apoptotic process; however, the
factors which trigger this process are not yet known.
1.1.6. Ovulation and oviposition in the hen
The ovulatory cycle of the hen varies in duration between 24 and 40 hours
(Etches, 1990). Ovulation is restricted to a portion of the day known as the "open
period" which lasts for approximately 8 hours in chickens (Etches and Schoch, 1984).
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Mature follicles occurring outside this period must wait for the next one before they can
ovulate, this results in gaps in the laying sequence, referred to as pause days. Fraps
(1955) proposed an hypothesis suggesting that the "open period" is caused by a
circadian rhythm of hypothalamic sensitivity to an ovulatory signal from the ovary.
Further work investigating this hypothesis has shown that progesterone produced by
the largest follicle during the LH surge initiates a positive feedback response from the
hypothalamus to increase the secretion of GnRH which triggers an increase in the
secretion of LH from the adeno-hypophysis. This, in turn, augments the production of
progesterone from the largest pre-ovulatory follicle which then builds a pre-ovulatory
cascade of progesterone and LH release (Furr and Smith, 1975; Wilson and Sharp,
1975; 1976; Etches and Cunningham, 1976; Johnson et al., 1985). During the "open
period" the hypothalamus is believed to increase its sensitivity to the positive feedback
actions of progesterone. Although oestrogen is a prerequisite for inducing hypothalamic
responsiveness to the stimulatory action of progesterone on LHRH release, it does not
create the increased responsiveness to progesterone in the "open period".
Reduction division of the primary oocyte to form the secondary oocyte and the
first polar body is completed approximately 2 hours before ovulation. The second
maturation spindle then starts to form but mitosis is arrested in metaphase, the division
being completed after ovulation and penetration by the sperm (Olsen, 1942). The
physical aspects of ovulation are the rupture of the follicle wall in the stigma region
followed by expulsion of the yellow yolky oocyte. It has been proposed that the stigma
region has a lower tensile strength than the surrounding region due to collagen fibres
running parallel with the stigma axis rather than being intertwined (Fuji et al., 1979).
Proteolytic enzymes and collagenase are involved in the dissociation of collagen fibres
at this time (Ogawa and Goto, 1984).
The secondary oocyte enters the infundibulum where sperm penetration occurs
15 minutes later. From there the fertilised ovum passes through the magnum, isthmus,
shell gland, where it stays for 18-20 hours as the shell is laid down, and finally the
vagina.
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Oviposition follows approximately 24-26 hours after ovulation, the next
ovulation in a sequence occurs 15-45 minutes after oviposition (Warren and Scott,
1935). Hens lay eggs daily, forming sequences punctuated by a pause days. These
sequences may range in length from 2 to 200; as hens age, the sequence lengths
decrease (Bahr and Johnson, 1991).
1.2. Endocrinology Of The Avian Ovary
1.2.1. The ovulatory cycle of mammals and birds
The process of ovulation and the associated ovarian steroidogenesis in birds
differs in many details from mammals (Gilbert, 1971; Gilbert and Wells, 1984; Bahr
and Johnson, 1991). The events of the ovulatory cycle in poultry occur over hours
whereas in mammals the oestrous cycle occurs over a more prolonged period. In
mammals the cycle is composed of follicular and luteal phases, in poultry there is no
luteal phase since the hormonal support provided by a corpus luteum during pregnancy
is not required. In hens the follicular cells appear to have different steroidogenic roles
compared with mammals.
1.2.2. The effects of gonadotrophins on ovarian function
The effects of gonadotrophins can be divided into those which are steroidogenic
and mitogenic in nature. LH causes increased progesterone secretion by granulosa cells
and progesterone is itself responsible for inducing a pre-ovulatory LH surge and
ovulation in the chicken (Fraps, 1955; Etches and Cunningham, 1976; Johnson and
van Tienhoven, 1984; Lang et al., 1984; Robinson et al., 1988). LH also stimulates
production of oestradiol and androstenedione in thecal cells (Marrone and Hertelendy,
1985). FSH induces the theca to secrete predominantly androstenedione (Robinson et
al., 1988). Oestradiol is also secreted by the theca of domestic hens when stimulated
with ovine FSH, calcium has been shown to be an important mediator in this
steroidogenic action of FSH (Ognasbesan and Peddie, 1989). Scanes et al. (1977)
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reported a rise in concentrations of circulating FSH at approximately 14-15 hours prior
to ovulation. However, the measurement of chicken FSH is not very reliable therefore
the precise role of this gonadotropin in preovulatory events is not clear.
The presence of FSH receptors and a responsive adenylyl cyclase system in the
ovary has led to speculation that it is involved in follicular selection and growth (Calvo
and Bahr, 1983; Ritzhaup and Bahr, 1987). More recently, Yoshimura and Tamura
(1988,1991) have shown that both FSH and LH significantly promote the proliferation
of chicken granulosa cells in vitro, they also showed that dibut^i cAMP has a similar
effect. These studies suggested that the gonadotrophins stimulate proliferation of
granulosa cells via cAMP, a recognised gonadotrophin second messenger (Richards,
1980).
1.2.3. Ovarian steroids
In poultry it has been determined that preovulatory peaks of oestrogen,
progesterone and LH occur simultaneously approximately 4-6 hr prior to ovulation
(Wilson and Sharp, 1973; Johnson and van Tienhoven, 1980a,b).
The majority of oestrogens produced by the ovary of the laying hen are the
product of the small follicles, less than 10 mm diameter (Senior and Furr, 1975;
Robinson and Etches, 1986), the rest being produced by the larger follicles. One of the
major functions of oestrogens is to sensitize the hypothalamic-pituitary axis to the
positive feedback effects of progesterone. (Wilson and Sharp, 1976 - see Section
1.1.6.). Other functions include the stimulation of vitellogenin formation in the liver
(Redshaw and Follett, 1972), regulation of calcium metabolism (Etches, 1987), and the
maintanence of a functional oviduct and secondary sexual characteristics.
Progesterone is produced by granulosa cells in the five largest preovulatory
follicles, this production is stimulated by LH in vitro. (Etches et al., 1983). It has been
shown to have a direct role in ovulation, specifically in follicular wall breakdown
(Tanaka et al., 1987). Progesterone is also required for albumin secretion (Bahr and
Johnson, 1991).
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Androgens are produced by the small ovarian follicles and all but the largest of
the large yolky follicles (Bahr et al., 1983; Robinson and Etches, 1986). The main
source of these steroids is the thecal layer although the granulosa cells produce small
amounts. Androgens have been shown to induce ovulation in chickens at supra-
physiological levels (Fraps, 1955a; Croze and Etches, 1980) and passive immunisation
with anti-testosterone serum has been shown to block ovulation (Furr and Smith,
1975). The action of androgens in the ovary are possibly due to the structural similarity
of testosterone and progesterone.
1.2.4. Steroidogenesis in the developing follicle
As follicles mature in the final growth phase, progesterone production by the
granulosa cells increases and production of androgens and estradiol by the thecal cells
decreases (Huang et al., 1979; Etches et al., 1981; Bahr et al., 1983; Etches and Duke,
1984). The granulosa cells of small follicles (F5-F3) have more FSH receptors and
produce more progesterone in response to FSH than the granulosa cells of the larger
follicles (F1-F2) (Hammond et al., 1981; Calvo & Bahr, 1983; Ritzhaup & Bahr,
1987). In contrast the granulosa cells of the larger follicles are primarily regulated by
LH (Calvo et al., 1981; Hammond et al., 1981) Therefore as follicles mature, they
progress from an FSH to an LH dominated phase. This alteration in the responsiveness
of granulosa cells to FSH and LH is similar to that observed in mammals. Recent work
shows that the number of LH receptors in thecal layers drop suddenly on the day of
ovulation in japanese quail (Kikuchi and Ishii, 1992); this may account for the drop in
production of androgens and oestragen by the theca prior to ovulation (Marrone and
Hertelendy, 1985). Following ovulation a post-ovulatory follicle is formed that
contains functional granulosa cells, which secrete progesterone; however, the cells of
this follicle do not luteinize.
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1.2.5. Ovarian cell-cell interactions
An alternative to the two-cell model established for steroid production within the
mammalian ovarian follicle (Armstrong and Dorrington, 1977) in which thecal cells
produce androgen substrates for granulosa cell synthesis and secretion of oestradiol,
has been proposed for steroid production in the chicken ovary (Huang et al., 1979). In
the avian two-cell model, granulosa cells are the source of progesterone (production of
which is LH dependent) which is then used by the thecal cells to produce androgens
and oestrogens under the influence of FSH. This model has been elaborated into a
three-cell model (Porter et al., 1989) which suggests that progesterone is converted to
testosterone in the theca interna cells and that the theca externa cells convert androgens
(including testosterone) into oestradiol by aromatisation. A recent study of the
expression of steroidogenic enzymes in the follicle by Nitta et al. (1991) broadly
supports this theory and also showed that cells in the theca externa are also capable of
androgen synthesis.
Perifusion of granulosa layers taken from the largest follices (Fl) at different
times before they are due to ovulate with LH results in similar progesterone production.
However, the co-incubation of theca and granulosa layers from a relatively immature
Fl follicles (8 hours of age) results in a suppression of progesterone secretion, whereas
co-incubation of these layers from a more mature follicle (32 hours of age) does not
(Johnson et al., 1987). Lee and Bahr (1990) found that progesterone production by
granulosa cells is suppressed by testosterone and estradiol which act as competitive
inhibitors of the enzymes which catalyze progesterone synthesis (P450 side chain
cleavage and 3B-HSD). These two studies show that thecal and granulosa cells interact
in the regulation of follicular steroidogenesis.
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1.3. The Insulin-Like Growth Factors
1.3.1. The somatomedins
The discovery of insulin-like growth factors has several origins. Daughaday
and co-workers observed that in hypophysectomised rats, sulphate uptake into cartilage
in vivo was lower than that in intact rats; however, this deficiency was restored by the
administration of growth hormone (GH) (Murphy et al., 1956). Following this study,
it was found that serum from hypophysectomised rats administered with GH restored
the sulphate incorporation into cartilage in vitro to normal levels; however, treatment of
the cartilage with GH in vitro did not stimulate sulphate uptake (Salmon and
Daughaday, 1957). This led the investigators to consider the possibility that the effects
of GH were mediated through an intermediate component of serum for which the term
"sulphation factor" was proposed. This group then went on to show that sulphation
factor effects included the stimulation of collagen synthesis (Daughaday and Mariz,
1962), DNA synthesis (Daughaday and Reeder, 1966) and RNA synthesis (Salmon
and DuVall, 1970).
Sulphation factors were first purified by Hall (1972), who, by using bioassays
which measured the incorporation of thymidine into cartilage, the insulin-like effects on
epidydimal fat (the oxidation of glucose) and the incorporation of sulphate into
cartilage, discovered that thymidine factor and insulin-like activity co-purified with
sulphation factor. The implication of these experiments was that all three effects were
caused by the same molecule. Neutral and basic forms of the peptide were separated
and designated somatomedin A and C respectively (Daughaday, 1983).
1.3.2. Non-suppressible insulin-like activity
The second observation which led to the discovery of IGFs was that glucose
uptake by the rat diaphragm or adipose tissue was stimulated by serum as if in the
presence of insulin (Martin et al., 1958; Renold et al., 1960); but when anti-insulin
serum was added 90% of this activity remained (Froesch et al., 1963). This activity
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was then termed "non-suppressible insulin-like activity" (NSILA) and it was measured
in a bioassay using rat adipose tissue.
The large scale extraction of soluble NSILA (NSILA-s) from Cohn fraction IV
was described by Froesch (1983). The resulting crude preparation was purified by
Rinderknecht and Humbel (1978 a; b), who isolated two polypeptides, IGF-I and IGF-
II in sufficient quantities to determine their amino acid sequences. They found that both
peptides closely resembled insulin.
1.3.3. Multiplication stimulating activity
The third observation which led to the discovery of IGFs derives from studies
by cell biologists attempting to purify and characterise serum macromolecules required
for the multiplication of cells in culture. Insulin was found to stimulatory mitotic
activity in tissue cultures in early experiments by Gey and Thalheimer (1924) leading to
Temin's observations that insulin could partially replace the serum requirement for the
multiplication of chick embryo fibroblasts. However, concentrations of insulin much
higher than those found in serum were required (Temin, 1967). These experiments led
Pierson and Temin (1972) to search for the serum factor(s) responsible for these
insulin-like effects and resulted in the extraction of a low molecular weight fraction
which was described as multiplication stimulating activity (MSA). MSA was capable of
stimulating DNA synthesis in chicken embryo fibroblasts and possessed insulin-like
activity which was not suppressed by insulin antiserum. Analysis of MSA extracted
from BRL-3A (buffalo rat liver cell line) conditioned medium by isoelectric focussing
and acrylamide gel electrophoresis revealed a family of polypeptides ranging from 7100
to 16250 Da. Two of the species were 7100 Da; it was proposed that the sequences of
these species were contained within the larger forms. Marquardt et al. (1981) reported
the amino acid sequence of a 7,484 Da species of MSA purified from BRL-3A cell line
and found it to have only 5 amino acid differences with human IGF-II. They therefore
concluded that MSA is the rat homologue of human IGF-II.
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1.4. IGF Structure
1.4.1. IGF-I peptide structure
The insulin-like growth factors are a family of growth factors so named because
of their structural and functional similarity to insulin. IGF-I and IGF-II are single chain
polypeptides, the mature peptides consisting of 70 and 67 amino acids respectively.
IGF-I, IGF-II and insulin are all synthesized from single-chain precursors. Human
IGF-I is formed from pre-pro-IGF-I by proteolytic processing at both ends. Similarly
IGF-II is formed from human pre-pro-IGF-II. Pre-pro-insulin is cleaved to form pro-
insulin in the endoplasmic reticulum, subsequent conversion to insulin involves
removal of the C peptide by proteolysis (Steiner, 1977). The formation of insulin from
its precursors differs from that of IGF-I and -II since the C-peptides are not removed
from them. The amino acid sequences of both human (h)IGF-I and hIGF-II were first
determined and published by Rinderknecht and Humbel (1978 a; b) who deduced
structural and evolutionary implications which are summarised in Section 1.4.3. below.
The molecular weights calculated from the amino acid sequences were 7649 Da
for IGF-I and 7471 Da for IGF-II. There is considerable sequence homology between
IGF-I and IGF-II (62%) and the sequences of both closely resemble insulin, 45% of
amino acids in these peptides are located in the same positions as in human insulin and
the 3 di-sulphide bonds are in the same place in all 3 peptides. Of the 19 invariate
residues in insulins, 17 of them are identical in both hIGF-I and hIGF-II; the regions of
homology between insulin and IGF-I were identified as the A and B chains of the
molecules. Three dimensional models of these molecules have been constructed which
indicate that they differ in their antigenic domains (Blundell et al., 1978; Blundell et al.,
1983), the probable reason for the lack of binding of IGF-I to anti-insulin antibodies
and vice-versa.
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1.4.2. Comparisons of IGFs from different species.
Since the initial sequencing of the human peptide, the amino acid sequences of
IGF-I and IGF-II have been elucidated for a number of organisms including the rat,
cow, pig, sheep and chicken (Marquardt et al., 1981; Honegger and Humbel, 1986;
Shimatsu and Rotwein, 1987; Francis et al., 1988; 1989a; 1989b; Dawe et al. 1988;
Armstrong et al., 1990; Ballard et al., 1990) Bovine and porcine IGF-I have identical
sequences to that of the human peptide, in the case of sheep there is a single difference.
In rats and mice IGF-I differs from human IGF-I in three and four amino acid positions
respectively (Bell et al, 1986; Shimatsu and Rotwein, 1987). Chickens IGF-I differs
from human IGF-I in eight amino acid positions (Ballard et al., 1990). These small
inter-species variations in the amino acid sequences of IGFs have led to the suggestion
that the peptide plays a fundamentally important biological role (Daughaday and
Rotwein, 1989).
1.4.3. Chicken IGF peptides
Dawe et al. (1988) purified IGF-I and IGF-II from chicken serum and partially
analysed their amino acid sequences. The N-terminal 31 amino acid sequence showed a
single substitution at positions 26 with respect to the human peptide. Further analysis
of purified IGF-I by Ballard et al. (1990) revealed that there were 8 amino acid
differences between chicken and human IGF-I at positions 26, 38, 39, 40, 41, 50, 64
and 6. Dawe et al. (1988) also partially sequenced two IGF-II variants, one of which
had an identical N-terminal hexapeptide to mammalian IGF-II, the N-terminal
hexapeptide of the other was considerably different. This was thought to be a result of
alternative mRNA splicing. Further analysis of purified cIGF-II by Kallincos et al.
(1990) found only the cIGF-II variant with the different hexapeptide. They showed that
there were marked differences between the amino acid sequences of chicken and
mammalian IGF-II especially near the N-terminus, as previously described, and
between residues 32 and 40.
1 4
1.4.4. Evolution of the IGFs
Rinderknecht and Humbel (1978a;b) found that there were fewer differences
between the insulins of major vertebrate classes (birds, reptiles, fish, mammals) than
between hIGF-I and these insulins; they also found that the degree of identity between
human and rattlesnake insulin and that of the corresponding A and B domains of IGF-I
and -II is the same (76%). This led them to suggest that the gene encoding the common
ancestor of pro-insulin and IGF-I may have been duplicated before the appearance of
vertebrates (600 million years ago).
1.4.5. The IGF-I and IGF-II genes
The characterisation of a cDNA encoding IGF-I was first described by Jansen et
al. (1983), who screened a human adult liver cDNA library with chemically synthesized
oligonucleotides. One of the clones obtained contained an open reading frame of 470
nucleotides, 210 nucleotides of which corresponded to the complete amino acid
sequence of IGF-I. The cDNA contained flanking nucleotide sequences corresponding
to amino acid residues at both the amino-terminal and carboxy-terminal peptide ends.
This suggested that the hIGF-I peptide is synthesized as a precursor (130 amino acids
in length) which then undergoes proteolytic processing to form the mature IGF-I
peptide, similar to the situation with proinsulin and insulin.
Rotwein (1986) isolated another IGF-I cDNA (IGF-IB) from an adult human
liver cDNA library encoding a different C-terminal peptide from that isolated by Jansen
et al. (1983) (IGF-IA). Studies have shown that the human IGF-I gene consists of at
least five exons of which exons 1, 2, 3 and 5 make up IGF-IA cDNA and exons 1, 2, 3
and 4 make up IGF-IB cDNA. These arise by alternative splicing (Rotwein et al.,
1986).
IGF-II cDNA clones were first isolated from human liver (Bell et al., 1984) and
rat liver (Dull et al., 1984) cDNA libraries. Analysis of these clones led to the
prediction that the gene encodes a 180 amino acid precursor molecule (preproIGF-II)
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within which the mature IGF-II amino acid sequence (67 amino acids) was located 25
residues from the NH^-terminal of the larger molecule.
Kajimoto and Rotwein (1990) have cloned and sequenced IGF-I cDNA from
Xenopus iaevis for which the predicted primary translation product is 153 amino
acids. This consists of the sequence of the mature protein flanked by an NH2-terminal
sequence of 48 amino acids and a COOH-terminal sequence of 35 amino acids and
indicates that the IGF-I protein precursor has been conserved during vertebrate
evolution.
Since the original cloning of IGF-I and IGF-II gene sequences described above,
the IGF-I and IGF-II genes have been cloned in a number of species including mouse
(Stempien et al., 1986), chicken (Kajimoto and Rotwein, 1989; Fawcett and Bulfield,
1990; Taylor et al., 1991), sheep (Dickson et al., 1991), pig (Tavakkol et al., 1988)
and Xenopus (Kajimoto and Rotwein, 1990).
1.4.6. The chicken IGF-I gene
Chicken IGF-I cDNA clones have been sequenced independently by two
groups. Kajimoto and Rotwein (1989) isolated and sequenced a chicken IGF-I cDNA
814 nucleotides in length. This sequence led them to suggest that pre-pro chicken IGF-
1 resembles mammalian IGF-1A precursors in both length and sequence. The sequence
of the mature cIGF-I predicted from the cDNA clones was 70 amino acids in length, 8
of which were different from hIGF-I, agreeing with the sequence published by Ballard
et al. (1990) described above. In the COOH-terminal E domain, 30 of the 35 residues
are identical between chicken and human, the 48 amino acids at the NH2-terminal
showed less homology (77%) with the human counterpart. Further work led this group
to suggest that the gene is composed of 4 exons which are transcribed and processed
into mRNAs of sizes 1.9 and 2.6 kb (Kajimoto and Rotwein, 1991).
Fawcett and Bulfield (1990) isolated an 860 b.p. cDNA clone from a chicken
liver cDNA library with a sequence analagous to human exons 1,2,3 and 5 (similar to
hIGF-IA cDNA) with an additional exon (la) between exons 1 and 2. In another clone
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they found evidence of exons 1 and 2 spliced together without la in between, implying
that there is alternative splicing of cIGF-I mRNAs. The additional exon la was not
reported by Kajimoto and Rotwein (1989). Northern blot analysis with a probe
constucted from the 860 b.p.cDNA revealed a major transcript of 0.65-0.85kb with
other bands of 9.5, 8.4, 4.1, 3.6, 3.1 and 1.65-1.75kb. This pattern is quite different
from that obtained by Rotwein's group. The amino acid sequence deduced from the
860 b.p cDNA clone of Fawcett and Bulfield (1990) predicts a 130 amino acid peptide
in which cIGF-I is flanked by a leader peptide (25 amino acids) and an E peptide (35
amino acids). The predicted mature cIGF-I sequence (70 amino acids) was identical to
that described by Kajimoto and Rotwein (1989).
1.4.7. The chicken IGF-II gene.
Chicken IGF-II cDNA has been cloned recently. Taylor et al. (1991) screened a
chicken embryo cDNA library with a human IGF-II probe containing the complete
coding region for prepro-IGF-II. They isolated a clone with a high degree of homology
with the second exon of the IGF-II genes in humans, mice and rats. The predicted
amino acid sequence from the clone was the same as one of the partial amino acid
sequences obtained by Kallincos et al. (1990), the other C-terminal sequence being
identical to those in all other species studied so far. When this sequence was used to
probe RNA extracted from chick embryos, four transcripts were identified with sizes of
1.4, 2.2, 4.7 and 7 kb, the most abundant was the 4.7 kb form. This range of
transcripts is similar to that seen in humans and rats. The existence of multiple
transcripts indicates the use of alternative promoters, polyadenylation sites and
alternative splicing patterns for these transcripts (Sussenbach, 1989). Interestingly,
Taylor's group describe the expression of antisense RNA transcripts from the cIGF-II
gene. There has been speculation that the these could regulate the level of protein
synthesis.
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1.4.8. The IGF-I gene promoter
The IGF-I promoter region is yet to be fully elucidated. However, Dickson et
al. (1991) found that in the sheep, IGF-I mRNA transcription initiated from a point
within exon 1 A. Kajimoto and Rotwein (1991) identified several transcription initiation
sites at the 5' end of the cIGF-I gene within a 74-nucleotide portion of exon 1 that was
found to be highly conserved between chickens and mammals. This putative IGF-I
promoter when fused with a reporter (luciferase) gene caused enhanced luciferase gene
expression, providing evidence of the function of this sequence (Kajimoto and
Rotwein, 1991).
1.5. IGF Receptors
The IGFs and insulin elicit similar biological responses including the
stimulation of fibroblast DNA synthesis and adipose cell glucose metabolism. These
responses are typically non-additive, suggesting that the effects are mediated through
the same receptor (Renold et al., 1960; Froesch et al., 1963; Morell and Froesch,
1973).
When partially purified preparations of IGFs became available they were
radiolabeled and used to demonstrate specific receptors in placental and liver
membranes and fibroblasts (Marshall et al., 1974; Megyesi et al., 1974; Takano et al.,
1975; Zapf et al., 1975). Receptors for IGFs and insulin preferentially bind the
homologous ligand (Rechler et al., 1980; 1983). Insulin receptors have a weak affinity
for IGFs and IGF receptors to have a weak affinity for insulin. Additionally insulin
cross-reacts with IGF receptors in some tissues but not in others. This situation was
clarified in studies using purified IGF-I and -II which revealed that these peptides bind
to two distinct receptor sites in rat liver cells (Rechler et al., 1980; Nissley et al., 1983).
Radiolabeled IGF-I binding is inhibited by IGF-I, IGF-II and insulin in decreasing
order of potency. Radiolabeled IGF-II binding to receptors is inhibited by IGF-II and
high concentrations of IGF-I but not by insulin. Thus IGF receptors are defined by
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Figure 1.3 Comparison of the structures of human insulin and IGF type-I
receptors. The a and (3 subunits are appropriately marked. Cross-
hatched boxes indicate regions of high cysteine residue concentration.
Single cysteine residues are shown as black circles. Open boxes
indicate tyrosine kinase domains. Ullrich et al.,. 1986.
19
are known as type I and type II receptors, although some authors refer to the type I
receptor as an IGF-I receptor and the type II as an IGF-II receptor. Rosenfeld et al.
(1987) compared cross-reactivity of IGF-I preparations of different purities with the
type II receptor and found that the purest IGF-I did not bind to this receptor, leading
them to suggest that the previous findings were due to the use of IGF-I preparations
which were contaminated with IGF-II.
1.5.1. Receptor structure
1.5.1.1. Type I IGF receptors
The two IGF receptors have been identified by affinity cross-linking studies in
which radio-labelled ligands were cross-linked to their respective receptors and then
analyzed by SDS PAGE. The type I receptor was found to consist of alpha (a) and beta
(P) subunits. The a subunit is 130 kDa in size (Kasuga et al., 1981; Massague et al.
1981; Rechler et al. 1983) and the P subunit is 90 kDa (Jacobs et al., 1983; Kull et al.,
1983). Massague and Czech (1982) presented evidence to show that the type I receptor
consists of two a subunits and two P subunits connected by disulphide bonds to form
a P-a-a-P heterotetromeric complex (Figure 1.3.).
More detailed analysis of structure was made possible when cDNA was cloned
from purified receptors. Ullrich et al. (1986) deduced the amino acid sequence of the
type I receptor from its cDNA and used it to predict that the a subunit is completely
extracellular and that the P-subunit has both intracellular and extracellular domains (see
Figure 1.3); A similar structure has been described for the insulin receptor (Ullrich et
al., 1985; Ebina et al., 1985). In the IGF type I and insulin receptors, the a-subunit
contains a cysteine-rich region showing less sequence identity than the surrounding
region, suggesting that it is involved in determining the specificity of ligand binding to
these receptors. The cytoplasmic domain in type I and insulin receptors contains a
region homologous with other tyrosine-specific kinases (Ullrich et al., 1985; Ebina et
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al., 1985), this is the region most homologous with the insulin receptor and also
contains the consensus sequence for an ATP binding site.
Phosphorylation of the (3 subunit of the type-I receptor is enhanced by IGF-I or
by large doses of insulin. Studies with antibodies against receptors, showed that the
tyrosyl kinase activity responsible for phosphorylation is intrinsic to the type-I receptor
or tightly associated with it (Jacobs et al., 1983b).
1.5.1.2. Type II IGF receptor
In contrast to the type I receptor, the type II receptor is composed of a single
polypeptide ofMr 250 kDa (August et al., 1983; Oppenheimer et al., 1983). It has no
sequence homology with either the type I or the insulin receptor (Morgan et al., 1987),
in fact the sequence is 80% identical with the bovine cation independent-mannose-6-
phosphate receptor and studies have shown that these receptors are indeed the same
protein (Roth, 1988); 93% of the type II receptor is an extracellular domain and there is
no cysteine-rich region.
The type II receptor polypeptide is phosphorylated when rat liver cells are
stimulated with IGF-II. Since phosphorylation was not observed in solubilised type II
receptors, it seems that the type II receptor does not possess intrinsic protein kinsase
activity (Haskell et al., 1984).
1.5.2. The regulation of IGF receptors
Rosenfeld et al. (1982b) incubated lymphocytes with IGF-I and noted a
reduction of radiolabeled IGF-I binding which, as shown by Scatchard analysis, is
caused by a decrease in receptor number. IGF-I, IGF-II and insulin regulate receptor
number in proportion to their ability to inhibit rIGF-I binding (i.e in order of potency
IGF-I > IGF-II > insulin), suggesting that down-regulation depends on receptor
occupancy. IGF-I and insulin have similar effects on type I receptors on human skin
fibroblasts (Rosenfeld and Dollar, 1982).
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Incubation of mouse muscle cells with IGF-I, IGF-II or insulin does not down-
regulate type II receptors (De Vroede et al., 1984); however, incubation of rat
adipocytes with insulin causes an increase in IGF-II binding to type II receptors
(Schoenle et al., 1976; King et al., 1982; Oppenheimer et al., 1983). Wardzala et al.
(1984) showed that IGF type II receptors are re-cycled, but when recycling is blocked
by KC1, insulin treatment increases the number of type II receptors. The increased
binding of IGF-II to adipose cells treated with insulin, therefore, appears to involve a
redistribution of type II receptors cycling between an intracellular pool of receptors and
the plasma membrane.
Lin et al. (1988) found that treatment of rat Leydig cells with hCG, FSH or GH
causes an increase in their IGF-I binding capacity which is due to an increase in
receptor number rather than affinity. Adashi et al. (1988b) also showed that FSH
increases IGF-I receptor number on rat granulosa cells, and that the increased IGF-I
binding caused by this treatment was enhanced by simultaneous treatment with GH.
1.5.3. IGF receptors in chickens.
Binding sites for IGF peptides have been found in embryonic chicken tissues
including fibroblasts and hepatocytes (Rechler et al., 1980; Widmer et al., 1985).
Cross-linking studies have shown the presence of an IGF binding site in chicken
tissues similar to the type I receptor (Kasuga et al., 1982); however, no evidence has
been found for the existence of a type II receptor (Bassas et al., 1988; Canfield and
Kornfeld, 1989; Duclos et al., 1991). Duclos and Goddard (1990) examined binding
sites for IGF peptides in liver microsomal membranes from young chickens and found
that IGF-II has a greater affinity for the receptor than IGF-I but that insulin is also a
potent competitor; affinity cross-linking revealed the presence of a 130 kDa polypeptide
characteristic of the type I receptor. The evidence suggests that the biological effects of
both IGF peptides are mediated through this 'type I' receptor in chickens. Recently,
Huybrechts et al. (1991) have reported the presence of a type I receptor in chicken
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granulosa cells which has equal affinity for IGF-I and -II and a lower affinity for
insulin.
1.6. IGF Binding Proteins
1.6.1. IGF-binding protein complexes
The IGF peptides have a molecular weight of 7.5 kDa, but in plasma, serum
and other extracellular fluids they are present in both small (30-40 kDa) and large (150
kDa) macromolecular complexes which consist of peptides in association with specific
binding proteins (Zapf et al., 1975b; Hintz and Liu, 1977). The structures of these
complexes are illustrated in Figure 1.4. The 150 kDa complex consists of three
subunits (Baxter and Martin, 1989): an acid labile protein, which appears as a doublet
of 84 and 86 kDa on SDS-PAGE (Baxter et al., 1989); an acid stable binding protein
and an insulin-like growth factor (-1 or -II). In human serum there are two forms of the
acid stable protein which have molecular weights of 41.5 and 38.5 kDa respectively
(Martin and Baxter, 1986). These represent different glycosylated forms of the protein
now known as IGFBP-3. The smaller complexes consist of IGFs with acid stable
binding protein subunits which have been named IGFBP-1 to IGFBP-6 (Binoux et al.,
1991; Shimasaki and Ling, 1992). The numbers refer to the chronological order in
which they were characterised.
As described above, there are two main types of IGF-binding protein
complexes. The 150 kDa complex barely crosses the capillary barrier from serum,
making its availability to tissues less than the smaller 40 kDa complexes, which cross
more easily (Binoux and Hossenlopp, 1988). The half life of IGF is 12-15 hours when
associated with the 150 kDa complex, 20-30 minutes with the smaller (40 kDa)
molecular weight complexes and 10 to 12 minutes as the free peptide (Guler et al.,
1989). Thus, the way in which IGFs are complexed to their binding proteins could
determine their availibility to tissues and their stability. The view that binding proteins
control the supply of IGF-I to tissues, is supported by the study of Lassare et al.
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(1991). This showed that the serum of human foetuses and newborn children contains
small amounts of IGFBP-3-sized proteins (components of the 150 kDa complex),
compared with adult serum; and larger amounts of the smaller IGF binding proteins
(components of the 40 kDa complexes). Thus, where the growth rate is high, the type
of IGF binding proteins present appear ensure the maximum supply of IGF-I at the
tissue level.
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Figure 1.4. The structures of the circulating 150 kDa (1.) and 40 kDa
(2.) binding protein comlexes.
1.6.2. Binding protein structure
The binding protein subunits have been the focus of intense investigation in
recent years. So far 6 of the smaller binding protein complex subunits have been
identified and named in human and rat, and these are described below. Full-length
clones encoding the acid-labile subunit have recently been isolated from human liver
cDNA libraries, the predicted mature protein sequence is 579 amino acids in length.
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These clones have been fuctionally expressed in mammalian tissue culture cells (Leong
etal, 1992)
1.6.2.1. IGFBP-1
The first IGF binding protein gene to be cloned and sequenced coded for
IGFBP-1 (Brewer etal., 1988; Brinkman etal., 1988; Julkunen etal., 1988; Lee etal.,
1988). The cDNA sequence of human IGFBP-1 predicts a mature protein of 234 amino
acids and a moecular weight of 25.3 kDa. The apparent molecular mass of the purified
protein is 28 kDa (Baxter et al., 1987). The deduced amino acid sequence of rat
IGFBP-1 shows 66% homology with the human sequence (Murphy et al., 1990).
1.6.2.2. IGFBP-2
The second IGF binding protein to be cloned and sequenced was named
IGFBP-2 (Brown et al., 1989; Margot et al., 1989; Binkert et al., 1989). It has less
than 40% homology with hIGFBP-1 and a predicted molecular weight of 31.3 kDa.
1.6.2.3. IGFBP-3
The sequence deduced for the third IGF binding protein, IGFBP-3, predicts a
mature protein of molecular mass 28.7 kDa (Wood et al., 1988; Shimasaki et al.,
1990a; Albiston and Herrington, 1990). Analysis of the purified protein in human
serum shows two bands at 41.5 and 38.5 kDa which are differently glycosylated forms
of IGFBP-3 (Binoux et al., 1991). Enzymatic removal of N-linked carbohydrate on
IGFBP-3 yields a product of apparent molecular mass about 35 kDa, suggesting that
the deglycosylated protein behaves anomalously on SDS-PAGE or that N-glycanase
does not fully deglycosylate the protein (Baxter, 1991).
1.6.2.4. IGFBP-4, -5 and -6
The fourth, fifth and sixth binding proteins, IGFBP-4, IGFBP-5 and IGFBP-6
have been cloned and sequenced by Shimasaki and co-workers (Shimasaki et al.,
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1990a; 1991a;b). The sequence predicted for hIGFBP-4 is 237 amino acids with a
molecular weight of 25.7 kDa; rat IGFBP-4 is 4 amino acids smaller, both proteins
contain a potential Asn-linked glycosylation site. The sequence predicted for both
human and rat IGFBP-5 consists of 252 amino acids with 97% homology, the
predicted weights of the mature proteins are 28.4 kDa (rat) and 28.5 kDa (human). The
sixth binding protein (IGFBP-6) sequence consists of 216 amino acids for human and
201 for rat with predicted masses of 22.8 kDa and 21.5 kDa, respectively. The
sequence for the human protein predicts an Asn-linked glycosylation site.
1.6.2.5. Comparisons of the stuctures of the IGFBPs
The six IGF binding proteins identified so far are distinct members of family of
related proteins: features of homology are 18 cysteine residues and conserved amino
acid sequence in the amino and carboxyl ends (Rechler and Nissley, 1990; Shimasaki
and Ling 1992). IGFBP-6 is slightly anomalous in that it lacks 2 and 4 of the 18
cysteine residues in the rat and human proteins respectively (Shimasaki et al., 1991b).
The deduced amino acid sequence also permits insights into the possible functions of
these binding proteins. For example, both IGFBP-1 and -2 contain an arg-gly-asp
(RGD) sequence (Julkunen et al., 1988; Brown et al., 1989; Binkert et al., 1989)
which has been shown to be important in other proteins such as fibronectin and
collagen for interaction with integrins, a superfamily of structurally-related receptors,
characterised by their abililty to bind ligands containing the RGD tripeptide (Ruoslahti
and Pierschbacher, 1987). The presence of RGD in these binding proteins could
enhance IGF-I action by aligning the binding protein-IGF complex with the IGF
receptor on cells which have integrins on their surfaces. This hypothesis could explain
non-enhancing or inhibitory effect of IGFBP3 on IGF action (described in Section
1.6.4.1. below) since its stucture does not contain an RGD sequence.
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1.6.3. IGFBP Expression
IGF-binding proteins are expressed in a number of tissues.
Immunocytochemical studies in human fetal liver, lung, muscle, kidney, intestine,
pancreas, adrenal, skin, bone / growth plate and thymus tissues (Hill et al., 1989b)
demonstrated that the cellular distribution of a 26 kDa IGF binding protein and IGF
peptides is similar, suggesting that IGFs exist in bound form in, or adjacent to, their
sites of action. IGFBP-2 mRNA is found in multiple fetal rat tissues and in adult brain
stem, hypothalamus and cerebral cortex (Ooi et al., 1990) and in human cerebro-spinal
fluid (Romanus et al., 1989). Endometrial and breast carcinoma cell lines secrete
IGFBP-1, -2 and -3 (Camacho-Hubner et al., 1991). Northern analysis of IGFBP-6
mRNA expression shows it to be present in multiple rat tissues indicating a ubiquitous
nature (Shimasaki et al., 1991). IGFBP mRNA has been shown to be expressed in rat
and human ovaries (Nakatani et al., 1991; Giudice et al., 1991a). Studies of the
involvement of IGFBPs in the ovary are discussed in greater depth below.
1.6.4.Regulation of IGFBP expression/production
1.6.4.1. Regulation by GH
The expression of IGF binding proteins is controlled by hormones and growth
factors and is dependent on the particular tissue. The dependence of concentrations of
IGFBP in serum and isolated rat liver perfusates, on GH, has been demonstrated in the
rat (Moses et al., 1976; Schalch et al., 1979; Schwander et al., 1983). In vitro, bovine
GH caused a 50% increase in IGFBP production by rat hepatocyte monolayers (Scott et
al., 1985). The IGFBP produced was not characterised in these studies, however it
was postulated to be IGFBP-3 (Baxter and Martin, 1989). Serum concentrations of
IGFBP-1 and IGFBP-2 have been found to be inversely related to GH secretory status
(Hardouin etal., 1987).
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1.6.4.2. Regulation by insulin and the IGFs
The effects of insulin and the insulin-like peptides on the patterns of IGFBP
expression in various tissues and cell types has been examined. Hill et al. (1989b)
showed that the pattern of IGF binding protein expression in human tissues was similar
to that of the peptides (see Section 1.6.2. above) suggesting the possibility of mutual
regulation. The role of IGFs in the regulation of binding proteins was further elucidated
by studies in vivo that showed serum concentrations of IGFBP-2 and IGFBP-3 in
mice, and IGFBP-3 in rats, are raised by IGF administration (Zapf et al., 1989;
Camacho-Hubner et al., 1991a). Studies in vitro showed that production of IGFBPs is
increased by IGF-I in rabbit articular chondrocytes (30 kDa, 24 kDa and 20 kDa
IGFBPs), bovine epithelial cells (IGFBP-3 and IGFBP-2), human fibroblasts (26 kDa
IGFBP) and human carcinoma cells (IGFBP-3 and IGFBP-2) (Froger-Gaillard et al.,
1989; Hill et al., 1989a; McGrath et al., 1991; Camacho-Hubner et al., 1991b).
Production of IGFBPs is inhibited by IGF-I in human decidual cells (IGFBP-
l)(Thrailkill et al., 1990). The way in which IGFs regulate their IGFBPs was
investigated with human fibroblasts (Hill et al., 1989a; Martin and Baxter, 1990). An
IGF analog with reduced receptor affinity stimulated IGFBP-3 secretion from these
cells, while an analog with reduced binding protein affinity had minimal effect,
implying that the IGF receptor was not important. This was supported by Conover
(1991) who investigated the regulation of IGFBP expression by IGF-I using human
fibroblasts. Treatment with IGF-I markedly stimulated the appearence of IGFBP-3, a
36 kDa IGFBP and 28-32 kDa IGFBPs and reduced the expression of a 24 kDa
IGFBP in conditioned medium. This response was also induced by IGF-I and -II
analogues with reduced IGF receptor affinity, but not by an IGF-I analogue with
normal receptor affinity and reduced affinity for IGFBP. The response was not induced
by high levels of insulin and was not abolished by antibodies to the IGF type-I
receptor. The conclusion drawn was that IGF-I regulates IGFBP availibility via a novel
receptor-independent mechanism. Cohick and Clemmons (1991) found that the same
analogs had opposite effects with bovine epithelial cells, implicating the IGF receptor.
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IGFBP concentrations in serum show a diurnal rhythm which is affected by
nutritional status; IGFBP-1 concentrations are raised, while those of IGFBP-3 are
depressed in patients with diabetes mellitus (Baxter and Martin, 1986; Brismar et al.,
1988; Holly et al., 1988; Suikkari et al., 1988). Reviewing the evidence, Lewitt and
Baxter (1991) suggested that insulin and hexoses are important independent regulators
of plasma IGFBP-1 levels in vivo. IGFBP-1 is known to suppress the insulin-like
activity of IGFs (Drop et al., 1979; Ritvos et al., 1988). Binding proteins may prevent
IGF-I from binding to the insulin receptor and thereby protect against hypoglycaemia
caused by the insulin-like effects of IGFs (Daughaday et al., 1980; Zapf et al., 1986;
Guler et al., 1988). Insulin has been shown to inhibit IGFBP-1 secretion from rat
hepatocytes and human carcinoma cells and to down-regulate both IGFBP-1 and
IGFBP-2 mRNA expression in rat liver cells (Boni-Schnetzler et al., 1990; Orolowski
et al., 1991; Camacho-Hubner et al., 1991b). However, production of three distinct
binding proteins by rabbit chondrocytes was increased by administration of supra-
physiological doses of insulin (Froger-Gaillard et al., 1989).
1.6.4.3. Regulation by other factors
Giudice et al. (1991b) found that the steroid hormones progesterone and
oestradiol and progesterone analogs stimulated the release of IGFBP-2 from human
endometrial cells in vitro and modulated IGFBP-2 mRNA expression; in the rat ovary
FSH has been found to regulate IGF binding protein release from granulosa cells in a
biphasic manner (Adashi et al., 1990b; 1991c).
Other factors which have been shown to regulate IGFBP production from cells
in vitro include TGF-B (Martin and Baxter, 1991), parathyroid hormone and
parathyroid hormone-related peptide (Torring et al., 1991) and forskolin (Cohick and
Clemmons, 1991).
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1.6.5. Effects of IGFBPs
The IGFBPs were first discovered and characterised by their ability to bind
IGF-I and IGF-II and form stable complexes (Cohen and Nissley, 1976; Zapf et al.,
1986). There has been a great deal of investigation into the effects of these proteins on
the biological activity of IGF-I; some workers suggesting that the formation of
complexes with IGFBPs impairs the peptides' ability to interact with their cellular
receptors, others suggesting that IGFBPs enhance these interactions.
1.6.5.1. Inhibitory effects of IGFBPs
Initial studies showed that IGFBP purified from human amniotic fluid (32-38
kDa) inhibited the stimulatory effects of the IGFs on fibroblast DNA synthesis (Knauer
and Smith, 1980). This effect of binding protein has been confirmed by later work,
amongst which was a study involving Des-(l-3)-IGF-I, a peptide identical to IGF-I
except for the omission of the amino terminal tripeptide which is required for binding of
the peptide to binding protein (Ballard et al., 1987; Szabo et al., 1988). Des-(l-3)-IGF-
I has been shown to be more potent than the other IGFs in stimulating DNA synthesis
and protein accumulation in some cells; however, in chick embryo fibroblasts, which
did not secrete binding proteins, all three peptides were equipotent (Ross etal., 1989).
IGFBPs have also been shown to inhibit the effects of IGF-I on glucose oxidation in
adipose tissue (Ooi and Herrington, 1986; 1988; Walton et al., 1989), thymidine
incorporation in chick embryo fibroblasts (Blat et al., 1989) and FSH-stimulated
estradiol synthesis by rat granulosa cells (Shimasaki et al., 1990a).
The inhibitory effects of IGFBPs can be explained by their competition with the
receptor for free IGFs. IGFBPs bind to IGFs in a 1:1 molar ratio and compete with the
receptor for IGF-I binding in a dose-dependent manner (Ritvos et al., 1988). This
observation provides the basis of a mechanism whereby IGFBPs inhibit the actions of
IGFs, since this action is mediated through the receptor. The affinity constant of
IGFBP-1 for IGF-I is greater than that of the receptor for IGF-I (Ka= 1010and
109 M-i respectively, Jones et al., 1991). Although explaining the inhibitory nature of
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IGFBPs this hypothesis suggests that IGFs may not bind to the receptor in the presence
of binding proteins unless the affinity of IGFBPs for IGF is lowered. Recent studies of
the proteolysis and phosphorylation of binding proteins indicate that these processes
may regulate the affinity of the binding proteins for IGF-I in vivo, thereby releasing the
peptide to bind to its receptor. Hossenlopp et al. (1990), observed that there is a
degradation of IGFBP-3 in the serum and plasma of pregnant women after the second
month of gestation and that this could be inhibited by EDTA or aprotinin. This suggests
that the degradation is caused by metallo and/or serine proteases.
IGFBP-3 is found in a truncated form in vivo (due to proteolysis). Schmid et
al. (1991) investigated the biological properties of truncated IGFBP-3 in osteoblast cell
culture and found that in contrast to full length IGFBP-3 the truncated IGFBP-3 did not
inhibit the stimulatory effects of IGF-I on DNA synthesis. These observations provide
further evidence that IGFBP-3 is modified by proteolysis in vivo and that this could
control its affinity for IGF-I.
The effect of phosphorylation of binding proteins was investigated by Jones et
al. (1991) who showed that phosphorylated IGFBP-1 had an affinity constant 6-fold
higher for IGF-I than the same protein following de-phosphorylation. These
observations coupled with those showing that IGFBP-1 in hepatoma or decidual cell-
conditioned medium is more phosphorylated than that found in fetal serum suggest that
the degree of phosphorylation of IGFBP-1 varies in vivo and this determines its affinity
for IGF-I.
1.6.5.2. Stimulatory effects of IGFBPs
IGFBPs have been shown to increase the binding of IGF-I to its receptor and
increase cell proliferation in porcine muscle cells, human and chick fibroblasts
(Clemmons et al., 1986; Elgin et al., 1987); and baby hamster kidney cells (Blum et
al., 1989). Recombinant hIGFBP-1 enhances IGF-I-induced mitogenesis in human
breast carcinoma cells in vitro (Camacho-Hubner et al., 1991b). IGFBP-3 influences
DNA synthesis in human skin fibroblasts depending on the conditions. Thus, pre-
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incubation with IGFBP-3 enhances, while co-incubation inhibits the stimulatory effect
of IGF-I on these cells (DeMellow and Baxter, 1988).
Explanations of the stimulatory effects demonstrated by binding proteins are
more complicated than those for the inhibitory effects described in Section 1.6.4.1.
above. Blum et al. (1989) suggested that the slow release of IGFs from binding protein
complexes creates a steady state of high IGF receptor occupancy which may elicit a far
greater response than that caused by transient levels of IGF. Another explanation is that
the RGD sequences in IGFBP-1 and -2 allow the protein to bring IGF closer to the cell
surface receptors by binding to integrins on the cell surface (see Section 1.6.1.5.
above).
1.6.6. Chicken IGFBP
A protein produced by chick embryo liver cells in tissue culture binds human
IGF-I (Hasselbacher et al., 1980) and IGF-I specific binding proteins have been found
in chicken serum (Armstrong et al., 1989; Francis et al., 1990) . Armstrong et al.
(1989) showed that 70% of the IGF-I immunoreactivity in chicken serum is associated
with a large protein complex (150 kDa), 20-25% is associated with an intermediate
sized complex (45 kDa) and 6% is presumed to be free IGF-I. In the same study, SDS
PAGE analysis revealed three IGF-I binding proteins (28.8, 33.1 and 40.7 kDa).
Franciser al. (1990) injected [125I]-IGF-I into the circulation of chickens and then
analysed plasma samples; most of the IGF-I was complexed with binding proteins. By
gel permeation chromatography, the circulating binding protein complex in plasma had
a molecular mass of 55 kDa. The absence of a 150 kDa complex in the study of Francis
et al. (1990) conflicts with the findings of Armstrong et al. (1989) and may be due to
differences in purification which have led to the removal of the complex.
The greater proportion of free IGF-I in chicken serum (6%) in comparison with
that in human serum (0.8%) (Daughaday et al., 1982; Armstrong et al., 1989),
indicates that birds may be less sensitive to the insulin-like effects of this peptide and
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implies that the function of binding proteins in protection from the insulin-like effects of
free IGF-I (Zapf et al., 1986) is not as important in birds as in mammals.
1.7. The Mode Of action Of IGF-I
1.7.1. Endocrine IGF-I actions
In an endocrine mode of action IGFs are synthesized in an organ or tissue and
then transported in the circulation to their sites of action. The liver has been regarded as
the main source of IGF-I synthesis (e.g. Phillips et al., 1976; Schalch et al., 1979). An
endocrine mode of action is supported by evidence that IGF-I is present in the
circulation (see Section 1.7.2. below), and that hepatic IGF-I gene expression and
peptide synthesis in vivo is stimulated by GH (Schwander et al., 1983; Mathews et al.,
1986). Further evidence of the endocrine role of the liver is that in humans, it only
contains very low levels of IGF-I receptors, probably a pre-requisite to protect it from
responding to the locally high concentrations of IGF-I to which it is exposed (Caro et
al., 1988).
1.7.2. Paracrine IGF-I actions
In a paracrine mode of action, IGF-I has an effect on tissues or cells which are
adjacent to the cells in which it is produced. Evidence of production of IGF-I in tissues
other than in the liver has been provided by immunocytochemical and in situ
hybridisation studies of rat and human tissues respectively (Han et al., 1987; Hansson
et al., 1988), these studies show that both IGF-I and its mRNA are produced in most
tissue types. Further evidence of a paracrine mode of action for IGF-I comes from the
work of Minuto et al. (1991) who set up a human tissue culture system in which
keratinocytes were grown on fibroblast cell layers. In this system the fibroblasts
produced IGF-I but the keratinocytes did not. The medium conditioned by fibroblasts
stimulated increased [3H]-thymidine incorporation into keratinocytes, an effect which
was inhibited by IGF-I or IGF Type I receptor antibodies. This experiment indicated
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that IGF-I produced by fibroblasts has a paracrine effect on keratinocytes in vitro. In
another study of paracrine interactions, Naville et al. (1990) investigated the production
of IGF-I by porcine testicular cells under the influence of hCG (amongst other factors).
They discovered that hCG stimulated cultures of Leydig and Sertoli cells to produce
IGF-I: however, when the two cell types were cultured together hCG stimulated a
greater IGF-I production than might be expected from the combined amount produced
by separate cultures. These results suggest that there is paracrine regulation of IGF-I
production in porcine testes.
1.7.3. Autocrine IGF-I actions
In an autocrine mode of action, IGF-I is synthesized by cells on which it also
has an effect. Autocrine mechanisms have been proposed to be responsible for the
growth of cancer cells which are believed to produce growth factors for, which they
also have receptors, resulting in self-sustained growth stimulation (Sporn and Todaro,
1980). Autocrine actions have been proposed for IGF-I since many cell types which are
capable of synthesising IGF-I also possess IGF receptors. IGF-I is known to be
mitogenic for many cell types; thus, if it has autocrine actions, normal cells must be
able to control them. Cells possibly do this through the production of IGF-I binding
proteins. Minuto et al. (1991) showed that lung cancer cells secrete an IGF binding
protein (CALU-6) which inhibits the mitogenic effects of IGF-I on the lung cancer
cells, but not on 3T3 fibroblasts. This indicates an autocrine control mechanism
for IGF-I in lung cancer cells.
1.7.4. Relative importance of the endocrine, paracrine and autocrine
modes of action
The way in which endocrine, paracrine and autocrine modes of action of IGF-I
interact in the whole organism is not fully understood. However, studies of
concentrations of serum IGF-I in the human fetus show that it is low compared with the
levels in childhood, but there is IGF-I gene expression in many foetal tissues, also GH
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receptors numbers rise post-partum (Gluckman et al., 1983; Maes et al., 1984;
Daughaday and Rotwein, 1989). This suggests that the autocrine or paracrine actions
predominate over endocrine actions initially, but that the relative importance of the two
are developmentally linked. Daughaday and Rotwein (1989) suggested that
autocrine/paracrine actions are important in tissues such as lung, kidney and ovarian
granulosa cells with high local IGF-I gene expression and IGF-I tissue concentrations.
1.8. IGF-I and Growth
1.8.1 IGF-I and the cell cycle
Serum is required for the growth of cells in culture, and IGF-I is one of the
many factors it contains. The role of IGF-I in the growth of cultured cells is to allow
progression of the cell cycle from the G0/G1 stage into the S phase (Leof et al., 1982).
EGF has a similar function but is only required for the initial phase of the GO to S
stage, while IGF-I is required throughout the stage (Leof et al., 1982; Campisi and
Pardee, 1984).
1.8.2. IGFs and growth in chickens
Sulphation factor activity, now known to be IGF-I, was demonstrated in chick
embryo and chicken serum by Shapiro and Pimstone, 1977 and Gaspard et al., 1981.
The possibility that IGF-I is required for growth in this species was suggested by the
work of Huybrechts et al. (1985) and Goddard et al. (1988) who showed that total
serum immunoreactive IGF-I increases during the rapid phase of chicken growth.
Ballard and co-workers (1990) measured the concentrations of IGF-I in the plasma of
male broiler chickens and found a two-to-threefold increase in birds from week one to
week seven post hatch, the IGF-I peak concentrations being 30-45 ng/ml. When birds
were starved for 24 hours the IGF-I levels fell from 40 to 15 ng/ml. No significant
difference was found in concentrations of plasma IGF-I between various strains of
broilers.
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IGF-I serum levels in chick embryos havebeen measured in several studies. De
Pablo et al. (1991) found that IGF-I concentrations peaked at day 15(18 ng/ml) and
then decreased until hatching but in growth retarded embryos IGF-I remained low (2-4
ng/ml) during the same period. Kikuchi et al. (1991) studied embryos from 9 days of
age until hatch at 21 days and chicks from hatch up to 7 weeks of age. Their results
were similar to those of De Pablo et al. (1991) in that they detected a rise in serum
IGF-I to a peak of 30-35 ng/ml on day 16, falling back to 10 ng/ml at hatch; they also
observed a second peak at six weeks of age (35-40 ng/ml), similar to that observed by
Ballard et al. (1990). This second rise in IGF-I levels was found to coincide with a rise
in GH levels, and in IGF-I mRNA expression in the liver; the pre-hatch peak was not
associated with a rise in GH levels, indicating that IGF-I production in chick embryos
is independent of GH.
Further evidence of the involvement of IGF-I in the growth of chicken tissues is
that IGF-I receptors have been identified in chick embyonic tissues such as brain, heart,
muscle, liver and eye (Bassas et al., 1988, 1989). Additionally, Girbau et al. (1987)
have shown that exogenous insulin and IGF-I stimulate growth-retarded chick embryos
between days 2 and 4 of development.
Although the evidence reported above does not show that serum levels of IGF-I
are positively correlated with increased growth, it indicates that IGF-I could be
important in the growth of chickens at embryonic and post-hatch ages and that GH may
be involved in this growth, post-hatch.
1.9. IGFs And The Ovary
Recent studies show that insulin and the insulin-like growth factors have an
important role in the ovary. Experimentally induced diabetes in female rats is associated
with reduced ovarian function (Davoren and Hsueh, 1984), and there is much evidence
to suggest that IGF-I (Hammond et al., 1982; Hammond et al., 1985; Davoren and
Hseuh, 1986) and IGF-II (Voutilainen and Miller, 1987; Ramasharma and Lee, 1987)
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are produced by mammalian granulosa cells; subsequently, there has been intense
investigation into the particular functions of these peptides in the ovary.
1.9.1. Expression and production of IGFs in the ovary
An immunocytochemical study of rat tissues using antisera specific for IGF-I
located the peptide in samples from the ovary, specifically in oocytes, granulosa and the
theca interna (Hansson et al., 1988). Studies of mRNA expression have shown that
IGF-I mRNA occurs in rat ovarian tissue, specifically in granulosa cells but not in
thecal cells. GH increases the level of IGF-I mRNA expression in granulosa cells in
vivo. A transformed rat granulosa cell line described by Zilberstein et al. (1989) has
been shown to secrete IGF-I and express IGF-I mRNA. The IGF-I receptor has also
been identified in rat granulosa cells (Davoren et al., 1986; Adashi et al., 1988b). IGF-
II mRNA expression was not detected in rat ovary (Murphy et al., 1987; Oliver et al.,
1989). More recent studies have revealed that IGF-II mRNA is
expressed in thecal cells but not in granulosa cells (Hernandez et al., 1990). Human
granulosa cells demonstrated the presence of IGF-II mRNA but not IGF-I mRNA
(Geisthovel et al., 1989). Thus there are clear differences in the pattern of IGF
expression between mammalian species.
Once it had been established that cells of the mammalian ovary produced IGFs,
the control of their synthesis by the endocrine system was investigated. As noted
above, Hammond and co-workers found that IGF-I is present in follicular fluid and is
produced by porcine granulosa cells in vitro. This production was found to be
stimulated by gonadotrophins and oestrogens (Hammond et al., 1985; Hsu and
Hammond, 1987b). Studies by D'Ercole et al. (1984) showed that the testicular IGF
content in the rat is reduced after hypophysectomy and that this effect was be reversed
by administering oGH. Later experiments by Davoren and Hsu (1986) showed that
treatment of rats with GH resulted in elevated IGF-I levels in ovarian tissues in vivo,
implying that GH is also important in the regulation of IGF production in the ovary.
Other experiments with porcine granulosa cells in vitro showed that treatment with LH,
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FSH and oestradiol or GH stimulated IGF-I production as did the growth factors EGF
and TGF-a (Hsu and Hammond, 1987a; Mondschein and Hammond, 1988). In the
pig, PMSG and hCG treatment resulted in a rise in concentrations of IGF-I in follicular
fluid (Hammond et al., 1988). Hsu and Hammond (1987b) found that cAMP analogs
had similar effects to gonadotrophin treatments with respect to IGF-I secretion in
porcine granulosa cells in vitro, implying that this effect of gonadotropins is mediated
by cAMP.
1.9.2. IGF receptors in the ovary
IGF type I receptors have been shown to be present on porcine and rat
granulosa cells on rat corpora lutea and on luteinised rat granulosa cells; type II
receptors have been shown to be present on rat luteal cells (Baranao and Hammond,
1984; Adashi et al., 1985b; Davoren et al., 1986; Parmer et al., 1991; Talavera and
Menon, 1991). Concurrent treatment of FSH with IGF-I, IGF-II or insulin enhances
the production of progesterone and oestrogen and the induction of LH/hCG receptors in
the order of potency IGF-I > IGF-II > insulin (Davoren et al., 1986). These
observations suggest that the biological actions of IGF-I in the rat ovary are mediated
preferentially by the type I receptor. The treatment of rats with oestradiol inhibits IGF
type I receptor mRNA expression in corpora lutea (Parmer et al., 1991).
The gonadotrophins, FSH and LH, stimulate cAMP production in ovarian cells
(Marsh, 1976) and FSH increases IGF-I binding to the type-I receptor on rat granulosa
cells in vitro and in vivo (Adashi et al., 1986b; 1988a; see Section 1.5.2. above). This
is due to increased binding capacity rather than increased affinity. These observations
are supported by in situ hybridisation studies, showing that treatment of rats with
PMSG results in an increase in follicular IGF type I receptor mRNA levels (Zhou et al.,
1991). A possible conclusion is that FSH up-regulates type I receptors via a mechanism
involving cAMP, this is supported by work showing that cAMP-generating agonists
have a similar effect to FSH on IGF-I binding (Adashi et al., 1986b).
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More recent work by Adashi's group has shown that a GnRH receptor ligand
([D-pGlm1,D-Phl2,D-Trp3'6]GnRH) also regulates the binding of IGF-I to the type I
receptor in rat granulosa cells (Adashi et al., 1991d), receptor agonists inhibit IGF-I
binding by decreasing binding capacity without reducing receptor affinity. The rats
used in this study were hypophysectomised to eliminate the involvement of pituitary
hormones. GnRH attenuatesFSH-stimulated cAMP generation by granulosa cells
(Hsueh et al., 1984; Birnbaumer et al., 1985), suggesting that GnRH receptor ligands
regulate type-I receptors via cAMP. Antagonists of GnRH receptors have been shown
to enhance hCG-stimulated progesterone production by granulosa cells and to increase
ovarian weight and protein content (Adashi et al., 199Id).
Thus, there is evidence that the regulation of the type I receptor complement in
rat granulosa cells is cAMP dependent and consequently influenced by FSH and GnRH
receptor ligands. Adashi et al. (1991b) suggested that an intraovarian GnRH system
exists; however, identification of the putative endogenous GnRH receptor ligand which
may regulate type-I receptors remains elusive.
1.9.3. IGF binding proteins in the ovary
The existence of IGF binding proteins (IGFBPs) in ovarian follicular fluid was
first demonstrated by the direct binding of radiolabeled IGF (Hammond, 1981;
Hammond et al., 1985). Since then immunoreactive IGFBP-I has been shown to be
present in human and porcine ovarian follicular fluid and in human luteinized cells of
hyperstimulated preovulatory follicles (Seppala et al., 1984; Seppala and Than, 1987;
Mondschein et al., 1991). Human granulosa cells synthesize an IGFBP-1 -related
species as assessed by incorporation of [35S]-methionine into immunoreactive IGFBP
detected by SDS PAGE (Suikkari et al., 1989). In related experiments, acid-
chromatographed whole ovarian extracts of murine origin, and media conditioned by
porcine granulosa cells were found to contain hormonally-dependent, low molecular
weight IGF-I binding activity (Hammond et al., 1985; Davoren and Hsu, 1986).
Adashi et al. (1990b; 1991c) showed that three IGF binding proteins are released
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constitutively by rat granulosa cells in vitro, 29, 28 (postulated to be rat IGFBP-2 and
IGFBP-1 respectively) and 23 kDa in size. Porcine IGFBP-3 is the most abundant
IGFBP in porcine follicular fluid (Mondschein et al., 1991); this protein has been
purified and its cDNA cloned (Ui et al., 1989; Shimasaki et al., 1990a). Nakatani et al.
(1991) used in situ hybridisation to study the pattern of IGFBP-1,-2,-3 and -4 mRNA
expression in adult rat ovaries. They found that there is tissue-specific synthesis of
IGFBP subtypes in specialised ovarian cells; IGFBP-2 is confined to thecal cells,
IGFBP-3 is expressed in some corpora lutea and IGFBP-4 is expressed exclusively in
the granulosa cells of atretic follicles.
Ovarian IGFBP production is under the control of FSH. Adashi et al. (1991c)
showed that FSH both stimulates and inhibits the constitutive release of unspecified
IGFBPs from rat granulosa cells at different doses (1-3 ng/ml and 10 ng/ml,
respectively). The gonadotrophins hCG and FSH have no effect on IGFBP-1
production in human granulosa-luteal cells; however, IGFBP-1 production is
stimulated via the protein kinase-C pathway and the cAMP pathway (by PGE2)
(Jalkanen et al., 1989). In the pig, IGFBP-2 expression is correlated with follicular
development, IGFBP-2 being more abundant in follicular fluid from small follicles than
in fluid from large ones (Mondschein et al., 1991). IGFBP-4 mRNA expression in the
granulosa cells of atretic rat follicles is cyclical - varying with the oestrous cycle,
indicating that binding proteins are involved with follicular development (Erickson et
al., 1992). The most likely mechanism is via control by FSH which has been shown by
radioimmunoassay to be present in high concentrations in the follicular fluid of large
human pre-ovulatory follicles (McNatty et al., 1975) and to differentially regulate
IGFBP expression in rat granulosa cells as described above.
1.9.4. Mechanisms of IGF action in the ovary
Antibodies to insulin have been used to block insulin receptors in porcine
granulosa cells in vitro (Veldhuis et al., 1984) resulting in the inhibition of the
stimulatory effects of insulin on progesterone production. This observation supports
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the view that this effect of insulin is mediated by the insulin receptor. However a cross-
reaction of the antibody with the IGF type I receptor can not be ruled out, and this idea
is supported by the finding that the effects of insulin and IGF-I on progesterone
synthesis are non-additive suggesting they act through the same receptor. This view is
strengthened by the observation that this IGF-I stimulates progesterone production in
granulosa cells at nanomolar concentrations, compatible with its recptor binding affinity
as observed in other cell types (Rosenfeld et al., 1984; Adashi et al., 1985b). The
observation that IGF-I is much more potent than insulin in augmenting granulosa cell
progesterone synthesis (Adashi et al., 1985c) suggests that IGFs act through high
affinity recognition sites of their own rather than as insulin surrogates.
Cyclic AMP is generally accepted to be the second messenger for FSH action.
Following FSH stimulation of cAMP production, cAMP activates protein kinase A
which results in subsequent phosphorylation of key proteins involved in granulosa cell
differentiation (Richards et al., 1979). Additional evidence of the involvement of cAMP
is that FSH action in granulosa cells is enhanced by co-treatment with
phosphodiesterase inhibitors that minimise cAMP breakdown (Welsh et al., 1984).
IGF-I alone does not affect cAMP accumulation in conditioned medium from rat
granulosa cells, but treatment with both IGF-I and FSH results in increased
accumulation compared with that caused by FSH alone, suggesting that the synergy of
IGF-I and FSH is mediated in part by cAMP (Adashi et al., 1986b; c).
Recently Dor et al. (1991) reported that a woman with IGF-I deficiency had
normal ovarian function and suggested that IGF-I is not essential to normal human
ovarian development, but that its primary role is as a non-essential modulator of FSH
action on granulosa cells. There is also a suggestion from this study that induction of
response pathways (e.g. receptor induction) possibly by IGF-I is necessary for normal
IGF-I action. However, this is a study based on a single patient which needs to be
confirmed before these results can be regarded as significant with respect to IGF-I
function in the normal ovary.
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1.9.5. The mitogenic effects of IGF-I in the ovary
IGF-I is a potent mitogen for cells derived from primitive germ layers
(Clemmons and Van Wyk, 1981) therefore it may be expected to have a role in the
multiplication of ovarian somatic cells. However, while the regulation of the
steroidogenic functions of ovarian cells by IGFs has been extensively investigated (see
Section 1.9.6. below), fewer studies have been undertaken to determine the effects of
IGFs on the growth and proliferation of ovarian cells.
Insulin and the insulin-like peptides have been shown to induce dose-dependent
mitogenesis in granulosa cells in vitro (Veldhuis and Hammond, 1979; Savion et al.,
1981; Baranao and Hammond, 1984). May et al. (1988) found that IGF-I stimulated
thymidine incorporation into DNA of porcine granulosa cells in combination with EGF,
but not on its own. A mitogenic effect of insulin on granulosa cells has been described
several times (Aidells et al., 1975; May and Schomberg, 1981) but its mitogenic action
on granulosa cells in vitro is much less than that of IGF-I or IGF-II (Hammond et al.,
1983; Baranao and Hammond, 1984; Otani et al., 1985).
1.9.6. Steroidogenic and differentiating effects of IGFs
As the follicle grows and approaches ovulation, the cells in its walls replicate.
After ovulation in mammals a corpus luteum forms from the remains of the ovulated
follicle. As part of this process granulosa cells become luteinized (see Austin and Short,
1984), that is, they differentiate and become more responsive to LH due to an increase
in the number of LH receptors on the cells. The result is that progesterone secretion is
enhanced. IGF-I has been shown to promote differentiation in cell types such as
chondrocytes (Hill, 1979), myoblasts, (Turo and Florini, 1982) and osteoblasts
(Schmidt et al., 1984), suggesting that IGF-I could also have a role in the maturation
and development of ovarian cells. The major actions of IGFs which have been studied
are progesterone and oestradiol synthesis and the induction of LH receptors. The
results of work undertaken to investigate these effects are summarised in the following
sections.
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1.9.6.1. IGF effects on progesterone synthesis
IGF-I plays a role in the control of progesterone synthesis in the granulosa cells
in mammals. It stimulates progesterone secretion directly and also appears to act
synergistically with several factors, especially FSH (Adashi et al., 1985b; Russell et al.
1984; Baranao and Hammond, 1984). Work done on the effect of IGF-I on granulosa
cell progesterone synthesis points to a role in cholesterol side-chain cleavage
cytochrome P450 activity. Addition of DNA synthesis inhibitors does not reduce the
effect of IGF-I on progesterone production, implying that this effect of IGF-I on
steroidogenesis is distinct from its mitogenic effect (Adashi et al., 1985b). FSH-
stimulated porcine granulosa cells cultured in serum-free conditions respond to IGF-I,
IGF-II and insulin with increased progesterone synthesis, with an overall order of
potency of IGF-I > IGF-II > insulin (Channing et al., 1976; May and Schomberg,
1981; Baranao and Hammond, 1984; Adashi et al., 1985b). Progesterone synthesis in
porcine thecal cells is also stimulated by insulin treatment (Barbieri et al., 1983).
1.9.6.2. IGF effects on oestrogen synthesis
IGF-I on its own does not affect the development of aromatase activity or
oestrogen synthesis by rat granulosa cells, but it synergises with FSH to increase
oestrogen synthesis above that produced with FSH alone (Adashi et al., 1985a).
Insulin also behaves in this manner (Adashi et al., 1985b). Human granulosa cells have
been shown to respond to IGF-I alone with increased oestrogen synthesis (Erickson et
al., 1989; Dor et al., 1992). Recent in vitro studies of oestradiol production by
granulosa cells from a woman with an IGF-I deficiency, indicate that these cells were
not as responsive to IGF-I, as cells from normal controls. However, after an extended
period in culture the cells did respond well to IGF-I treatment (Dor et al., 1992).
Adashi et al. (1985a) found that treatment of rat granulosa cells with FSH and IGF-I
significantly increased oestrogen accumulation over basal FSH treatment alone. The
enhancement of FSH-stimulated oestrogen synthesis by IGF-I is probably acting
through aromatase which is stimulated by the growth factor. IGF-II has been shown to
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mimic the differentiative effects of IGF-I on cultured rat granulosa cells by stimulating
FSH-induced oestrogen production (Davoren et al., 1986) as has insulin at high doses
(Hsueh et al., 1989).
1.9.6.3. IGF effects on LH receptor induction
The induction of LH receptors plays a central role in the luteinization of
mammalian granulosa cells. FSH is important in this process, since it stimulates
increased receptor acquisition (Hsueh et al.. 1984, Adashi et al., 1985b). IGF-I
synergistically enhances the effect of FSH as do IGF-II and insulin (May and
Schomberg, 1981; Adashi et al., 1985b; Davoren et al., 1986). The relative order of
potency is IGF-I >IGF-II > insulin. This indicates that insulin and the IGFs are acting
via the IGF type I receptor in this case (see Section 1.5 above).
1.9.7. Other effects of IGFs on ovarian cells
Other actions of the insulin-like growth factors on ovarian cells which have
been noted in the literature include IGF-I stimulation of proteoglycan synthesis and
inhibin production in rat granulosa cells (Adashi et al., 1986a; Zhiwen et al., 1987),
oxytocin secretion in bovine granulosa and luteal cells (Schams et al., 1988; McArdle
and Holtorf 1989, Holtorf et al., 1989), plasminogen activator activity in chicken
granulosa cells (Tilly and Johnson, 1990) and IGF-II stimulation of ornithine
decarboxylase activity in porcine granulosa cells (Veldhuis and Hammond, 1979).
Thus, there is evidence that the IGFs have a variety of receptor-mediated effects
in ovarian tissues. Combined with the evidence showing that IGFs are also produced
here, the conclusion which can be drawn is that they act in an autocrine or paracrine
manner in the mammalian ovary.
1.9.8. The synergistic actions of IGF-I and other factors in the ovary
While IGF-I has been shown to exert a direct effect on ovaries, there is
evidence that its most potent steroidogenic effects are due to synergistic actions.
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In granulosa cells IGF-I has been shown to act synergistically with FSH or
PMSG in the in the stimulation of progesterone biosynthesis (Veldhuis and Rodgers,
1987; Veldhuis et al., 1987; Adashi et al., 1988a; Maruo et al., 1988; Mondshein et al.,
1989), in the acquisition of aromatase activity and oestrogen accumulation (Adashi et
al., 1985a; Maruo et al., 1988; Hutchinson et al., 1988; Erickson et al., 1989), the
stimulation of proteoglycan biosynthesis (Adashi et al., 1986a), the stimulation of
adenylate cyclase activity (Adashi et al., 1986b), inhibin production (Zhiwen et al.,
1987) and LH/hCG receptor binding (Maruo et al., 1988). IGF-I also acts
synergistically with FSH, oestradiol, GH, low density lipoprotein or high density
lipoproteinin in stimulating progesterone production from porcine granulosa cells
(Veldhuis et al., 1987; Mondschein et al., 1989; Veldhuis and Gwynne, 1989). It has
recently been shown that progesterone production from chicken granulosa cells
stimulated with IGF-I and FSH together was elevated when the cells were pre-
incubated with LH (Decuypere et al., 1991). In luteal cells IGF-I acts synergistically
with hCG via cholesterol side chain cleavage activity to increase progesterone synthesis
(Talavera and Menon, 1991). IGF-II also synergises with FSH in the stimulation of
progesterone synthesis in granulosa cells, as does insulin which is much less potent
than IGF-I (Baranao and Hammond, 1984; Adashi et al., 1985b). In thecal cells IGF-I
acts synergistically with LH or hCG to stimulate progesterone, androstenedione and
other androgen production (Barbieri et al., 1983; Hernandez et al., 1988; Caubo et al.,
1989).
1.9.9. The interactions of IGF-I and GH in the ovary
The involvement of GH in ovarian function has been indicated in several
studies. Suppression of endogenous concentrations ofGH in the rat has been shown to
affect the onset of puberty, suggesting that this hormone can influence ovarian
functions (Ramaley and Phares, 1980; Advis et al., 1981). This view is reinforced by
the finding that a reduction of ovarian LH receptor content and hCG-stimulated
progesterone production is associated with this reduction of GH concentrations and that
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these effects could be reversed by the administration of GH in vivo (Bartke et al., 1964;
Advis et al., 1981). Additionally, recent work by Gong et al. (1991) shows that GH
administered to cattle increases the population size of small antral follicles in the ovary.
IGF-I levels have been shown to be influenced by GH; this was the basis of the
original somatomedin hypothesis derived from the work of Salmon and Daughaday
(1957). Since then, serum concentrations of IGF-I have been shown to be regulated by
GH in humans and cattle (Zapf et al., 1981; Grant et al., 1986; Gong et al., 1991). The
treatment of GH deficient mice with GH increases IGF-I transcription (Mathews et al.,
1986); and treatment of rat hepatocytes with GH in vitro causes an increase in IGF-I
mRNA expression (Johnson et al., 1989). Thus it is possible that the effects of GH on
ovarian functions are mediated via IGF-I. This has been emphasised by experiments
demonstrating that GH increases rat ovarian levels of IGF-I in vivo (Davoren and
Hseuh, 1986) and IGF-I production by porcine granulosa cells in vitro (Hsu and
Hammond, 1987a). GH has also been shown to enhance FSH-induced differentiation
of rat and porcine granulosa cells in vitro, as measured by changes in progesterone
production and LH receptor formation (Jia et al., 1986; Hsu and Hammond, 1987b),
an effect which has been well established for IGF-I (Adashi et al., 1985b; see Sections
1.9.6.1 and 1.9.6.3 above).
A recent study by Mason et al. (1990) has shown that GH can have direct
steroidogenic effects in human granulosa cells in vitro independent of FSH, IGF-I
production was undetectable in this study: however, in previous studies gene
expression of IGF-I has not been demonstrated in these cells (see Section 1.9.1.
above), making them unique among the granulosa cells of the species studied to date. It
is possible that GH may act both independently and with IGF-I in the ovary, via
separate pathways.
1.10. Research Objectives
The literature reviewed in this introduction shows that IGF-I is widely
expressed and is important for the growth of many cell types. It also shows that IGF-I
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is involved in mammalian ovarian cell function. Structurally, the mammalian ovary is
very different from the avian ovary and the role which IGF-I plays in the regulation of
avian ovarian function has not been established. Therefore, it is not known how
differences in the morphology of mammalian and avian ovaries may be reflected in the
functions of IGF-I in this organ.
The growth of cells is a fundamentally important aspect of the developmental
processes that precede ovulation in avian ovarian follicles. In the domestic laying hen,
follicles are arranged in a developmental hierarchy in the final 5-7 days before they
ovulate; providing an easily visible in vivo model of development that can be used to
examine the characteristics of growing follicles. Studies on the rat ovary have provided
evidence for local IGF-I synthesis and regulation, suggesting that IGF-I has a paracrine
or autocrine role in this organ.
Bearing in mind the work which has been done in mammals, and the resulting
hypotheses with respect to the function of ovarian IGF-I, a research programme was
initiated to establish the role of IGF-I in the chicken ovary. In designing the
programme, advantage was taken of the availability at IAPGR of chicken IGF-I cDNA
clones. The research objectives of the study were:-
1. To establish whether the cIGF-I gene is expressed in the ovary of the domestic hen,
and if so to identify the cellular compartments in which expression occurs.
2. To determine the mitogenic effects of IGF-I in the different compartments of the
avian ovary.
3. To examine how the biological effects of IGF-I are related to development within the
yellow yolky follicular hierarchy.
4. To establish whether the pre-ovulatory chicken ovarian follicle contains IGF-I
receptors and binding proteins.
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CHAPTER 2: MATERIALS AND METHODS
2.1. General Materials
2.1.1. Animals
Animals used in all these experiments were ISA Brown laying hens supplied by
ISA Poultry Services Ltd. (Peterborough, U.K.). Birds were fed a starter diet (at 1-8
weeks of age), grower diet (9-18 weeks) and a layer diet (19 weeks onwards) as
specified by the suppliers; water was available ad lib. Birds were killed by cervical
dislocation between 50 and 70 weeks of age. The hens used in any one study were of
the same age, i.e. they had been reared from the same batch. The birds were kept caged
under a 24 hour artificial lighting pattern (14 hours light and 10 hours dark). Egg
laying records were kept for each hen and only hens laying daily were selected for
study. Most hens laid between 4 and 6 hours after the beginning of the light period.
The time of ovulation in these birds was estimated from the time of oviposition, since
ovulation occurs about 30 minutes after oviposition of the oviductal egg (Warren and
Scott, 1935). Birds were killed in the morning 4-6 hours after lights were switched
on, after checking for the presence of an egg in the oviduct (by palpation). In this way
hens were selected which were predicted to be due to ovulate within 0 - 2 hours.
2.1.2. Reagents
All reagents were obtained from FSA Laboratory Supplies, Loughborough,
U.K. and were of analytical grade unless otherwise stated. Water used was purified by
pre-filtration, reverse osmosis and further, complex filtration by the Milli-RO and Milli-
Q systems (Millipore Waters, Watford, U.K.). Water was further treated as indicated
in the individual experimental protocols.
The peptides used in the experiments described below were human recombinant
insulin-like growth factors I and II (Bachem, Saffron Walden, U.K.) and porcine
monocomponent insulin (Novo Bioloabs Ltd., Cambridge, U.K.). The oLH used was
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NIADDK-oLH-25 and the oFSH was NIADDK-oFSH-17, both were gifts from
NIADDK (Bethesda, Maryland., U.S.A.). The chicken LH used was preparation AE1,
obtained from Dr. P. J.Sharp (IAPGR, Roslin, Midlothian).
The anti oLH (R288) and anti cLH antisera (3/9) were kindly supplied by Dr.
R. Webb and Dr. P. J. Sharp respectively (IAPGR, Roslin, Midlothian), who also
supplied binding data used to calculate optimal dilutions of the antisera. All other
antisera were obtained from the Scottish Antibody Production Unit (Law Hospital,
Carluke, U.K.) unless otherwise stated.
2.2. Tissue concentrations of IGF-I
2.2.1. Tissue collection
Birds were killed by cervical dislocation. The liver was dissected immediately,
samples were weighed and placed in polyurethane microcentrifuge tubes then snap
frozen in liquid nitrogen. The ovary was then dissected and the five largest pre¬
ovulatory follicles (Fl, F2, F3, F4 and F5) were removed. The theca and granulosa
layers were separated as described below and frozen in the same way as the liver.
These tissues were stored at -80°C prior to further processing.
2.2.2 Follicle dissection
Follicles were removed immediately from the ovary and placed in a glass
dissection dish containing Dulbecco's phosphate-buffered saline (D-PBS) solution,
made up according to the manufacturer's instructions (Oxoid Co., Basingstoke, U.K.)
and then autoclaved for 30 minutes at 115°C. The vascular and connective tissue
surrounding the follicles was removed with forceps and an incision was made in the
follicle in the stigma region allowing most of the yolk to flow out. The remains of the
follicle were transferred to a clean dissecting dish containing fresh D-PBS and the
granulosa cell layer carefully separated from the thecal layer with forceps
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Figure 2.1. Illustration of the method used to separate granulosa and thecal layers. 1. Stroma
and exterrnal blood vessels removed. 2. Incision made in stigma. 3. yolk and
granulosa removed from theca. 4. Granulosa teased from yolk.
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(see Figure 2.1). Both layers were rinsed briefly in D-PBS to remove any adhering
yolk and then stored as described in Section 2.2.1. above.
2.2.3 IGF-I Extraction
2.2.3.1 Acid ethanol extraction
This was based on the methods described by by D'Ercole et al. (1980) and
Enright et al. (1989). Tissue samples were homogenised in acetic acid (1 mol/1) using a
Polytron homogeniser (Kinematica, Lucerne, Switzerland). The homogenate was
centrifuged at 1000 g for 15 minutes and the supernatant removed to a clean tube.
Ethanol and acetone was then added to the supernatant until the solution had a
composition of 60 : 30 : 10, ethanol : acetone : acetic acid. This solution was then
vortexed, incubated at room temperature for 30 minutes then centrifuged at 1860 g for
30 minutes at 4°C. The top half of the supernatant was then removed, its pH adjusted to
7.5 with Tris base (4 mol/1) (Sigma Chemical Co., Poole, U.K.) and analysed for
IGF-I content by radioimmunoassay (RIA).
2.2.3.2 Acid Chromatography
A chromatography column (30cm x 2cm2) was packed with Sephadex G50
superfine (Pharmacia LKB, Milton Keynes, U.K.) which had been pre-swollen in
acetic acid (1 mol/1) with protamine sulphate (0.02 % w/v) (Sigma Chemical Co.,
Poole U.K.) at 90 °C for 60-90 minutes. The column was connected to an HPLC pump
and U.V. detector (Millipore Waters, Watford, U.K.) set to detect at a wavelength of
280 nm, fractions were collected with an automatic fraction collector. The column was
packed under pressure at a flow rate of at least 1.5 ml/min. in the buffer described
above (this buffer was used throughout this procedure).
The column was run at 0.55 ml/min. for several hours and then characterised.
The void voume (Vo) was measured by running 0.5 ml of a solution of blue dextran
(10 mg/ml)(Pharmacia LKB, Milton K^Jies^LJ.K.) down the column and measuring
the absorbance peak and the volume of buffer eluted, the dextran peak was eluted at a
volume of 18 ml, which was then taken as Vo. The separation of proteins by the column
was characterised with molecular weight markers; bovine serum albumin (66
kDa)carbonic anhydrase (29 kDa), cytochrome-C (12.4 kDa) and aprotinin (6.5 kDa),
all of which were obtained from Sigma Chemical Co. (Poole, U.K.). The two larger
proteins were eluted in the void volume, cytochrome-C was eluted at 21.5 ml and
aprotinin was eluted at 34.5 ml. The elution of IGF-I from the column and the total
volume (Vt) of the column was characterised with [125I]-IGF-I, which eluted between
27 and 36 ml with the peak at 31 ml. The free 125I eluted between 57 and 62 ml, with a
peak at 59 ml, therefore the total column volume (Vt) was taken as 59 ml.
The efficiency of the recovery of free IGF-I from the column was calculated by
measuring the radioactivity (d.p.m.) in the peak and comparing this with the total
d.p.m. of radioactive IGF-I label added. The calculation showed that 70.5% of the total
radioactivity was recovered in one column volume and 66% of this was eluted in the
"IGF-I" peak.
Tissue samples were homogenised with a Polytron homogeniser in acetic acid
(1 mol/1) with Triton X-100 (1% v/v) at 3.5 ml/g of wet tissue. The homogenate was
centrifuged at 1000 g for 15 minutes and the supernatant removed in 1 ml aliquots then
stored at -20°C.
Samples (500 }il volume) were loaded and the U.V. absorbance was measured.
Fractions (1 ml) were collected from the point of sample injection for the total volume
of the column. At least 1 column volume of buffer was run through the column in
between samples. The fractions were adjusted to pH 7.5 with Tris base (4 mol/1) and
assayed for IGF-I by RIA as described below.
2.2.4. IGF-I radioimmunoassay.
The IGF-I assay used was a double antibody RIA using the antiserum R2/2 as
previously described by Goddard etal. (1988).
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Samples and standards (200 |il of each) were dispensed into polystyrene
reaction tubes with the anti-IGF-I primary antiserum (R2/2), used at an initial dilution
of 1:4000 (100 |il per tube) and then incubated at 4°C for 24 hours. The standards were
prepared from recombinant human (h) IGF-I, at concentrations of 10, 60, 100, 200,
400, 600, 800, 1000, 2000 and 4000 pg per tube. Radio-labelled [125i]_igF I was
added (100 |il per tube) and the tubes vortexed then incubated at 4°C for a further 16
hours. A solution in assay buffer of the donkey-anti-rabbit IgG second antibody,
diluted to 1:20, and normal rabbit serum (NRS) carrier, diluted to 1:200, was added to
each tube (100 |il) and the tubes incubated for 3 hours at room temperature. The tubes
were centrifuged at 1500 g then 1 ml polyethylene glycol (4% w/v) (Sigma Chemical
Co., Poole, U.K.) was added prior to re-centrifugation. The supernatant was aspirated
and the radioactivity of the pellets measured using a Gammamaster gamma counter
(Pharmacia LKB, Milton Keynes, U.K.). The reaction was kept on ice during all
additions and in a 4°C cold room during incubations until the addition of the second
antibody. The assay buffer was composed of sodium dihydrogen orthophosphate (26
mmol/1), EDTA disodium salt (10 mmol/1), polyoxyethylenesorbitan monolaurate
(Tween 20) (0.5% v/v) (Sigma Chemical Co., Poole, U.K.), sodium azide (2% w/v)
and RIA grade BSA (0.1% w/v) (Sigma Chemical Co., Poole, U.K.). The pH of the
buffer was adjusted to 7.5 with sodium hydroxide (2 mol/1). Assay reagents decribed
above were diluted with the assay buffer unless otherwise stated.
2.3. IGF-I Gene Expression
2.3.1 Reagents
Reagents used for RNA preparation procedures were purchased as guaranteed
to be free of ribonucleases (RNases) where available, those that were not were treated
with DEPC by adding it to solutions (0.1% v/v) for 24 hours followed by autoclaving.
Water used in these procedures was also DEPC-treated. All Glassware was baked at
180°C for at least 2 hours to inactivate RNases and only disposable plasticware that had
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not been handled was used. Restriction enzymes were obtained from Boehringer
Mannheim U.K. Ltd. (Lewes, U.K.) unless otherwise indicated and the reactions were
performed in buffers supplied by this company.
2.3.2. Tissue collection
Birds were killed by cervical dislocation. Liver and pre-ovulatory ovarian
follicles (F1-F5) were removed and placed in a chaotropic solution of guanidinium
isothiocyanate (4 mol/1) (Life Technologies Ltd., Paisley, U.K.), sodium citrate (25
mmol/1, pH 7), sarcosyl (0.5% w/v) and B-mercaptoethanol (0.1 mol/1) (Fluka
Chemicals Ltd., Glossop, U.K.). Pre-ovulatory ovarian follicles were first dissected in
RNase-free sterile D-PBS as described above in Section 2.2.2.
2.3.3. RNA Preparation
The method of preparation used was based closely on that described by
Chomczynski and Sacchi (1987). The tissues were homogenised in a chaotropic
solution (see Section 2.3.2 above). The homogenate was passed by syringe through a
needle several times in order to shear the DNA and then centrifuged at 400 g for 5
minutes to remove the cellular debris. Aliquots (0.5 ml) of the homogenates were then
dispensed into 1.5 ml microcentrifuge tubes, then 50 pi of sodium acetate (2 mol/1,
pH4), 500 pi of water-saturated phenol and 100 pi of chloroform : isoamyl alcohol
mixture (49 : 1) were added to each tube (with mixing following each addition).
Samples were cooled on ice for 30-60 minutes and centrifuged at 10,000 g for 20
minutes at 4°C after which each had separated into a non-aqueous phase and an
aqueous phase containing the RNA. The latter was carefully removed with a Pasteur
pipette to a clean tube. The RNA was then precipitated by adding an equal volume of
cold isopropanol (propan-2-ol) and placing the sample in a deep freeze at -20°C for at
least 1 hour. The RNA was pelleted by centrifugation at 10,000 g for 20 minutes, re-
suspended in 300 pi of the chaotropic solution, and re-precipitated as described above.
The pellet was washed with 70% ethanol, dried in a vacuum desiccator and then re-
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suspended in water. An aliquot (5 pi) was taken, diluted to 1 ml with water and the
optical densities at 260 and 280 nm measured to quantify the RNA and the
contaminating protein, repecively, using a U.V. spectrophotometer. The sample was
then diluted with water to a known RNA concentration and stored frozen at -80°C.
2.3.4. Reverse transcription-polymerase chain reaction
The polymerase chain reaction (PCR) is described in publications by Mullis and
Faloona (1987) and Saiki et al. (1985; 1988). PCR allows amplification of DNA
segments in vitro through a succession of incubation steps at different temperatures.
Briefly, double stranded DNA is heat-denatured, two primers complementary to the 3'
boundaries of the target sequence are annealed at low temperature then extended at an
intermediate temperature. These three steps comprise a single PCR cycle.
RNA prepared as described in Section 2.3. was reverse transcribed to cDNA as
follows: 2.5 pi DEPC-treated H2O; 0.5 units (1 pi) RNA Block II (Stratagene Ltd,
Cambridge, U.K.); 1 pi of 1 pig/jj.1 acetylated BSA (Sigma Chemical Co.Ltd., Poole,
U.K.); 2 pi 5 x RT Buffer; 1 pi Pd(N)6 (100 pg/ml in TE) (Pharmacia LKB, Milton
Keynes, U.K.) and 1 pi RNA sample (1 pg/pl) were added, in the order shown, to a
microcentrifuge tube. This mixture was incubated for 3 minutes in a hot block (65°C)
and cooled immediately on ice: 1 pi dNTPs (5 mmol/1) and 0.5 pi M-MLV reverse
transcriptase (200 units/pl) (Life Technologies Ltd., Paisley, U.K.) were then added.
The reaction was incubated at room temperature for 10 minutes to ensure that the
primers had annealed, then at 37°C for 1 hour in a water bath and finally at 95°C for 10
minutes to stop the reaction, this was then chilled on ice immediately. The resulting
cDNA was used as a template for the PCR.
The PCR was set up with reagents supplied as a kit (Perkin-Elmer,
Beaconsfield, U.K.) and following the protocols supplied with it. The reaction mixture
contained the reverse transcribed cDNA, dNTPs, oligo primers, Taq polymerase and a
buffer supplied with the kit. Volumes of reagents used are shown in Table 2.1. The
total reaction volume was 50 pi.
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Table 2.1. Reagents used in the polymerase chain reactions.
Reagents Volumes (pi.)
(3-actin igf-i igf-i + (3-actin
h2o 35 33.5 32.2
10 x PCR buffer 5 5 5
dNTPs (1.25 mmol/1) 8 8 8
5' oligo primer 8 8 8
3' oligo primer 0.65 0.8 0.8 + 0.65
Taq polymerase 0.65 0.65 0.65 + 0.65
cDNA 0.5 0.5 0.5
total 50 50 50
The reaction mixture (50 pi) was dispensed into autoclaved microcentrifuge
tubes and covered with 100 pi of mineral oil (Sigma Chemical Co., Poole, U.K.) to
reduce evaporation. The tubes were placed in a hot block with a programmable control
system (Techne, Cambridge, U.K.) which was set to specify cycles of melting,
annealing and extending temperatures and the times at which they were to be applied.
The program also specified a longer extension period on completion of the set number
of cycles in order to complete transcription in partly transcribed strands. On completion
of the reaction the oil was removed from the reaction tubes by extracting twice with
chloroform equilibriated in TE; tubes were vortexed and centrifuged on addition of 200
pi of chloroform, the bottom (oil) phase was then aspirated and discarded. A further
200 pi chloroform was added and, following further vortexing and centrifugation, the
upper (aqueous) phase containing the DNA was transferred into new tubes.
In the experiments described in Sections 3.2.1, 3.2.2 and 3.2.4., DNA oligo-
primers specific for both IGF-I and B-actin were used. The expression of B-actin
measured using PCR was used as a positive control for the integrity of the RNA
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samples under investigation. Both sets of primers were chosen in order to avoid
generation of primer-dimers i.e. complementarity at the 3' ends and palindromic
sequences within primers. These synthetic oligo primers were made commercially
(Oswel DNA, Edinburgh, U.K.). The IGF-I primer sequences are shown in Figure
2.3 below.
The IGF-I primers were complementary to 21 base sequences within the
chicken IGF-I gene shown in Figure 2.2. The 5' sequence was complementary to the
3' end of exon 2 and the 3' sequence was complementary to the 3' end of exon 3. The
cDNA which was predicted to be amplified with IGF-I primers in the PCR was
200 b.p. consisting of 28 b.p. of exon 2 and all of exon 3 except 10 b.p. at the 3' end.
This sequence was chosen because it codes for the mature cIGF-I peptide (see Figure
2.2 above). An intron/exon boundary was also included in the sequence to be amplified
so that amplification of any contaminating genomic IGF-I DNA would result in cDNA
much greater in length than 200 b.p. and would therefore be easily identified. The
predicted size of the PCR product produced with 8-actin primers was 290 b.p.
IGF-I 5'
5'- GTA TGT GGA GAC AGA GGC TTC -3'
IGF-I 3'
5'- TTT GGC ATA TCA GTG TGG CGC -3'
Figure 2.3. The DNA sequences of oligo primers specific for
cIGF-I DNA.
To avoid contamination of reactions with DNA from other sources (reported as
a problem by some workers), reactions were set up using positive displacement
pipettes (which avoid cross-contaminating aerosols) in clean laminar flow cabinets.
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2.3.5. Gel electrophoresis of PCR products
The products of the PCR reactions were analysed by two different methods of
electrophoresis; vertical polyacrylamide gel electrophoresis (PAGE) and horizontal
agarose gel electrophoresis. For PAGE, an acrylamide solution (5% w/v) was made
with 5 ml lOx TBE buffer; 8.3 ml 30% acrylamide solution (29 : 1: 70, acrylamide :
bis-acrylamide : water) and 36.7 ml water, lx TBE is Tris-borate (89 mmol/1), boric
acid (89 mmol/1) and EDTA (2 mmol/1, pH 8). The solution was de-gassed with a
vacuum pump, then 160 (il of ammonium persulphate solution (10% w/v) and 160 |il
of TEMED were added to the solution. The gel was cast on glass plates and allowed to
set for 15 minutes, following which the casting comb was removed and the wells were
washed out with lx TBE. Samples were loaded and run at 100 V for 2-3 hours or at 20
V overnight in lx TBE. Following electrophoresis the gel was stained with ethidium
bromide and then photographed while transilluminated with U.V. light (nucleic acids
stained with ethidium bromide fluoresce in these conditions).
For the second method, PCR product samples were mixed 1 : 6 with a gel
loading buffer (bromophenol blue (0.25% w/v), xylene cyanol (0.25% w/v) and
glycerol (30% v/v) in DEPC-treated water), loaded on 4% NuSieve GTC agarose gels
(ICN Biomedicals Ltd., High Wycomb, U.K.) with DNA size markers and run
submerged in lx TAE buffer (Tris acetate (40 mmol/1), EDTA (1 mmol/1, pH 8)) at 50
V for 4-5 hours. Following electrophoresis the gel was stained, photographed and
bands measured as described above.
2.3.6. Southern analysis
Agarose gels were soaked and agitated in a denaturation buffer (sodium
hydroxide (0.5 mol/1); sodium chloride (1.5 mol/1)) for 20 minutes; this was repeated
with fresh denaturation buffer and then twice with a neutralising buffer (Tris-HCl (1
mol/1); sodium chloride (1.5 mol/1)). Filters were cut to the size of the gels from
Hybond-N hybridising membrane (Amersham International pic, Amersham, U.K.),
soaked in 2x SSC for 20 minutes and placed on the gel. The gel was placed on a wick
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of blotting paper fed from a reservoir of lOx SSC below. The ensemble was then
covered with absorbent blotting material and left for at least 16 hours to blot by
capillary action. Following blotting the filter membrane was rinsed in 2x SSC in order
to remove adhering agarose. The nucleic acids were fixed to the filter by exposing it to
U.V. light in a Stratalinker.
Filters were pre-hybridised at 37°C for 3 hours in 25 ml of a solution containing
de-ionised formamide (50% v/v), 20 x SSC (25% v/v), 100 x Denhardt's solution
(RIA grade BSA (2% w/v), Ficoll (2% w/v)(Pharmacia LKB Ltd., Milton Keynes,
U.K.) and polyvinylpyrrolidone (2% w/v)) (5% v/v), SDS (0.5% w/v), dextran
sulphate (3% w/v) and sonicated salmon sperm (4% v/v). For hybridisation the
solution was replaced with a similar solution which did not contain sonicated salmon
sperm. The [32P]-cDNA chicken IGF-I probe, made as described below, was added.
A 224 b.p. chicken IGF-I cDNA fragment was cut with a SauSa restriction
enzyme digest from the IGF507 clone (Fawcett and Bulfield, 1990), the sequence is
indicated on Figure 2.2. The [32P]-cDNA probe was made (using this fragment as a
template) with a random primed DNA labelling kit (Boehringer Mannheim U.K. Ltd.,
Lewes, U.K.). The DNA (25 ng) was boiled for 10 minutes, aliquoted into a
microcentrifuge tube then the following reagents from the kit were added; 3 p.1 dATP
dGTP dTTP mixture (1:1:1), 2 |il hexanucleotide solution, 1 (il Klenow enzyme and 5
fil [32-P]-adCTP (Amersham International pic, Amersham, U.K.). The reaction
mixture was then incubated at 37°C for 30 minutes and the reaction stopped by adding
2 |il EDTA (0.2 mol/1, pH 8.0). The probe was diluted with autoclaved TE to 200 |ll,
boiled for 5 minutes and placed on ice immediately prior to use.
Hybridisation was performed for approximately 16 hours at 37°C. Both the pre-
hybridisation and hybridisation steps were carried out in sealed perspex hybridisation
chambers, placed on a shaker. Following hybridisation the filter was rinsed with 2x
SSPE, SDS (0.1% w/v). It was then washed in the same solution for 2x 20 mins (at
65°C) followed by washes in lx SSPE, SDS (0.1% w/v) then O.lx SSPE, SDS (0.1%
w/v) at the same temperature. Filters were air dried and placed in cassettes with X-ray
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film. Exposures were usually for 16 hours at -70°C but the time varied according to the




The medium used for cell culture was medium 199 (Ml99) containing EarlCS
salts and sodium bicarbonate, supplied as a sterile filtered solution. This was
supplemented with HEPES buffer (20 mmol/1), L-glutamine (2 mmol/1), sodium
pyruvate (2 mmol/1), streptomycin (0.1 mg/ml) and penicillin (1000 u/ml) before use in
the culture systems described below. The collagenase used had been purified from
Clostridium histolyticum. The serum used was fetal calf serum (FCS), this was heat
inactivated by heating to 56°C for 30 minutes prior to use. All of the reagents listed
above were obtained from Sigma Chemical Co.(Poole, U.K.).
2.4.2. Coating tissue culture plates
In some experiments, the tissue culture plates were coated with substrates as
described in the following sections.
2.4.2.1. Collagen treatment
A solution of collagen type I (2.5 pg/ml) from calf skin, (Sigma Chemical Co.,
Poole, U.K.) was prepared with sterile acetic acid (0.1 mol/1) according to
manufacturers instructions. Multiwell tissue culture dishes were coated with 250 |il
collagen solution per 1 cm2 well and the dishes were dried in a laminar flow hood. The




A solution of gelatin in water (0.1 % w/v) was prepared and filtered into a sterile
bottle. This solution was autoclaved and used to coat wells (250 p.1 per 1 cm2well)
using the methods described above (there is no requirement to rinse the wells).
2.4.2.3. FCS treatment
Wells were coated with 250 |il heat-inactivated FCS and incubated at 37°C in a
humidified incubator overnight. The FCS was aspirated from the wells prior to use.
2.4.3. Tissue collection
Pre-ovulatory ovarian follicles were removed from the ovary immediately after
the hen was killed and placed in sterile, Dulbeco?. phosphate-buffered saline (D-PBS)
at room temperature. Follicles were then transferred to a laminar air-flow tissue culture
cabinet. The follicles were dissected as described in Section 2.2.2.under sterile
conditions. The dissected tissues were placed in separate sterile 30 ml Universal tubes




Granulosa cell layers were placed in sterile plastic petri dishes where they were
minced with fine scissors and transferred by pipette to a sterile 30 ml plastic
Universal vial containing 1 ml of a 1 mg/ml|collagenase solution (in supplemented
medium M199). The cells were digested in this solution for 5 minutes at room
temperature, aided by repeatedly drawing in and aspirating the partially digested
suspension with a pipette. The cell suspension was then diluted to a volume of 5 ml
with supplemented medium Ml99 and pelleted by centrifugation at 300 g for 10
minutes, the supernatant was discarded and the cells re-suspended in 5 ml of fresh
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supplemented medium M199. The cells were washed twice more by this procedure in
order to remove the collagenase.
2.4.4.2. Thecal cells.
Thecal cell layers were placed in sterile plastic petri dishes and minced as
described in Section 2.4.4.1. above. They were then transferred to a sterile 30 ml
Universal vial containing 1ml of a 5 mg/ml collagenase solution This vial was
submerged in a shaking water bath at 37°C and the cells were digested for 90 minutes,
assisted by pipetting (as described above in Section 2.4.4.1.) every 15 minutes. The
volume of the suspension was then made up to 5 ml with supplemented medium Ml99
and percoll (Sigma Chemical Co., Poole, U.K.) to produce a 40% percoll solution
(v/v); this was then mixed and centrifuged at 400 g for 20 minutes. The gradient
separated the thecal cells (at the top) from the red blood cells (RBCs) which were in the
pellet; the top layer containing thecal cells was carefully removed to a sterile 30 ml
universal vial and medium Ml99 added to produce a solution with less than 20%
percoll (v/v). Thecal cells were then pelleted by centrifugation at 300 g for 10 minutes
and the pellet re-suspended in 1 ml lysing buffer (ammonium chloride (0.13 mol/1),
Tris (17 mmol/1), potassium hydrogen carbonate (10 mmol/1), pH 7.5) for 2-3 minutes
in order to lyse any remaining RBCs. Supplemented medium M199 was then added to
make up the volume to 5 ml and the cells were pelleted and washed as described in
Section 2.4.4.1. Microscopic examination of the dispersed cells showed that no RBCs
were present in the preparation.
2.4.5. Cell culture
The cell density and viability of cell preparations was measured by the trypan
blue exclusion test. Viable cells do not take up and, therefore, are not stained with the
dye; cells with damaged cell membranes are stained. Therefore, by measuring the
proportion of unstained to total cells the cell viability of the particular preparation can be
calculated. Equal aliquots of the cell preparations and the trypan blue dye (ICN
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Biomedicals Ltd., High Wycombe, U.K.) were mixed. This suspension was loaded on
an improved Neubauer haemocytometer, depth 0.1 mm and smallest square 1/400 mm2
(FSA Laboratory Supplies, Loughborough, U.K.). The total cell density and the
percentage cell viability was measured and from these values the total viable cell density
calculated. Cell viability of both cell types was always greater than 90% and usually
greater than 95%. All cell densities quoted in subsequent sections are for viable cells.
Cells were plated on sterile nWtiwell plastic tissue culture plates (Costar U.K. Ltd,
High Wycombe, U.K.). During manufacture, these plates were subjected to corona
discharge; this process involves subjecting them to very high voltages in a controlled
atmosphere resulting in the removal of oxygen and the production of a charged surface.
The plates were also subjected to radiation to render them sterile. Both of these
processes enhance cell attachment to the plastic surfaces. Plates were used as supplied,
or treated with serum, fibronectin, collagen or gelatin (as described in Section 2.4.2.).
Cells were cultured in a humidified CO2 incubator, with an atmosphere containing 5%
CO2 and at a temperature of 41°C (avian body temperature).
In experiments involving anti-LH antisera, the antibodies were added in
sufficient quantity calculated to bind at least twice the amount of LH used. Final
concentrations of 1 : 1000 for anti chicken LH (3/9) and of 1 : 5000 for anti ovine LH
were used to immunoneutralize chicken and ovine LH , respectively, added to the
culture media at a concentration of 25 ng/ml.
2.4.6. Immunocytochemistry
Cells were prepared for culture as described in Sections 3.3.1 and 3.3.2.
Granulosa and thecal cells were plated on autoclaved glass coverslips in 12-well
multiwell plates at 50,000 and 250,000 cells per cm2 respectively in 1 ml medium
Ml99 with FCS (3% v/v). Cells were allowed to attach in a 48 hour period after which
they were washed with serum-free medium Ml99 then stained.
The principles of the immunocytochemical method used to determine IGF-I







Figure 2.4. The immunocytochemical staining process used to detect IGF-I. The primary antiserum
(Rl) binds to IGF-I and is then bound to the second antiserum (D), donkey anti-rabbit.
The rabbit peroxidase anti-peroxidase is then bound to this complex by the second antibody.
The complex is visualised when 3,3' Diaminobenzidine (DAB) is added, the peroxidase (P)
oxidises the DAB substrate to a brown product.
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rabbits and the second antiserum (which binds to the primary antiserum) was raised in
donkey against rabbit immunoglobulins. The primary antibody binds IGF-I, the second
(bridging) antibody is added in excess and binds the primary antibody and the rabbit
peroxidase anti-peroxidase complex. The addition of 3, 3'-diaminobenzidine (DAB)
results in a complex reactionof this substrate with peroxidase, the end point of which is
a development of brown colouration. The chemistry of the oxidation ofDAB has not
been clearly established, partly because the reaction product is so highly insoluble and,
therefore, difficult to work with (Karnovsky and Robinson, 1981).
Cells were fixed in 4% paraformaldehyde for lh at room temperature, washed
for 15 minutes in PBS (0.1 mol/1) (repeated x3). Cells were then incubated for 60
minutes in H2O2 (1% v/v), 10 minutes in saponin and 30 minutes in NDS (5% v/v) and
were washed as described above with PBS between each incubation. The primary
antibody was incubated with the cells at 4°C overnight which were then incubated
with donkey anti rabbit serum (DARS), the second antibody, used at 1:200 for lhour at
room temperature and with rabbit peroxidase-anti-peroxidase (PAP) used at 1:150 for
lhour at room temperature; cells were washed in PBS following each incubation. The
cells were then washed with Tris-HCl (50 mmol/1, pH 7.4) for 5 minutes at room
temperature then with 10 ml of a DAB solution (DAB (0.05% w/v), Tris-HCl (50
mmol/1, pH 7.4), H2O2 (0.1% v/v)) was added to stain the antibody complex. At this
point the cells were photographed on an inverse microscope using Kodak Ektachrome
64T slide film. Following photography the cells were washed twice in Tris-HCl (50
mmol/1, pH 7.4), then dehydrated with alcohol followed by xylene and mounted with
DPX on glass slides.
2.4.7. Cell growth
2.4.7.1. Measurement of [3H]-thymidine incorporation
In order to measure DNA synthesis, the incorporation of a tritiated [3H] species
of the nucleoside, thymidine (a constituent of DNA) into the DNA of cells was used as
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an index of this activity. This radioisotope was obtained from Amersham International
pic (Amersham, U.K.).
Cells suspended in medium M199 supplemented as described in Section 2.4.1.
were plated in accurately measured volumes with a pipette and then placed in the
incubator, undisturbed for 24 hours; this was the attachment period during which any
movement or fluctuation in temperature or CO2 inhibited attachment. Cells were
visually inspected using a phase-contrast microscope after 24 hours and every 24 hours
thereafter until termination of the culture. After 48 hours the original medium was
replaced with fresh supplemented medium Ml99 without any FCS in order to starve
the cells and remove serum which may otherwise interfere with cell growth
measurements. The cells were growth restricted in order to synchronise them in GO.
After 72 hours the medium was replaced and supplemented with the experimental
treatments to stimulate cell growth, 8 hours following this (80 hours) [3H]-thymidine
label (Amersham International pic, Amersham, U.K.) was added to each well (0.3
pCi/ml). The culture procedure was terminated after 96 hours by aspirating the medium
completely, taking care not to disturb the monolayer of cells. Wells were washed twice
with unsupplemented medium Ml99 (2 x 500 pi per well) warmed to room
temperature, then 1 ml of cold trichloroacetic acid (10% w/v) was added to each well
and the plates incubated at 4°C for 20 minutes to precipitate the DNA. The acid was
aspirated and 500 pi of sodium hydroxide (0.5 mol/1) added per well, then the plates
were incubated at 37°C for 2 hours on a shaker to solubilise the attached cells. The
solution from each well was transferred to scintillation vials which were filled with
Optiphase X scintillant (Pharmacia LKB, Milton Keynes, U.K.). The radioactivity in
the samples was then measured in a scintillation counter.
2.4.7.2. Measurement of DNA
The DNA content of cultured granulosa and thecal cells was measured using the
fluorometric assay described by West et al. (1985).
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DNA standards were set up in test tubes by diluting a stock solution of salmon
testis DNA (2 mg/ml) (Sigma Chemical Co., Poole U.K.), the final concentrations of
these were 100, 200, 400, 600, 800, 1000, and 2000 ng/tube. The cells and standards
were treated with 1.4 ml cold EDTA (10 mmol/1, pH 12.3), incubated at 37°C for 20
minutes and then cooled on ice. The pH was then lowered to 7 with potassium
dihydrogen orthophosphate (2 mol/1). Bisbenzamide (1.5 ml, 200 ng/ml) (Hoescht No.
33258, supplied by Sigma Chemical Co., Poole, U.K.) was added to all the samples
and the resulting fluorescence was measured by spectrophotometry: the excitation and
emission wavelengths were 350 and 455 nm, respectively.
2.4.8. Steroidogenesis
Oestradiol, progesterone and androstenedione were measured in cell-
conditioned medium by radioimmunoassay. Samples were stored frozen at -20°C
before assay.
2.4.8.1. Progesterone radioimmunoassay
The progesterone assay was a double antibody RIA previously described by
Corrie et al. (1981) and Webb (1987). The primary antiserum was produced in a rabbit
(code R 31/8, obtained from Dr. R. Webb, IAPGR, Roslin, U.K.)
The reagents were dispensed into glass tubes and diluted with phosphate gelatin
buffer containing di-sodium hydrogen orthophosphate (50 mmol/1) sodium chloride
(0.15 mol/1) and thimerosal (0.1% w/v) at pH 7.5. The progesterone standard curve
was constructed at concentrations of 10, 20, 40, 70, 130, 250, 500 and 1000 pg/tube.
The label used was [1251]-progesterone (obtained from Ian Swanson, MRC Centre for
Reproductive Biology, Edinburgh). The primary antiserum (R 31/8) was used at an
initial dilution of 1 : 8000. The secondary antiserum was DARS used at an initial
dilution of 1 : 35 (diluted with PBS containing EDTA (10 mmol/1)), the carrier was
NRS used at a dilution of 1 : 300.
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The standards and samples were diluted with assay buffer (to 500 jil), the label
was added (100 pi) then the primary antiserum (200 (ll). Tubes were then vortexed and
incubated for 3 hours at room temperature. The secondary antiserum (100 pi) and
carrier (100 pi) were added, the tubes re-vortexed and incubated overnight at 4°C. The
tubes were washed with 1 ml of buffer and spun at 1860 g for 30 minutes; the
supernatant was discarded and the radioactivity in the pellets measured on a
Gammamaster gamma counter.
2.4.8.3. Androstenedione radioimmunoassay
An androstenedione radioimmunoassay kit was purchased from Biogenesis
(Bournemouth, U.K.). The kit included a label ([125I]-androstenedione), standards
(final concentrations of 1, 3, 10, 30, 100, 300, 1000 and 3000 pg / tube), primary
antibody (rabbit anti-androstenedione serum) and a secondary antibody (goat anti-rabbit
gamma globulin serum). Precipitation of the antibody-antigen complex was aided with
polyethylene glycol. The antiserum supplied was diluted 1 : 3 prior to use.
Samples (150 pi) or standard were aliquoted into glass test tubes in duplicate.
To each tube 300 pi of label (approx. 20,000 c.p.m.) and 100 pi of the antiserum was
added. The tubes were then vortexed and incubated at 37°C in a water bath for 30
minutes. The precipitating reagent (750 pi) was added and the tubes centrifuged at
1500 g at 4°C for 20 minutes. The supernatant was then aspirated and the radioactivity
in the pellets measured on a Gammamaster gamma counter.
2.4.9. IGF Binding protein analysis
Cell-conditioned medium was concentrated using Microsep centrifugal micro-
concentrators (Flowgen Instruments Ltd., Sittingbourne, U.K.), following the
manufacturer's protocol. The concentrators had a 10 kDa molecular weight cut off and
the final concentrated volume was 50 pi. The concentrate was denatured by boiling for
5 minutes in Laemlli buffer (Tris-HCl (50 mmol/1, pH 6.8), SDS (1% w/v), glycerol
(10% (v/v) with bromophenol blue) prior to loading on an SDS polyacrylamide gel
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with protein molecular weight markers (Sigma Chemical Co., Poole, U.K.). A 12%
acrylamide separating gel was cast with a 5% stacking gel. Samples were run through
the stacking gel at a current of 40 mA/gel. Once the samples were stacked the current
was increased to 60 mA/gel. The running buffer used was Tris base (0.3% w/v),
glycine (1.44% w/v) and SDS (0.1% w/v) After electrophoresis the gel was carefully
placed on a sheet of nitrocellulose and electroblotted at 120 mA; transfer was complete
in 1-2 hours.
Following electroblotting, the nitrocellulose filters were placed in chambers
containing TS buffer (Tris HC1 (10 mmol/1, pH 7.4), sodium chloride (0.15 mol/1))
with sodium azide (0.5 mg/ml) and Nonidet P40 (3% v/v) and incubated for 30
minutes at 4°C. The filters were then rinsed with TS buffer and incubated with TS
buffer containing RIA grade BSA (1% w/v)(Sigma Chemical Co., Poole, U.K.) for 2
hours. This was followed by incubation for 2 periods of 20 minutes with TS buffer
containing tween 20 (0.1% v/v) then an overnight (minimum 16 hours) incubation with
TS buffer containing RIA grade BSA (1% w/v), Tween 20 (0.1% v/v) and [125I]-IGF-
I (200,000 cpm/ml) with or without unlabelled IGF-I (2 pig/filter, 0.2 (ig/ml). The filter
was then washed in TS buffer containing Tween 20 (0.1% v/v) (2 x 15 mins.) and then
in TS buffer (2x15 mins). All incubations and washes were carried out at 4°C. The
filter was air dried and placed in a cassette with X-ray film for autoradiography for
approximately 7 days at -70°C. The film was developed in an automated film
developing machine.
2.4.10. Ligand binding studies
The method used has been previously described (Ewton et al., 1987; Duclos et
al., 1991). Tissue culture plates were pre-incubated overnight with a solution of RIA
grade BSA (10% w/v) (Sigma Chemical Co., Poole, U.K.) to reduce non-specific
binding of the radiolabeled ligand to the surface of the wells. This solution was
aspirated immediately prior to cell plating. Ovarian cells were prepared for culture and
plated as described in Sections 2.4.4. and 2.4.5. Cells were seeded for 48 hours in
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medium Ml99 with FCS (3% v/v) then growth restricted for 24 hours in serum-free
medium M199. This medium was replaced with medium M199 containing 0.5% BSA.
Treatments were then added to the wells and the plates incubated at room temperature
on a slowly rotating shaker for 4 hours. Medium was aspirated and the cells washed
twice in cold medium M199. Cells were solubilised in SDS (0.2% w/v) on a rotary
shaker for 2-4 hours at room temperature. Dissolved cells were dispensed into
polystyrene tubes and the radioactivity measured on a Gammamaster gamma counter.
2.5. Data Analysis
Data from replicate experiments were meaned and the standard devaiation from
the mean calculated for each replicate group. Student's t test was used to test
significance between groups of data. Analysis of variance was performed on data using
MINITAB (Minitab, Inc.) in order to determine whether two treatments were
synergistic or not (an example of this analysis is shown in Section 2.5.1. below).
The AssayZap program (Biosoft, Cambridge, U.K.) was used to analyse and
plot the data obtained from the radioimmunoassays described in 2.2.3 and 2.4.7. The
ALLFIT program (De Lean et al., 1978) was used to calculate ED50s of dose-response
curves and for comparisons of curves, the LIGAND program (Munson and Rodbard,
1980) was used to fit the binding data generated in the receptor binding studies
described in Chapter 6.
2.5.1. Determination of synergy
An example of the data analysis performed to determine the occurrence of
synergy is shown below. In this example the data set represents the results of an
experiment in which granulosa cells were treated with IGF-I, LH or IGF-I with LH
and then the effects on [3H]-thymidine incorporation by these cells was measured
(values are c.p.m./well).
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MTB > ANOVA C3= C1+C2+C1*C2
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Factor Type Levels Values
CI fixed 2 01
C2 fixed 2 01
Analysis of Variance for C3
Source DF SS MS F P
CI 1 7475776 7475776 297.42 0.000
C2 1 6997172 6997172 278.38 0.000
CI *C2 1 2266787 2266787 90.18 0.000
Error 8 201083 25135
Total 11 16940818 1540074
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CHAPTER 3: THE EXPRESSION OF IGF-I mRNA AND THE
OCCURRENCE OF IGF-I IN CHICKEN FOLLICULAR
TISSUES
3.1. Introduction
IGF-I gene expression and peptide concentrations were measured in the
granulosa and thecal tissue of chicken ovarian pre-ovulatory follicles. RNA was
extracted from homogenised tissue samples and the IGF-I messenger (m) RNA content
analysed using a method involving the reverse transcription polymerase chain reaction
(RT-PCR) in which RNA was reverse transcribed to cDNA, amplified with IGF-I-
specific primers and the resulting DNA analysed for IGF-I cDNA. The concentrations
of IGF-I peptide in these tissues was examined by extracting tissue homogenates and
then measuring the immunoactive IGF-I activity in the extracts by radioimmunoassay.
The occurrence of IGF-I on granulosa and thecal cells in vitro was examined by
immunocytochemistry.
3.2. IGF-I Gene Expression In Follicular Tissues Using RT-PCR
3.2.1. Optimising PCR conditions
Polymerase chain reaction conditions were optimised in an experiment in which
the annealing temperature and melting and extension times were varied. Total liver
RNA was reverse transcribed and subjected to reactions with annealing temperatures
from 52°C to 54°C. Melting and extension temperatures were 94°C and 72°C,
respectively. The melting times were between 1 and 2 minutes and those for extension
were 3 to 5 minutes. Products of the reaction were analysed by polyacrylamide gel
electrophoresis (PAGE). The gels on which the IGF-I cDNA bands were clearest and
without extraneous bands were obtained with an annealing temperature of 53°C and
with melting and extending times of 1 minute and 3 minutes, respectively. These
conditions were used in the experiments described below.
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3.2.2. IGF-I gene expression in granulosa and thecal tissues
Each study was performed with RNA extracted from granulosa layers pooled
from the Fl, F2, F3 and F4 follicles of 3 laying hens and from similarly pooled thecal
layers. RNA from liver was used as a positive control, since the liver has been shown
to express IGF-I mRNA in chickens (Fawcett and Bulfield, 1990), distilled water was
used as the negative control.
RNA from the three tissues and an equivalent volume of distilled water was
reverse transcribed and the resulting cDNA (transcribed from 0.1 pg of RNA) was
used for PCRs. Two sets of oligo primers were used; IGF-I primers with a predicted
product size of 200 bp, and (3-actin primers with a predicted product size of 290 bp.
The second set of primers were used to control for the integrity of the RNA samples.
PCR products were subjected to PAGE. Analysis of the gels (shown in Figure
3.1a), showed that IGF-I cDNA and p-actin cDNA was present in samples derived
from granulosa, theca and liver RNA, neither was present in the negative control.
3.2.3. Southern analysis of PCR products
The experiments described above were repeated. The resulting PCR products
were run on 4% agarose gels, which were Southern blotted with a cIGF-I cDNA probe
(Figure 3.1b).
Careful examination of the gel revealed bands of DNA of 200 bp and 290 bp in
length, corresponding to the size of PCR reaction products expected for IGF-I cDNA
and P-actin cDNA respectively. No bands were visible in the negative control tracks.
On the Southern blot the probe hybridised with DNA bands in the granulosa, theca and
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negative control tracks. The hybridised DNA bands were 200 bp in length
corresponding with the size of the IGF-I PCR reaction product. This is further
confirmation that the bands of 200 b.p. are cIGF-I cDNA.
3.2.4. IGF-I gene expression in follicles at different stages of
development
RNA was extracted from granulosa and thecal tissues of Fl, F2, F3 and F4
follicles in the developmental hierarchy. These samples, together with liver RNA and
distilled water as positive and negative controls, were analysed by RT-PCR and
Southern blotting as described above. Photographs of the gels and the resulting
autoradiograph are shown in Figure 3.2.
DNA bands of 200 bp (cIGF-I) and 290 bp ((3-actin) in length were visible on
sample tracks from follicles at all four developmental stages. The 200 b.p. band was
confirmed as cIGF-I cDNA by the Southern blot. The degree of hybridisation intensity
of the IGF-I probe to the cDNA derived from thecal RNA was, in ascending order, Fl
< F2 < F3 < F4. However, when the experiment was repeated (results not shown)
there was no detectable difference in the intensity of the hybridisation.
3.3. The Measurement Of IGF-I Peptide Concentrations In
Chicken Follicular Tissues
IGF-I peptide concentrations in both granulosa and thecal tissues were
measured. IGF-I was extracted from these tissues by two different methods and then
measured by RIA.
3.3.1. Analysis of extracted tissue samples
Granulosa, theca and liver were removed from four laying hens; the material
from each hen was kept separate. Samples of each tissue (1 g) and 1 ml of distilled
water were extracted with acetic acid : ethanol; acetone (liver and distilled water were
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included as positive and negative controls, respectively). IGF-I concentrations were
measured by RIA. The results of this experiment and a repeat are shown in table 3.1.
Table 3.1 IGF-I concentrations in liver, granulosa and thecal tissue samples
extracted with acetic acid, ethanol and acetone. In both experiments n =
4; * denotes p > 0.001 versus the other tissues in the experiment.
Measurement was by radioiummunoassay.
IGF-I was present in all the tissues examined in these experiments, the greatest
concentrations were found in the granulosa samples in both experiments. However,
concentrations of IGF-I in the second experiment were lower. The next highest
concentration was found in the theca then the liver. IGF-I was undetected in the
negative controls in both experiments.
3.3.2. Analysis of acid chromatographed tissue samples
IGF-I extraction methods have been criticised for incomplete removal of the
binding proteins from this peptide, a potential source of interference. In an attempt to
confirm the results described above, similar tissues were subjected to acid
chromatography to separate IGF-I more completely from binding proteins.
3.3.2.1. Column characterisation
A chromatography column was set up and characterised as described in Chapter
2. This first peak was eluted from the column at a volume of 18 ml, this
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Figure 3.3. U.V. absorbance of marker proteins run on a Sephadex G 50-super-
fine column used to separate IGF-I from its binding proteins. The
column flow rate was 0.55 ml per minute. Cytochrome-C and
aprotinin peaks are marked as (a) and (b) respectively.
Figure 3.4. Radioactivity eluted in 1ml fractions from a Sephadex G 50-superfine
column loaded with [125I]-IGF-I.
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was the void volume (Vo) of the column. A range of molecular weight markers were
then used to characterise the column in more detail. The trace from the U.V. detector is
shown in Figure 3.3. The two larger markers were eluted in the void volume.
The characteristic behaviour of free IGF-I on the column was examined by
loading radiolabeled IGF-I on the column, collecting the resulting fractions and
measuring the radioactivity of each. There was a major peak of [125I]-IGF-I and a
smaller peak of free 125I (Figure 3.4). The total volume (Vt) of the column was
calculated from the small peak of free 125I. The column characterisation results are
summarised in table 3.2.; this was confirmed in a second experiment. Unbound IGF-I
eluted at a volume of 29-39 ml with a peak at 31 ml, within the total column volume.
This peak is clearly distinct from the peak of cytochrome-C (12.4 kDa). At present no
IGF binding protein has been characterised with a size less than 21.5 kDa. Thus, the
column appeared to separate IGF-I from its binding proteins.
Table 3.2 Elution volumes of proteins and radioisotopes on a sephadex G50-fine
chromatography column.
Marker Elution Volume (ml)
Blue Dextran (Vo) 18.5
Bovine Serum Albumin (66 kDa) 18.5
Carbonic Anhydrase (29 kDa) 18.5
Cytochrome C (12.4 kDa) 21.5
Aprotinin (6.5 kDa) 34.5
125I (Vt) 57-62 (peak at 59)
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Figure 3.5. IGF-I concentrations in granulosa (a), thecal (b) and liver (c) samples
which had been subjected to acid chromatography. Peaks corres¬
ponding to immuno-active IGF-I are appropriately labelled.
Measurement was by radioimmunoassay, fractions were 1 ml
volume.
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3.3.2.2. Acid chromatography of samples
Samples of granulosa, thecal and liver tissues (0.5 g of each) were
homogenised in acetic acid. The homogenates (0.5 ml of 0.6 g/ml) were loaded on the
column and run through it. Fractions of the eluate (1 ml) were collected, then assayed
for IGF-I. IGF-I activity was present in all three samples which were analysed (Figure
3.5). In each sample a peak of activity was observed in the range 27-36 ml indicating
the presence of free IGF-I. In theca and granulosa samples, activity was also present in
the void volume and had therefore eluted with an apparent weight larger than expected.
In all three samples activity eluted at Vt implying that degradation of the peptide had
occurred.
This experiment shows that the different tissues examined respond differendy to
acid chromatography, i.e. the separation of IGF-I from binding proteins appears to be
dependent on the tissue type.
3.4. Detection OfIGF-I In Granulosa And Thecal Cells In
Vitro
The expression of IGF-I in cultured granulosa and thecal cells was investigated
by immunocytochemical staining. Cells were prepared for culture as described in
Section 4.2. After 24 hours culture the cells were washed several times with serum-
free medium and then fixed with paraformaldehyde. Cells were incubated with an anti-
IGF-I antibody (Armstrong et al„ 1990) at dilutions of 1 : 1000 and 1 : 2000, or with
control normal rabbit serum (NRS). In order to determine the non-specific nature of the
antibody an aliquot of the antiserum was negated by pre-incubation with IGF-I and
then used as described. Following staining with DAB the cells were photographed.
Both the thecal and granulosa cells were stained when incubated with the anti-
IGF-I antibody but not when incubated with non-immune rabbit serum. Staining was
negated by pre-incubation of the antiserum with IGF-I. The staining of both cell types
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Cells containing immunocytochemically identified IGF-I are shown in Figures 3.6. and
3.7. Granulosa cells incubated with the anti-IGF-I antibody at 1 : 1000 with and
without negation with 5 |ig IGF-I or incubated with the control non-immune rabbit
serum are shown in Figure 3.6. Thecal cells subjected to the same treatments are shown
in Figure 3.7. These results indicate that R2/2 specifically stained IGF-I in both thecal
and granulosa cells, showing that the peptide is present in both cell types in vitro.
3.5. Summary and Discussion
Granulosa and thecal tissues were shown to express IGF-I mRNA in
experiments which used reverse transcription of extracted RNA and specific
amplification of IGF-I cDNA produced by the polymerase chain reaction (RT-PCR).
Further experiments in which RNA was extracted from follicles at different stages of
development showed that both tissues expressed IGF-I mRNA at all the stages
examined (Fl, F2, F3 and F4 follicles). IGF-I mRNA expression in chickens is
therefore different from that observed in the rat since rat thecal cells do not express this
gene (Oliver et al., 1989). The chicken ovary also differs from the human ovary, since
IGF-I gene expression was not detected in human granulosa cells (Geisthovel et al.,
1989). Thus no general pattern of ovarian IGF-I gene expression has emerged from the
studies in mammals or birds as yet.
The PCR amplifies the original transcribed DNA by up to 109-fold in a 30 cycle
reaction. One consequence of this is that differences in the efficiency of the reverse
transcription reactions and errors in aliquoting the RNA starting material result in large
differences in the amount of PCR product. For this reason the results could not be used
to quantify differences in IGF-I mRNA expression. This was emphasised by the study
described in Section 3.2.4. in which the first experiment indicated possible
developmentally-related changes in IGF-I gene expression in thecal tissues (Figure
3.2), but when this was repeated no such change was evident. Further work is
therefore required to determine whether there are developmentally, or tissue-related
changes in IGF-I expression in chicken follicles.
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The concentrations of IGF-I itself was measured in extracts from granulosa and
thecal tissues. Initially a method developed by D'Ercole et al. (1984) and modified by
Enright et al.{ 1989) was used. This showed that IGF-I was present in both the tissues,
in concentrations greater than in liver. This suggests that both tissues in the pre¬
ovulatory follicle which were examined, are important sites of production and possibly
action.
The effects of the binding proteins on immunoassays are complex and difficult
to predict since binding proteins may compete with anti-IGF-I antibodies for binding of
[125I]-IGF-I, this could result in higher estimates of concentrations of IGF-I than those
actually present. However, this effect is counterbalanced by an underestimate of IGF-I
due to binding of unlabelled IGF-I by binding proteins (Daughaday et al., 1987).
Methods to separate IGF-I from their BPs by acidification, followed by precipitation
with ethanol (Daughaday et al., 1980) have been criticised for incomplete removal of
BPs in more recent studies (Daughaday et al., 1987; Holland et al., 1988; Mesiano et
al., 1988). Therefore, to remove the interfering effects of binding proteins and thus
measure IGF-I tissue concentrations more accurately than by extraction alone, acid
extracted samples were subjected to acid chromatography. However, significant IGF-I
immunoactivity was present with larger eluted proteins in both granulosa and thecal
samples, possibly IGF-I binding proteins. This indicated that the separation of peptide
from binding protein was not complete in this experiment. Interestingly, the relative
order of concentrations of the protein fraction associated with IGF-I is the same as that
of the peptide as measured without chromatography. A possible explanation of this is
that IGFBP concentrations vary between the three tissues rather than the free peptide,
and it was these that were measured in the extracted samples and not the free peptide.
This was not proved in experiments described here, further work with a cIGFBP RIA
may elucidate this situation.
The third part of the experimental study described in this chapter confirmed,
immunocytochemically, that the peptide was present in both granulosa and thecal cells
in vitro.
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CHAPTER 4: THE EFFECTS OF IGF-I AND GONADO¬
TROPHS ON OVARIAN CELLS IN VITRO
4.1. Introduction
Tissue culture systems for chicken granulosa and thecal cells were developed to
examine the effects of exogenous IGF-I and its interactions with gonadotrophins on the
DNA synthesis of these cells. Cell cultures derived from follicles at different
developmental stages were used to determine whether the effects of IGF-I or
gonadotrophins on DNA synthesis are developmentally-regulated.
4.2. Cell Culture System Development
Existing tissue culture methods were adapted to establish a system for maintaining
both granulosa and thecal cells in culture. The conditions considered in this exercise
were the dispersal methods, attachment conditions and cell plating density. Granulosa
and thecal tissues are quite different in their structure; granulosa cells are epithelial-type
cells arranged in a single-cell layer, while the theca is more fibrous comprising a mixed
population of cells, the majority of which are fibroblasts. The cells of the granulosa
layer are consequently easier to disperse than those of the thecal layer. For these
reasons different approaches were taken to the development of culture systems for these
cells.
4.2.1. Granulosa cell culture system
The method of dispersion was esablished by adapting the protocol published by
Zakar and Hertelendy (1980a); this protocol involves enzymatic dispersion by
incubation of the granulosa layer for 10 minutes at 37°C with a collagenase solution
followed by mechanical dispersion by continuous pipetting of the cell suspension. The
10 minute incubation was found to be unecessary for good dispersal of the cells,
therefore the method was simplified to a single step in which cells were suspended in a
collagenase solution in Ml99 (5mg collagenase per ml) at room temperature and
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pipetted continuously for approximately 1-3 minutes. Following dispersal the
collagenase was removed by washing the cells in Ml99 as described in Chapter 2. Cell
viability of dispersed cells was measured by the trypan blue exclusion test, also
described in Chapter 2, which showed it to be invariably greater than 95%.
Experiments were conducted to optimise the attachment of granulosa cells to plates.
Tissue culture plates referred to as "untreated" in these experiments had, however, been
treated during manufacture by corona discharge and radiation. Both these processes
enhance the attachment of cells to the plastic surfaces (see Section 2.4.5.).
In an initial study granulosa cells suspended in Ml99 (at 5 xlO5 cells per ml) with
or without 10% (v/v) fetal calf serum (FCS) were seeded on "untreated" plastic
multiwell tissue culture plates. The unsupplemented cells did not attach to the wells;
however cells suspended with FCS did attach, but the efficiency estimated by
microscopic examination was very low. Several factors are known to affect the
attachment ofmany types of dispersed cells to plastic surfaces. Therefore, comparisons
of granulosa cell attachment to: "untreated" plates (group 1); plates pre-incubated for 24
hours with neat FCS or donor bovine serum (DBS) then aspirated (group 2); plates pre-
coated with gelatin, fibronectin, or collagen (group 3) were made. The cells were
seeded in suspensions containing 5 or 10% FCS (v/v) and incubated at 41°C and 5%
co2.
Examination of the plates after 24 hours revealed that cell attachment had occured to
the surfaces in all the treatment groups. However, the degree of attachment was greatest
on the plates of group 3. After 72 hours of culture no cells remained attached on the
plates of group 1 and there was a marked difference in the degree of attachment to the
plates of groups 2 and 3. After 120 hours the cells on the plates in group 3 remained
attached and appeared healthy. Thus pre-treating the plate surface affected the efficiency
of granulosa cell attachment.
To determine the optimum plate-coating material, granulosa cells were seeded on
plates coated with the treatments listed in group 3 above. Following 120 hours of
culture, the medium was changed to M199 containing 0, 1, 3 or 5% FCS (v/v). The
89
incorporation of [3H]-thymidine into these cells following 24 hours of these treatments
was then measured using the method described in Chapter 2. The results (Figure 4.1)
were analysed by Student's t test (unpaired, two-tailed) which showed that there were
no significant differences in the DNA synthesis response to FCS between cells on
plates coated in three different ways. The results also showed that the response was
significantly different between zero and 3% FCS treated cells on all plates, the
differences with the zero treatment were only significant for cells on fibronectin-coated



















Figure 4.1 Mean incorporation of [3H]-thymidine by triplicate cultures of
granulosa cells seeded on plates coated as indicated and
untreated or treated by fetal calf serum (FCS). Standard
deviation of the mean is shown as a vertical line. Significant
differences (P values) of incorporation by treated cells
compared with untreated cells are indicated.
These results led to the use of gelatin for pre-coating of plates in the granulosa cell
culture system, since gelatin is the most economic of the three treatments, and the
inclusion of 3% FCS in medium to facilitate the attachment of the cells.
* P < 0.05
** P < 0.01
*** P < 0.001
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In order to determine the optimum cell density for plating granulosa cells in this
system, cells were dispersed and suspended in medium containing 3% FCS at densities
ranging from 2 xKFto 1.5 xlO6 cells / ml of medium. These suspensions were then
plated on 48-well plates which had been gelatin treated at 0.5ml per well (area of each
well = 1cm2), six wells were plated per density group. Following the cell attachment
period (48 hours) the medium in the cultures was changed with fresh medium
containing 0.01% FCS (v/v) for 24 hours, whereupon this was repeated and half the
cultures were treated with 3% FCS (v/v). The incorporation of [3H]-thymidine into the
cells following 24 hours of treatment was measured as described in Chapter 2.
The total radioactivity from each triplicate set of cultures was measured and the
mean and standard deviation calculated. These values were plotted against density and
the resulting graph is shown in Figure 4.2. Uptake of [3H]-thymidine by granulosa
cells treated with serum was greatest when they were seeded at a density of 5 xlO4 cells
per 1cm2 well.
4.2.2. Thecal cell culture system
Methods published by Marrone and Hertelendy (1983) and Tilly and Johnson
(1989) were adapted to establish a protocol for the dispersion and purification of
chicken thecal cells. A different approach from that used to culture granulosa cells was
necessary since the thecal layer is more fibrous and contains blood vessels. This
requires more digestion to disperse the cells and the removal of contaminating red blood
cells (RBC). The main features of this method, (described in detail in Section 2.2.4.2.)
are enzymatic digestion in collagenase solution for 90 minutes at 37°C with regular





























Mean uptake of [3H]-thymidine by granulosa (a) and thecal
cells (b), cultured in triplicate and seeded at different
densities. Cells were untreated (control) or treated with fetal
calf serum (3% FCS).
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blood cells on a percoll gradient followed by lysis. Following these procedures, cells
were washed as in the method for preparing granulosa cells. The viability of dispersed
thecal cells was routinely measured by trypan blue exclusion and found to be 70-80%.
Initial experiments were conducted to examine the plating efficiency of dispersed
thecal cells. Cells were seeded on plastic mutiwell tissue culture plates which were
untreated or had been treated with collagen or gelatin. Examination of cultures after 24,
48 and 72 hours showed that the plating efficiency was good in all three groups and
that there was no visible difference between the groups. The supplementation of the
medium with 3% FCS was found to enhance the plating efficiency compared with
unsupplemented controls. Therefore in further experiments thecal cells were cultured on
untreated plastic plates in medium supplemented with 3% FCS.
In order to determine the optimum plating density, an experiment was conducted
with thecal cells, identical in design to that described for granulosa cells in Section
4.2.1. The results shown in Figure 4.2 indicate that [3H]-thymidine incorporation by
thecal cells stimulated with serum was greatest in cells cultured at a density of 2.5xl05
cells per 1cm2 well.
4.2.3. The granulosa and thecal cell culture systems
Tissue culture systems were based on the preliminary experiments described above
in Sections 4.2.1 and 4.2.2. These systems include a growth restriction step, during
which the cells are cultured in medium with a very low serum content (0.01% v/v) for
24 hours. This step is to make cells enter the resting stage (GO) of the cell cycle. This
results in synchronisation of their DNA replication cycles when stimulated with growth
factors. The main features of these systems are shown in Table 4.1. below.
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Table 4.1. Culture system conditions for chicken granulosa and thecal cells.
Conditions Granulosa Cells Thecal Cells
Incubation Temperature 41°C 41°C
coz 3.5% 3.5 %
Treatment of culture dishes Gelatin None
Serum in medium for plating 3%-5% 3%-5%
Plating density 5X104 cells/well 2.5x105 cells/well
Cell attachment period 48 hours 48 hours
Restriction period 24 hours 24 hours
4.2.4. Morphology of granulosa and thecal cells in vitro
During the preliminary experiments described in 4.2.1 and 4.2.2, both cell types
were photographed. Figure 4.3 shows photomicrographs of granulosa and thecal cells
72 hours following initial seeding of the cells on plastic, multi-well plates. Granulosa
cells which are initially round following dispersal become flattened on attaching to the
plates. Thecal cell cultures are heterogeneous; two cell types were clearly visible, these
were elongated fibroblasts and round cells, presumed to be steroidogenic cells. The
round cells were aggregated into well separated clumps on the plate, the intervening
areas of the plate were covered by the fibroblasts.
4.3. The Effects Of Serum On Follicular Cells In vitro
The effect of serum on DNA synthesis was investigated in granulosa and thecal
cells prepared from the three largest pre-ovulatory follicles of a single hen (Fl, F2 and
F3), pooled and cultured as described in Section 2.4.5. The cells were treated with
FCS at concentrations from 0.1% to 10% (v/v) or with medium
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The mean incorporation of [3H]-thymidine by granulosa (a) and
thecal cells (b), cultured in triplicate and treated with fetal calf
serum (FCS) in two independent experiments (1 and 2).
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containing no serum. The effects of this treatment on [3H]-thymidine incorporation into
the cultured cells are shown in Figure 4.4.
Both granulosa and thecal cells responded to FCS by incorporating [3H]-thymidine
in a dose-dependent manner, the ED50 values of these responses were 0.7 and 0.3 %
FCS for granulosa and 1 and 0.5 % FCS for thecal cells. For granulosa cells there was
a maximum response between the 1% and 5% FCS. The maximum response of thecal
cells to serum stimulation did not appear to have been achieved in the range of
concentrations used.
The greatest responses of thecal cells to stimulation were 14.2 and 14.4-fold greater
than the greatest response of granulosa cells in experiments 1 and 2 respectively. When
calculated as the response per plated cell, the maximum responses of thecal cells were
2.8 and 2.9-fold greater than those of granulosa cells in each experiment.
4.4. The Effects OfIGF-I And Gonadotrophins On Ovarian
Cells In Vitro
The mitogenic effects of IGF-I and gonadotrophins separately or in combination on
granulosa and thecal cells were determined in vitro. In addition, the steroidogenic
responses to gonadotrophin treatments were determined to confirm the biological
activity of these hormone preparations.
Ovine gonadotrophins were used because purified chicken (c) LH was in very short
supply and pure cFSH was unavailable. However, a limited quantity of cLH was
available and was used to repeat some of the experiments involving oLH in order to
determine whether there is any difference in the action of the two LHs in the in vitro
system.
In the experiments described below, the cells were obtained from the three largest
pre-ovulatory follicles of hens (Fl, F2 and F3) and placed in granulosa or thecal cell
pools.
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4.4.1. The mitogenic response of ovarian cells to IGF-I in vitro
Granulosa and thecal cells were prepared for culture as described in Chapter 2.
Cells were seeded and cultured according to the protocol described in Table 4.1. The
response of both cell types to IGF-I was examined by adding different doses of the
peptide and then measuring the stimulatory effect on the incorporation of [3H]-
thymidine into the DNA of the cells.
IGF-I doses ranged from 0.5 to 100 ng/ml. In addition, cells were stimulated with
3% (v/v) heat inactivated FCS as a positive control for the stimulation of [3H]-
thymidine incorporation in both granulosa and thecal cells. As a negative control, cells
were cultured during the treatment period in medium with a very low FCS content
(0.01% v/v). The treatments were carried out on triplicate cultures. In each experiment
the granulosa and thecal tissues were obtained from the same hen, the experiments were
repeated twice.
IGF-I stimulated uptake of [3H]-thymidine in a dose-dependent manner by both
granulosa and thecal cells (Figures 4.5 and 4.6). All the cultures responded to FCS
treatment (positive control) with an increased [3H]-thymidine incorporation compared
with untreated cells. The ED50 values (± S.E.M.) of IGF-I were 7.37 (± 1.46), 11.61
(+ 7.28) and 11.83 (± 2.57) ng/ml for triplicate granulosa cell cultures prepared from
the three individual birds and 20.05 (± 28.31), 15.16 (± 4.70) and 7.05 (± 0.60) for
triplicate thecal cell cultures.
The difference in the uptake of [3H]-thymidine by serum-treated cultures, compared
with that in the untreated control cultures was measured for granulosa and thecal cells.
The value for thecal cultures was significantly greater per plated cell than that in



































Figure 4.5. Mean incorporation of [3H]-thymidine by granulosa cells cultured in
triplicate and treated with IGF-I (•) in three separate experiments (i, ii
and iii). The incorporation in the presence of 3% fetal calf serum is
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Figure 4.6. Mean incorporation of [3H]-thymidine by thecal cells cultured in
triplicate and treated with IGF-I (•) in three separate experiments (i, ii
and iii). The incorporation in the presence of 3% fetal calf serum is















Figure 4.7 Differences in the mean incorporation of [3H]-thymidine into
triplicate untreated cell cultures and into those cultured in the
presence of 3% fetal calf serum. The incorporation is
expressed as c.p.m. per cell plated.
4.4.2. The steroidogenic response of granulosa and thecal cells in vitro
Measurement of the production of progesterone by granulosa cells and the
production of androstenedione by thecal cells treated with LH and FSH , respectively,
was used to assess the steroidogenic response of these cells. Granulosa cells were
stimulated with ovine (o) LH or chicken (c) LH for 24 hours; thecal cells were
stimulated with oFSH. The medium conditioned by the granulosa and thecal cells
during the treatment period was aspirated and analysed by radioimmunoassay for
progesterone and androstenedione content respectively.
Granulosa cells responded to both oLH and cLH by producing progesterone in a
dose-dependent manner (Figure 4.8). The ED50value for oLH (± S.E.M.) was 19.82
ng/ml (± 4.14) (Figure 4.8 a) and for cLH, 26.3 ng/ml (± 6.29) (Figure 4.8 b). There
was no significant difference in the response of granulosa cells to the two LHs. In two
independent experiments, thecal cells responded to oFSH by
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Figure 4.10. Progesterone production by granulosa cells treated with oLH or
IGF-I in two separate experiments, measured by radioimmuno¬
assay. The means and standard deviations (vertical bars) of
triplicate cultures are shown, The DNA content of the cultured
cells was measured following treatment and used to express the
progesterone concentration.
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Figure 4.9. Androstenedione production by cultured chicken thecal cells
treated with ovine (o) FSH in two separate experiments, measured
by radioimmunoassay. The means and standard deviations (vertical
bars) of triplicate cultures are shown. The DNA content of the
cultured cells was measured after stimulation and used to express
the androstenedione concentration.
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producing androstenedione (Figure 4.9). The ED50 values for oFSH (± S.E.M.) were
8.8 ng/ml (± 0.1) (Figure 4.9 a) and 6.5 ng/ml (± 1.6) (Figure 4.9 b) in the two
independent experiments.
4.4.3. The mitogenic effects of gonadotrophins on granulosa and thecal
cells in vitro
Granulosa and thecal cells were treated with oLH or oFSH in order to determine
their possible mitogenic effects on cells in the culture system. These effects were
examined by measuring the resulting stimulation of thymidine incorporation by the
cells.
Cell cultures were treated with a range of doses of LH or FSH up to 50 ng/ml, they
were also treated with IGF-I for comparison with the experiments described in Section
4.4.1. Positive and negative control treatments as described above were included. The
experiment was repeated with cells prepared from different birds.
Treatment with FSH did not stimulate [3H]-thymidine incorporation above the
baseline level of the untreated control in either cell type (Figures 4.10, 4.11). LH
treatment caused a dose-dependent increase in thymidine incorporation in granulosa
cells in both experiments with ED50 values (± S.E.M.) of 14.32 ± 2.57 and 10 ± 1.24,
respectively (Figure 4.10), but did not have this effect on thecal cells (Figure 4.11).
The granulosa cells responded to IGF-I in a similar (dose-dependent) manner to those
in Section 4.4.1, with ED50 values (± S.E.M.) of 13.57 ± 1.60 and 10.55 ± 6.01,
respectively (Figure 4.10). There was good agreement between the results from the two
independent experiments. The ED50 values of IGF-I and LH were not significantly

















































Figure 4.10. Uptake of [3H]-thymidine by granulosa cells in two
separate experiments (a and b). Cells were untreated or
treated with IGF-I, oLH or oFSH as indicated. Each point
represents the mean of triplicate measurements, the
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Uptake of [3H]-thymidine by thecal cells in two separate
experiments (a and b). Cells were untreated or treated
with IGF-I, oLH or oFSH as indicated. Each point
represents the mean of triplicate measurements, the
standard deviation of the mean is shown as a vertical
line around each point.
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4.5. Synergistic Effects OfIGF-I And Gonadotrophins On
Growth And Steroidogenesis in Ovarian Cells In Vitro
Work published on the effects of IGF-I in the mammalian ovary, described in
Chapter 1, shows that IGF-I and FSH have synergistic effects on steroidogenesis and
differentiation of granulosa cells. The possible synergistic effects of IGF-I and
gonadotrophins on mitogenesis and steroidogenesis in chicken granulosa and thecal
cells were examined in a series of experiments described below.
4.5.1. Uptake of [3H]-thymidine after treatment with IGF-I and
mammalian LH and FSH
Cultured granulosa and thecal cells were treated with 25 ng/ml doses of either IGF-
I, LH, FSH or IGF-I with LH or FSH. The effects of these treatments on the
incorporation of [3H]-thymidine were measured. All treatments were carried out on
triplicate wells; the experiment was replicated and the results are shown in Figures 4.12
and 4.13.
No significant difference was found in the incorporation of [3H]-thymidine into
thecal cells treated with IGF-I, with IGF-I and LH, or IGF-I and FSH (Figure 4.13 ).
Similarly no difference in the incorporation of [3H]-thymidine were seen in granulosa
cells treated with IGF-I or IGF-I and FSH (Figure 4.12). However, [3H]-thymidine
incorporation into granulosa cells treated with IGF-I and LH combined was
significandy greater than the incorporation into granulosa cells treated with IGF-I or LH
alone or to the sum of the separate treatments, P < 0.001 (Figure 4.12). Analysis of
variance, as described in Section 2.5.1., showed that IGF-I and LH acted
synergistically to induce DNA synthesis.
4.5.2. A comparison of the effects of IGF-I and oLH or cLH on
steroidogenesis and DNA synthesis in granulosa cells.
Granulosa cells obtained from two different birds were prepared and cultured
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Figure 4.12. Mean uptake of [3H]-thymidine by triplicate granulosa cell
cultures in two separate experiments (a and b). Cells were
treated as shown (the dose was 25 ng/ml for each treatment).
Vertical lines show the standard deviation of the mean.






















Figure 4.13. Mean uptake of [3H]-thymidine by triplicate thecal cell
cultures in two separate experiments (a and b). Cells were
treated as shown (the dose was 25 ng/ml for each treatment).
Vertical lines show the standard deviation of the mean.
Significance of differences to IGF-I treated cells are indicated.
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with IGF-I and cLH separately and together at doses of 25 ng/ml and measurement was
made of the incorporation of [3H]-thymidine into the DNA. After the treatment period
the cell-conditioned media from the cultures were analysed by r.i.a. to determine the
progesterone concentrations. In the second experiment cells were subjected to the same
protocol as those in the first with the exception that oLH replaced cLH in the
treatments.
In both experiments, IGF-I and LH stimulated the incorporation of [3H]-thymidine
into granulosa cells as observed in the previous experiment (Section 4.5.1.).
Incorporation of [3H]-thymidine stimulated by IGF-I and cLH together was
significantly greater than incorporation stimulated by IGF-I alone (P < 0.001) (Figure
4.14 a) as was the incorporation due to IGF-I with oLH (P < 0.001) (Figure 4.14 b).
Analysis of variance (see Section 2.5.1) showed that both oLH and cLH acted
synergistically with IGF-I to stimulate the uptake of [3H]-thymidine.
The medium of cells conditioned by granulosa cells treated with oLH or cLH
contained significantly more progesterone than medium from the untreated control
cultures (P < 0.001 in both cases) (Figure 4.15). Medium from cells treated with IGF-I
contained no more progesterone than the control medium in both experiments. The
concentrations of progesterone in medium conditioned by cells treated with LH was not
significantly different from that conditioned by cells treated with LH and IGF-I. There
was no evidence for a difference in the response of granulosa cells to oLH or cLH
(Figures 4.14, 4.15).
4.6. The Effects OfAnti-LH Antisera On The Uptake Of [3H]-
Thymidine By Granulosa Cells
Experiments were conducted to try and confirm the synergistic role of LH with
IGF-I in the induction of DNA synthesis. Polyclonal anti-LH antisera treatments were
used to immunoneutralize LH. Details of the antisera and the dilutions at which they
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Figure 4.14. Mean uptake of [3H]-thymidine by triplicate granulosa cell
cultures in two separate experiments (a and b). Cells were
cultured in the presence of cLH and/or IGF-I (a) or with oLH
and/or IGF-I (b) (the dose was 25 ng/ml for each treatment).
Vertical lines show the standard deviation of the mean.
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Figure 4.15 Mean progesterone concentrations in culture medium conditioned by
granulosa cells cultured in triplicate in two separate experiments (a
and b). In a Cells were treated with cLH and/or IGF-I (a) or with oLH
and/or IGF-I (b) (the dose was 25 ng/ml for each treatment).
Concentrations were measured by radioimmunoassay. Vertical lines
show the standard deviation of the mean value for each treatment.
Significant differences between zero and the others treatments are
indicated.
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In the first experiment, granulosa cells prepared from the three largest pre-ovulatory
follicles were cultured following the protocol described in Section 4.2.3. The first
group of cells were untreated or treated with IGF-I alone, LH alone, or with IGF-I and
LH together. The dose of IGF-I and LH used was 25 ng/ml for both, as described in
Section 4.5.1. In the second group the cells were subjected to the same treatments with
the addition of anti LH antiserum. Two experiments were conducted in parallel, the first
with oLH and anti-oLH antiserum and the second with cLH and anti-cLH antiserum.
The effects of these treatments on DNA synthesis by the cells were measured by
incorporation of [3H]-thymidine, the steroidogenesis by measuring the progesterone
content of the conditioned medium.
IGF-I and oLH stimulated incorporation of [3H]-thymidine into granulosa cells
(Figure 4.16 a) as described previously (Section 4.5.1.). Analysis of variance of the
results (see Section 2.5.1.) showed that the combined IGF-I and oLH treatments acted
synergistically to stimulate [3H]-thymidine uptake.
Incorporation of [3H]-thymidine by granulosa cells treated with oLH and anti oLH
antiserum was not significantly different from that in cells treated with oLH alone
(Figure 4.16 a), however the incorporation in cells treated with IGF-I and oLH together
was significantly attenuated in comparison with cells to which the antiserum was not
added (P < 0.05). The most significant effect of antiserum treatment was the greater
stimulation of incorporation into cells treated with IGF-I and antiserum, than into cells
treated with IGF-I alone (P < 0.01).
Treatment of granulosa cells with oLH stimulated the secretion of more
progesterone into the culture medium than that secreted by control cultures (P <
0.0001) (Figure 4.17 a). Treatment with IGF-I did not stimulate progesterone
secretion. This confirms the findings described previously (Section 4.5.2.). It was also
confirmed that treatment of granulosa cells with IGF-I and LH together did not
stimulate more progesterone release than that induced by treatment with LH alone (P =
0.7913). Progesterone production by cells treated with oLH and anti oLH antiserum
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Figure 4.16. Uptake of [3H]-thymidine by granulosa cells treated with LH
and/or IGF-I in the presence or absence (control) of anti-LH
antiserum as shown (each treatment 25 ng/ml) . Both ovine (o)LH
(a) and chicken (c)LH preparations (b) were used. Columns
represent the means of triplicate values. Significant differences











































Figure 4.17. Progesterone concentrations in culture medium conditioned by
granulosa cells treated with LH and/or IGF-I in the presence or
absence (control) of anti-LH antiserum (each treatment 25
ng/ml). Both ovine (o)LH (a) and chicken (c)LH preparations (b)
were used. Concentrations were measured by radioimmunoassay.
Columns represent the means of triplicate values. Significant
differences between the control and antiserum-treated cultures are
indicated.
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< 0.05). The antiserum did not decrease the production of progesterone by granulosa
cells treated with LH and IGF-I together (Figure 4. 17a).
Experiments with cLH and IGF-I showed that IGF-I, but not cLH significantly
stimulated the incorporation of [3H]-thymidine into granulosa cells comparison with the
untreated control cells (Figure 4.16b). Analysis of the conditioned medium showed that
the cLH preparation did not stimulate progesterone production from these cells either,
suggesting that it was biologically inactive. However, the addition of anti-cLH
antiserum significantly enhanced the increase in [3H]-thymidine incorporation induced
by IGF-I (P < 0.001) (Figure 4.16 b). This confirms the observation that treatment
with IGF-I and anti-oLH antiserum enhanced [3H]-thymidine uptake (Figure 4.16 a).
The synergistic stimulatory effects of IGF-I and LH antisera on the uptake of [3H]-
thymidine by granulosa cells was investigated further, cultured granulosa cells were
treated with IGF-I, LH or IGF-I with LH (25 ng/ml of each); anti-cLH, anti-oLH or
non-immune serum (NIS), alone and in combination with IGF-I. NIS was included as
a control for the antisera; unstimulated cultures were included as negative controls.
All the treatments caused a significantly greater incorporation of [3H]-thymidine
into the cells than observed in the untreated control cultures (Figure 4.18). IGF-I, LH
and IGF-I with LH caused similar effects to those seen in the previous experiment (see
above). Stimulation caused by treatment with the antisera alone was lower than that
caused by either IGF-I or LH. Stimulation caused by NIS was lower than that of the
antisera. The combinations of IGF-I with anti-oLH, -cLH or NIS all acted
synergistically to enhance the incorporation of [3H]-thymidine, but this synergism was
not as great as that between IGF-I and LH. The stimulation of [3H]-thymidine uptake
by IGF-I with NIS was not significantly different from that by IGF-I with anti-cLH
(Figure 4.18).
The possible synergistic effects of low doses of FCS on [3H]-thymidine
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Figure 4.19. The mean incorporation of [3H]-thymidine into triplicate granulosa
cell cultures, untreated (zero) or treated with IGF-I (25 ng/ml) and
FCS (0.1%, v/v). Standard deviations are shown as vertical bars.
These are the results of two independent experiments (a and b).
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granulosa cells were treated with IGF-I (25 ng/ml), FCS (0.1% v/v) or a combination
of both; untreated cultures were used as controls; the experiment was replicated. FCS
(0.1%) acted synergistically with IGF-I to enhance the incorporation of [3H]-thymidine
into granulosa cells in both experiments (Figure 4.19).
In summary, the results of the three experiments described in this section show that
the method used to negate the effects of LH on the uptake of [3H]-thymidine with
antisera was not effective, but that the treatment enhanced the stimulatory effects of
IGF-I on granulosa cells. This result was confirmed in the second experiment, which
also showed (as did the third experiment) that treatment of cells with non-immune
serum or fetal calf serum resulted in stimulation of [3H]-thymidine incorporation in a
similar manner to anti-LH antisera.
4.7. Developmentally Related Differences In The Response Of
Granulosa and Thecal Cells To IGF-I And Gonadotrophins
Experiments were conducted with cells from the largest ovarian follicles in the
hierarchy. Granulosa and thecal cells from the largest (Fl), third largest (F3) and fifth
largest (F5) follicles were used. Material from follicles at the same stages of the
ovulatory cycle was pooled and prepared for culture. The response of the cultures to the
treatments was measured by the incorporation of [3H]-thymidine into the DNA of the
cells.
4.7.1. IGF-I treatment of cells at different stages of development
Granulosa and thecal cells from the ovaries of two laying hens were set up in
culture. The cultures were treated in triplicate with IGF-I for 24 hours, with doses
ranging from 1.5 to 50 ng/ml, untreated cultures were included as controls. The uptake
of [3H]-thymidine by the cells during treatment was measured and the results expressed
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Figure 4.20 Mean uptake of [3H]-thymidine by triplicate granulosa cell cultures from Fl, F3
and F5 follicles in three independent experiments (a,b and c). Cells were treated
with IGF-I at the doses indicated for 24 hours. Standard deviations of the mean
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Figure 4.21 Mean uptake of [3H]-thymidine by triplicate thecal cell cultures from Fl, F3 and
F5 follicles in three independent experiments (a,b and c). Cells were treated
with IGF-I at the doses indicated for 24 hours. Standard deviations of the mean
are expressed as vertical bars.
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each, the experiments for each cell type are labelled a, b and c (Figures 4.20. and
4.21.). Additionally, the mean values for each follicle size were themselves meaned for
the three thecal and the three granulosa cell experiments (Figure 4.23). The granulosa
data was first normalised with respect to the uptake of [3H]-thymidine by untreated
cells from the F1 follicle, since the range of values in the three experiments did not
overlap sufficiently to allow a direct comparison. This was done by dividing the value
of each data point by the value of the unstimulated F1 cultures in each experiment
Granulosa cells from the smallest follicles (F5) incorporated less [3H]-thymidine
than those from F3 or F1 follicles; however this difference was not significant over the
whole IGF-I dose range in the third experiment (c). The results also indicated that [3H]-
thymidine uptake was greatest by cells from F3 follicles; however, this was only
significant in the first experiment (a) (Figure 4.20).
In two of the three experiments (b and c) thecal cells incorporated [3H]-thymidine in
the order F5>F3>F1, in the first experiment (a) the uptake by F3 and F5 cells were not
significantly different from each other, but both were significantly greater than that by
the F1 cells.
The dose-response curves were compared in each experiment by the ALLFIT
statistical package (Table 4.2). There were no significant differences in the shapes of
the curves from Fl, F3 and F5 cultures of either cell type. The ED50 values for IGF-I
were in the range of 4.07 to 8.68 for thecal cultures and 4.75 to 12.05 for granulosa
cultures.
Overall, the results of these experiments indicate that granulosa and thecal cells
respectively incorporate [3H]-thymidine in the orders F3 > Fl > F5 and F5 > F3 > Fl
in response to stimulation by IGF-I. However, no significant differences in the dose-
response curves due to follicle size were detected.
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Table 4.2 The ED50 values of IGF-I with respect to the stimulation of [3H]-thymidine
incorporation into granulosa and thecal cells in three independent
experiments. In each experiment the effect on cells from Fl, F3 and F5
follicles was examined..
Experiment No. Follicle Type ED so (± SEM)
Thecal cells Granulosa cells
1 Fl 6.14 ±4.83 4.75 ± 1.14
F 3 4.07 ± 0.99 6.58 ± 0.84
F 5 4.20 ± 1.45 6.25 ± 4.83
2 Fl 4.54 ± 1.56 4.23 ±2.11
F 3 5.91 ±1.32 5.63 ± 1.50
F 5 3.67 ±0.67 5.35 ± 7.69
3 F 1 8.68 ±7.61 11.21 ±4.66
F 3 5.18 ±1.75 12.05 ±6.13
F 5 5.45 ±1.08 6.67 ± 1.46
Table 4.3 The ED50 values of LH with respect to the stimulation of [3H]-thymidine
incorporation into granulosa cells in three independent experiments. In
each experiment the effect on cells from Fl, F3 and F5 follicles was
examined..
Experiment No. Follicle Type EDso (± SEM)
1 F 1 9.54 ±0.656
F 3 5.6 ±0.173
F 5 16.35 ±1.85
2 F 1 12.69 ±0.57
F 3 11.64 ±1.08
F 5 13.22 ±7.22
3 Fl 8.22 ± 1.3
F 3 7.37 ±0.24
F 5 8.3 ±0.12
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4.7.2. Gonadotrophin treatment of cells at different stages of
development
Granulosa and thecal cell cultures were set up from follicles at different
developmental stages as described in the preceding section. The cultures were
untreated, or treated with LH and FSH separately at doses of 5, 25 or 50 ng/ml;
cultures were also treated with IGF-I with and without LH or FSH (all treatments
added at 25 ng/ml). The effect of treatments on the [3H]-thymidine incorporation by the
cells was measured; this experiment was repeated twice.
FSH did not stimulate [3H]-thymidine uptake in either cell type; LH stimulated
uptake by granulosa cells (at all three stages of development), but not by thecal cells.
These results are similar to those described previously (Section 4.5.), in which
experiments, cells were pooled from follicles of different developmental stages. LH
stimulated [3H]-thymidine incorporation in a dose-dependent manner for granulosa
cells from all follicle types in all three experiments (Figure 4.22). The ED50 values
were calculated for each dose response curve shown in Figure 4.23 using the ALLFIT
statistical program, these values are shown in Table 4.3. The results of this analysis
showed that there was no significant differences in the ED50 values of these curves.
The maximum incorporation per F3 culture was significantly greater than that in F1
cultures, which in turn was significantly greater than that in F5 cultures. The mean of
the triplicate values for each LH dose in the three experiments were normalised with
respect to the untreated F1 value as described in Section 4.7.1. (Figure 4.23c); this
provided a comparison of results between experiments. There was no significant
difference in the maximum incorporation into F1 and F3 granulosa cells when
stimulated with LH; however, the incorporation into F5 cells was significantly less
when compared at each dose than that of the other two (P < 0.05).
In summary, the results of this experiment show that granulosa cells from follicles
at different stages of development respond differently to LH stimulation, and that the
order of response is F3 > F1 > F5.
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Figure 4.22 Three independant experiments (a,b and c) in which cultured granulosa cells from Fl,
F3 and F5 follicles were stimulated with LH at the doses indicated for 24 hours. The
resulting incorporation of [3H]-thymidine into the cells was measured (c.p.m. per well)
and is expressed on the y axis. Each point is the mean of triplicate cultures, standard
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Figure 4.23 Meaned values from three independent experiments measuring the response of
cultured granulosa (a) and thecal (b) cells from Fl, F3 and F5 follicles to IGF-I
treatment, and the response of cultured granulosa cells from Fl, F3 and F5 follicles
to LH treatment (c). In (a) and (c), the data was normalised to the mean
incorporation by the untreated Fl cells in each experiment. The vertical bars
represent the standard deviation of the means in each set of three experiments.
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In the experiment described above, granulosa cells were treated with IGF-I, LH, LH
with IGF-I, FSH or FSH with IGF-I, in each case the treatments were 25 ng/ml. The
combined effects of IGF-I and FSH on [3H]-thymidine incorporation in these cells was
not significantly different from that of IGF-I treatment alone (results not shown).
However, IGF-I and LH treatments were synergistic for cells derived from each follicle
type in each of the three experiments.
4.8. Summary And discussion
Chicken granulosa and thecal cell culture systems were developed to determine the
role of IGF-I in the growth of chicken ovarian cells in vitro. Protocols for short term
cell culture for the measurement of steroid output were available; however, there was a
requirement to develop new protocols since the exisiting ones were not suitable for the
experiments required. The systems which were developed allowed the culture of cells
for at least 4 days with the opportunity to measure DNA synthesis and the steroid
output of the cells over the last 24 hours of this period.
Serum contains growth factors (including EGF, NGF, the IGFs and PDGF),
nutrients, attachment proteins and transport proteins which are required by cells for
growth in vitro (Temin, 1971; Gospodarowicz and Moran, 1976). Serum was added to
cultures of granulosa and thecal cells and its effect on DNA synthesis was measured
(Section 4.3), demonstrating the ability of cells in the culture system to respond to
growth stimuli. The results of these experiments showed that cells of both types
responded positively to serum stimulation and in a dose-dependent manner.
The steroidogenic responses of chicken granulosa and thecal cells in vitro are well
established (see Chapter 1). For example, Robinson et al. (1988) showed that LH and
FSH stimulate progesterone and androstenedione production by cultured granulosa and
thecal cells, respectively. The results described in Section 4.4.2 confirmed these
observations.
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The cell culture systems were thus shown to be responsive to stimuli intended to
induce cell growth and steroidogenesis. Hence, the systems were validated for
measuring these parameters in granulosa and thecal cells in vitro.
The remaining experiments in this chapter used the cell culture systems to study the
effects of IGF-I and the gonadotrophins (LH and FSH) on both cell types. The primary
aim of the experiments was to examine the effect of treatments on cell growth,
steroidogenesis was measured to confirm the biological activity of the gonadotrophins.
IGF-I has well-documented mitogenic effects on virtually all cell types, evidence
for this activity was reviewed in Chapter 1. The experiments in Section 4.4.1 showed
that IGF-I stimulates DNA synthesis in avian granulosa and thecal cells in vitro and that
this occurs in a dose-dependent manner, the range of doses used being physiologically
significant (Hammond et al., 1985). The maximum synthesis resulting from stimulation
was greater in thecal cell cutures than granulosa cultures, but more cells were plated in
the thecal cultures. When the stimulation per plated cell was calculated, it remained
greater for thecal cells. This shows that differences exist in the response of granulosa
and thecal cells to IGF-I, the thecal cells demonstrating a greater response. A possible
explanation for the differences in DNA synthesis between cell types is that the theca is a
faster growing tissue than the granulosa in vitro.
The effect of IGF-I in these experiments indicates that it is involved in the process
of growth in both granulosa and thecal cells. Work by Leof et al. (1982) and Campisi
and Pardee (1984) has shown that IGF-I is one of many factors that have been
identified as a requirement for the functions of the cell cycle - the sequential processes
of DNA replication, mitosis and cell division. Therefore, the demonstration of IGF-I's
ability to stimulate DNA synthesis is consistentwith a role in the mitosis of granulosa
and thecal cells. However, no study (including this one) has investigated the complex
area of cell cycle control in chicken ovarian cells, therefore the specific role of IGF-I
with respect to the growth of these cells is not clear. A study of the effects of IGF-I on
cell cycle events in these cells may clarify the role that it has on growth regulation of
chicken ovarian cells.
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The results of experiments described in Section 4.4.3 show that LH has an effect
on DNA synthesis in granulosa cells which is similar to that observed for IGF-I in the
experiments described above. However, this effect was not seen with thecal cells.
These cell-specific effects show that clear differences exist in the growth stimulation
pathways of thecal and granulosa cells with respect to LH action and further suggest
that its effects on growth are not mediated by the same pathway as that used by IGF-I.
In contrast to LH, FSH had no effect on DNA synthesis in either granulosa or thecal
cells in vitro.
Gonadotropins have previously been shown to stimulate the growth of chicken
granulosa cells in vitro (Yoshimura and Tamura, 1988), corroborating the results in
Section 4.4.3. Further work has shown that when dibutyryl(db) cAMP is added to
chicken granulosa cell cultures, it causes cell proliferation (Yoshimura and Tamura,
1991). The implication of that work is that the mitogenic effects of LH observed in this
study and by the studies described above, are mediated by cAMP since it is well
established that this molecule mediates other gonadotrophin-induced effects
(steroidogenesis) in mammalian ovarian cells (Richards et al., 1979; Richards, 1980).
The lack of similar effects with FSH contrast with the work of Yoshimura and Tamura
(1988) which showed that FSH had the same effects as LH with respect to granulosa
cell proliferation; In the latter case the cells were cultured for 7 days, whereas in those
decribed in 4.4.3 the changes over 24 hours of culture were measured. Thus it is
possible that FSH might not be as effective as LH in the shorter term cultures.
The biological activity of the FSH preparation used in these experiments was
demonstrated by its ability to elicit an androstenedione production response from
chicken thecal cells (Section 4.4.2); however, this is an ovine preparation and no
comparison has been made with effects on DNA synthesis of a chicken FSH (pure
cFSH was not available). Therefore it is possible that while ovine FSH is ineffective,
the chicken species may be potent in this respect. However, both cLH and oLH were
shown to elicit very similar responses from granulosa cells in these experiments with
repect to both DNA synthesis and progesterone production (Section 4.5.2).
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Following the discovery that both IGF-I and LH stimulated granulosa cell DNA
synthesis in a similar manner, the possibility of additive or synergistic interactions
between IGF-I and gonadotrophins was investigated. The results were described in
Section 4.5. FSH was found to have no effect on IGF-I-mediated DNA synthesis in
either granulosa or thecal cell cultures, and LH had no effect in this respect on thecal
cell cultures, confirming the results in Section 4.4.3. However, LH and IGF-I were
synergistic with respect to DNA synthesis in granulosa cell cultures, but not with
respect to progesterone output. The results indicate that the mitogenic and steroidogenic
activities of LH are mutually exclusive and that IGF-I does not affect the latter.
Mammalian granulosa cells have been shown to respond to IGF-I treatment by
producing pregnenolone in a time-dependent manner (Veldhuis et al., 1986), with
pronounced effects not apparent until 62-84 hours of treatment. These experiments
were conducted with a treatment period of 24 hours; therefore, it is possible that
extending the period for which cells are treated with IGF-I and LH could elicit a
synergistic effect with respect to progesterone synthesis, similar to that reported for the
effects IGF-I and FSH on several steroidogenic functions of mammalian granulosa
cells (Adashi et al., 1985b; 1988a).
Experiments were conducted to investigate the mechanisms of the synergy observed
between IGF-I and LH. Initially, an attempt was made to eliminate the synergy by
using anti-LH antiserum; this did not affect the DNA synthesis of cells in any of the
LH-treatment groups but had a synergistic action with IGF-I similar to that observed
with LH. This experiment led to speculation that the antiserum effects were serum-
mediated, since serum contains many mitogens which could potentially act in a
synergistic manner with IGF-I. To investigate this, the second experiment compared
the effects of two separate LH-antisera and non-immune serum (NIS) on the mitogenic
effects of IGF-I. This experiment showed that there were no significant differences in
the three treatments. A third experiment showed that 0.1% FCS was similarly
synergistic with IGF-I.
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The conclusions drawn from the three experiments described above, were that
serum has a synergistic effect with IGF-I on DNA synthesis in granulosa cells, and that
the effects of antisera were due to the presence of serum rather than antibodies. The
results indicate that serum and LH act via a common pathway with respect to their
synergism with IGF-I since serum significantly stimulated [3H]-thymidine uptake by
granulosa cells above the level observed in unstimulated cultures, but did not have a
significant effect on the uptake of [3H]-thymidine due to LH. One possible mechanism
suggested by these results is that LH synergy could be mediated by secondary factors
produced by granulosa cells into the culture medium, and that these factors are also
present in serum. One candidate for such a factor is progesterone, which was shown to
be produced by granulosa cells in response to LH; it is also present in low
concentrations in the serum used (100 pg/ml) according to the suppliers (Sigma
Chemical Co.). However, this could not be confirmed in this study since the
progesterone r.i.a. available has a sensitivity limit of lOOpg/ml. A direct role of LH on
the cells could not be eliminated since the serum used contained LH (900 pg/ml)
according to the suppliers (Sigma Chemical Co.). Another candidate for an intermediate
role is EGF which is present in serum and has been shown to promote chicken
granulosa cell proliferation in vitro (Yoshimura and Tamura, 1988; Peddie, 1992).
The existence of a developmental hierarchy in the domestic hen in which follicles
exist in well-defined developmental states has prompted much speculation into how it is
regulated. One possible explanation is that most follicles are susceptible to atresia, but
follicles destined to ovulate may be sensitised to the effects of growth factors and thus
able to develop. The involvement of gonadotrophins in such a mechanism has been
suggested by work in human ovaries, showing that FSH concentrations in follicular
fluid are different in follicles destined to ovulate compared with those in smaller
follicles (McNatty et al., 1975). It has has also been shown that IGF-I and
gonadotrophins have synergistic effects in avian (this study) and mammalian (Adashi et
al., 1985b) follicles. Therefore, there is a possibility that LH may sensitise the cells of
ovarian follicles in the domestic hen to the effects of IGF-I and possibly other growth
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factors. Recent work shows that endonuclease enzyme activity mediates follicular
atresia in the avian ovary (Tilly et al., 1991) and suggests that factors, possibly
gonadotrophins or growth factors, mediate this enzyme activity and thus control atresia.
Further study of the response of cells to IGF-I / gonadotrophins from follicles over a
much greater developmental range may indicate the role(s) of these factors in atretic
processes.
Another important conclusion of these experiments is that when designing
experiments to investigate IGF-I effects, precautions should be taken to ensure that
serum is not used in any significant amounts since it clearly has an effect on the actions
of IGF-I.
Further experiments were carried out to investigate the mechanisms of LH and IGF-
I synergy with respect to granulosa cells. These involved a study on the effects of BP
production by the cells and the effects on receptor binding. These experiments are
described in detail in Chapters 5 and 6 respectively.
The final set of experiments described in this Chapter were conducted in order to
elucidate the effect of developmental stage of cells on the responses described above.
There were no significant differences in the shape of the dose-response curves of the
cells from different aged follicles to any of the stimuli and IGF-I and LH were
synergistic with respect to the stimulation of DNA synthesis in granulosa cells from all
three follicle types. However, the maximum response of cells to IGF-I stimulation was
dependent on the developmental stage of the follicle from which they were removed.
Thecal cells had an inverse relationship with follicular age in this respect; the maximum
response of granulosa cells to either IGF-I or LH was seen in the F3 follicles in both
cases and the smallest in the F5 follicles with the response of F1 granulosa cells
intermediate between the two.
Thus, developmentally-related changes in the mitogenic response of both granulosa
and thecal cells exist, and in thecal cells the response declines with follicle size. The
discovery that the order of response of granulosa cells from different follicles is the
same for both IGF-I and LH treatments indicates that the mitogenic response is by a
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common pathway. The order of response in granulosa cells also indicates that
granulosa cells are capable of their maximum response to mitogenic agents at the F3
stage. Developmentally-related changes also occur in the steroidogenic responses of
granulosa cells (Bahr et al., 1983); however, these do not appear to correspond with
the pattern of growth response discovered here. Any link of the cells' growth and
steroidogenic responses would predict a greater growth response of F1 granulosa cells
to LH than F3 cells since follicles progress from an FSH to an LH-controlled phase as
they approach ovulation (Calvo et al., 1981), the converse was observed here.
To summarise, a tissue culture system was developed which was shown to support
mitosis and steroidogenic activity of both cell types. Through this system, IGF-I was
shown to stimulate DNA synthesis in both thecal and granulosa cells and LH was
shown to stimulate this activity in granulosa cells in a manner similar to IGF-I. When
IGF-I and LH treatments were combined they were synergistic with respect to DNA
synthesis in granulosa cells, but not with respect to progesterone production.
Examination of developmental effects revealed that thecal cells from larger follicles
were less responsive to IGF-I, but that granulosa cells were most responsive to IGF-I
at the F3 stage of development.
Amongst the conclusions drawn from the work described in this chapter are those
that IGF-I has a role in the growth of both granulosa and thecal cells in the domestic
hen, and that there are differences in the effects of this peptide in vitro which are
dependent on the cell type. LH is involved in granulosa but not thecal cell growth, and
it has a synergistic action with IGF-I in this respect. Experiments to elucidate the
mechanism of this synergy revealed that serum is similar to LH in this respect.
However, no conclusions could be drawn from this discovery, but it was speculated
that LH may stimulate the production of a factor (or factors) from granulosa cells which
act with IGF-I, and that such factors are present in serum. It was also concluded that
the growth responses of both granulosa and thecal cells to IGF-I and of granulosa cells
to LH are developmentally regulated.
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CHAPTER 5: IGF-I BINDING PROTEINS IN THE AVIAN
OVARY
5.1. Introduction
The production of IGF-I binding proteins by chicken granulosa and thecal cells
in vitro was investigated using the culture systems described in Section 4.2. A series of
experiments was conducted which compared endogenous production of IGFBPs with
production from cells treated with IGF-I. The influence of IGF-I and LH on IGFBP
production by granulosa cells was investigated to determine whether binding proteins
are involved in the synergistic effects of IGF-I and LH on the uptake of [3H]-thymidine
by chicken granulosa cells (Chapter 4).
The size of the cultures was greater than in other experiments described in order
to procure binding protein production by the cells at detectable levels. Therefore, cells
were plated on 25 cm2 area flasks at cell densities of 50,000 and 250,000 cells/cm2 for
granulosa and thecal cells, respectively. No serum was included in the culture medium
for the treatment period in order to eliminate the possibility of adding exogenous IGF
binding proteins which are present in serum. Cell-conditioned medium samples were
concentrated and then run on PAGE gels which were blotted to nitrocellulose
membranes and incubated with [125I]-IGF-I.
5.2. Production Of IGFBPs By Granulosa Cells In Vitro
Granulosa cells were treated with IGF-I (25ng/ml), LH (25ng/ml) or IGF-I and
LH (25/ng/ml of both). Analysis of the resulting cell-conditioned medium (GCM)
showed that the radioactive ligand had bound to five regions in each sample track
(Figure 5.1 a). When compared with the marker proteins, these bands were found to
correspond to proteins with approximate molecular weights of 32.5, 31.5, 30.5, 29.5
and 24.5 kDa. Measurement of the intensity of these bands (Shimadzu densitometer,
not shown) revealed differences in the band intensities between samples. The treatment











Figure 5.1 Autoradiograph of 2 Western ligand blots. Blot (a) shows the binding of
[125I]-IGF-I to samples of granulosa cell conditioned medium; the cells had
been treated as indicated (25 ng/ml per treatment) or were untreated (zero).
Blot (b) shows the binding of [125I]-IGF-I to samples of thecal cell
conditioned medium which were untreated (zero), or treated with IGF-I (25
ng/ml).
135
five binding proteins, the greatest increase being in the concentration of the 29.5kDa
protein. The treatment of cells with LH alone had no effect on the production of these
binding proteins by granulosa cells, and the production of binding proteins in cells
treated with IGF-I was not different from that in cells treated with IGF-I and LH.
5.3. Production Of IGFBPs By Thecal Cells in Vitro
The endogenous production of IGF binding proteins by cultured thecal cells was
compared with the production of IGF binding proteins from cells treated with IGF-I.
Thecal or granulosa cells were cultured in serum free conditions or were treated with
IGF-I (25 ng/ml). The thecal cell-conditioned medium (TCM) was concentrated then
loaded on a PAGE gel which was blotted onto nitrocellulose. The resulting
autoradiograph (Figure 5.1 b) showed that thecal cells produced four sizes of proteins
with IGF-I-binding capacity (32.5, 31.5, 29.5, and 24.5 kDa). These proteins were of
the same sizes as those found in GCM (Section 5.2), except for a protein of 30.5 kDa.
The concentration of the proteins in untreated TCM was greater than that in untreated
GCM (Figures 5.1 a, 5.1 b), however whereas treatment with IGF-I caused increased
concentration of binding proteins in GCM (as seen in the previous experiments), IGF-I
treatment did not appear to alter the level of expression in TCM in this experiment.
5.4. Comparison Of IGFBPs Produced By Granulosa And
Thecal Cells With Those In Chicken Serum
IGF-I binding proteins produced by granulosa and thecal cells obtained from the
ovaries of laying hens were compared with those present in the serum of the same
birds. Granulosa and thecal cells were prepared as described previously, the cells were
cultured and treated with IGF-I. The resulting GCM and TCM were concentrated and
run on PAGE gels with a chicken serum sample. Since thecal cells were cultured at a











Figure 5.2 Autoradiograph of a Western ligand blot. The blot was made from a
PAGE gel in which samples of serum (S), granulosa cell conditioned
medium (G) and thecal cell conditioned medium (T) were run. The
blot was incubated with [125I]-IGF-I. The sizes of proteins to which
the [125I]-IGF-I bound are indicated.
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more GCM was loaded than TCM so that the volume of conditioned medium per plated
cell was equivalent. The gels were blotted and incubated as described in Chapter 2.
The resulting autoradiograph (Figure 5.2) showed that thecal cells treated with
IGF-I produced medium containing proteins with approximate molecular weights of
32.5, 31.5, 29.5, and 24.5 kDa. GCM produced under the same conditions contained
the same proteins with an additional 30.5 kDa protein. Although very faint on the
autoradiograph, chicken serum contained 3 proteins with approximate molecular
weights of 32.5, 29.5 and 24.5 kDa.
5.5. Binding Specificity Of [125I]-IGF-I Ligand
Granulosa cells were cultured and treated with LH and IGF-I as described in
Section 5.2. The concentrated conditioned medium samples were then split into two
equal parts and electrophoresed in two groups of tracks on the same gel and each group
was blotted separately. One of the filters was incubated with [125I]-IGF-I as in the
previous experiment, the other was incubated with [125I]-IGF-I in the presence of 5 (ig
(0.5 pg/ml) of unlabelled IGF-I.
An autoradiograph of the resulting ligand blot is shown in Figure 5.3. Samples
incubated without the unlabelled ligand (Figure 5.3 b) were found to contain the same
binding proteins as seen in the first experiment (Figure 5.1 a). The samples incubated
in the presence of unlabelled IGF-I did not bind the radiolabeled IGF-I (Figure 5.3 a).
Thus, excess unlabelled IGF-I displaced the radiolabeled form from the binding sites,
confirming the specificity of the IGF-I binding sites.
5.7. Summary and Discussion
Studies showing that IGF-I and IGFBP have similar distributions in human
tissues (Hill et al., 1989a) indicate that IGF-I binding proteins may form a complex










Figure 5.3 Autoradiograph of a Western ligand blot incubated with [125I]-IGF-I.
Samples of granulosa cell conditioned medium, from cells which had
been treated as indicated (25 ng/ml per treatment) or were untreated
(zero), were split and run in two sets (a) and (b). The filter (a) was
incubated with unlabelled IGF-I (0.5 |ig/ml).
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level. The production of IGFBPs by cells and their regulation by IGF-I (Hill et al.,
1989b; Thrailkill et al., 1990) suggests that IGFBPs may form part of an autocrine or
paracrine control mechanism. Chapter 3 shows that IGF-I is produced by both
granulosa and thecal cells; the experiments described in this chapter demonstrated the
production of IGFBPs by these cells in vitro and there is thus, a potential role for
IGFBPs in the regulation of IGF-I function at the local level in the chicken ovary. In
order to avoid the possibility of interference from IGFBPs present in serum, the tissue
culture protocol was modified so that no serum was present in the culture medium at the
beginning of the treatment period.
The experiments described in Sections 5.2 to 5.4 show that granulosa and thecal
cells produce 5 and 4 IGF-I binding proteins, respectively. The range of proteins is
similar in size to some of those which have been identified in the rat ovary by Nakatani
et al. These are BPs 2 and 4 with sizes of 31.3 and 25.7 kDa, respectively. Analysis of
chicken serum by Armstrong et al. (1989) demonstrated the presence of 3 IGF binding
proteins with molecular weights of 28.8, 33.2 and 40.7 kDa. The largest of these
proteins could be a chicken equivalent of human IGFBP-3, which was shown by
Binoux et al. (1991) to have similar molecular weights in human serum (41.5 and 38.5
kDa). The absence of a protein of this size from granulosa and thecal cell-conditioned
medium (Sections 5.2 to 5.4) suggest that there are differences between the binding
proteins present in serum and those produced by ovarian cells. This may also suggest
that this putative chicken BP-3 is not involved in autocrine or paracrine control systems
of IGF-I action in the ovary.
An experiment to compare proteins present in granulosa and thecal conditioned
media with serum (Section 5.4) was not conclusive since the bands present in the
serum tracks were faint. Although those detected were the same sizes as bands in both
samples of conditioned media, it is possible that other proteins were present, but not
detected because they were present in very low concentrations.
The experiments described in Sections 5.2 and 5.3 were carried out to determine
whether IGFBP production by granulosa and thecal cells is regulated by IGF-I. IGFBP
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production by granulosa cell cultures was stimilated by IGF-I; however, no such effect
was observed for thecal cell cultures. IGF-I regulates production of IGFBPs from
several cell types in vitro, for example IGFBP production is increased in bovine
epithelial cells (McGrath et al., 1991) and rabbit articular chondrocytes (Froger-Gaillard
et al., 1989) and reduced in human decidual cells (Thrailkill et al., 1990) following
treatment with IGF-I. This study shows that IGF-I also modulates the production of its
binding proteins by cultured chicken granulosa cells. However, under the same
conditions, no such regulation by IGF-I was observed in thecal cell cultures. This
shows that cultured granulosa and thecal cells respond differently to treatment with
IGF-I.
In addition to the differences in response of granulosa and thecal cells to IGF-I,
the binding protein concentration in thecal cell-conditioned medium was greater, per
cultured cell, than that in granulosa cell-conditioned medium. A possible explanation
for these two results is that IGFBP synthesis is inhibited by a factor in granulosa cells
which is down-regulated by IGF-I, and which is not present in thecal cells.
Alternatively it is possible that IGF-I is stimulatory for binding protein synthesis in
both granulosa and thecal cells, the stimulation threshold being lower in thecal cells.
This would enable low levels of endogenously produced IGF-I to activate the
production of IGFBPs in thecal cells. Endogenous IGF-I production by chicken
granulosa and thecal cells in vitro has not been quantified, although
immunocytochemical evidence presented in Chapter 3 shows that the peptide is present
in both these cells in culture.
The release of IGFBPs from rat granulosa cells is modulated by FSH (Adashi et
al., 1990b; 1991c) and LH stimulates mitogenic activity in chicken granulosa cells, as
shown by this study (Section 4.4.3) and others (Yoshimura and Tamura, 1988).
Therefore, the effects of LH on IGFBP production in chicken granulosa cells were
investigated, with consideration to a possible role for IGFBPs in the synergistic
mitogenic actions of LH and IGF-I (Chapter 4).
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The results presented in Sections 5.2 and 5.5 showed that LH did not detectably
alter the production of IGFBPs by granulosa cells. In the rat, a gonadotrophin (FSH)
has been shown to control IGFBP production by granulosa cells, being both
stimulatory at lower doses (1-3 ng/ml) and inhibitory at higher doses (10 ng/ml)
(Adashi et al., 1991c); however, another gonadotrophin, LH, does not appear to
regulate IGFBP production in chicken granulosa cells. This suggests that the
synergistic effect of LH and IGF-I on mitogenesis in granulosa cells (Section 4.5.1.) is
not due to the actions of LH on binding protein synthesis.
Thus, it has been shown that both granulosa and thecal cells release IGF binding
proteins in vitro and that this is modulated by IGF-I but not by LH in granulosa cells.
However, apart from determining their sizes, no further characterisation of these
proteins was undertaken in this study. Further characterisation work, for example by
immunoblotting with antisera raised against mammalian IGFBPs, could indicate
similarities or differences of these proteins with the mammalian IGFBPs.
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CHAPTER 6: IGF RECEPTORS IN THE AVIAN OVARY
6.1. Introduction
The experiments were conducted to determine whether the cells used in the in
vitro studies described in Chapters 4 and 5 have receptors for insulin-like growth
factors. The cells used in this study were granulosa and thecal cells mixed from Fl, F3
and F5 follicles of laying hens.
In the experiments described below, the IGF-I receptors were measured by
competitive ligand binding studies. These compared the relative affinities of the ligands
IGF-I, IGF-II and insulin for IGF-I binding sites on the basis of their competition with
radiolabelled IGF-I.
6.2. Demonstration Of IGF Receptors In Granulosa And
Thecal Cells
Granulosa and thecal cells were cultured in 48-well culture plates and then
treated with [125I]-IGF-I (20,000 cpm/well) alone or with unlabelled IGF-I, IGF-II or
insulin. Ligands were added separately in a range of doses and each treatment was
repeated three times (Figure 6.1). As a control for non-specific binding of the label to
the plates, wells without cultured cells were incubated with [125I]-IGF-I with and
without unlabelled IGF-I.
Radiolabelled [125I]-IGF-I bound to the granulosa and thecal cells with an
efficiency which ranged from 0.9 to 1.5% of the total counts added per well. Non¬
specific binding of label to plates in which no cells were present was less than 0.1% of
the total added per well.
The binding of [125I]-IGF-I to both granulosa (Figure 6.1 a) and thecal cells
(Figure 6.1 b) was displaced in a dose-dependent manner by the addition of increasing
concentrations of unlabelled IGF-I, IGF-II or insulin (Figure 6.1). Values of IC50 for
granulosa cells were 2.87 ± 0.27 (s.e.m.) pmol/1, 3.31 ± 0.97 pmol/1 and 248.2 ± 39.4
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Figure 6.1. Binding of [1251]-IGF-I to (a) granulosa cells and (b) thecal cells
in the presence of increasing concentrations of unlabelled IGF-I,
IGF-II or insulin. Cells were cultured and the binding studies
performed as described in the text. Values are the means of





Figure 6.2. Scatchard analysis of the data from the experiments described in
figure 6.1. a) analysis of [125-1] IGF-I binding to granulosa cells, b)
analysis of [125-1] IGF-I binding to thecal cells. The analysis was
performed with the LIGAND analysis program.
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1.36 ± 0.15 (s.e.m.) pmol/1, 4.7 ± 0.74 pmol/1 and 249.3 ±31.9 pmol/1 for the same
ligands; these values were calculated with the ALLFIT program (De Lean et al., 1978).
Thus the order of potency with which the unlabelled peptides displaced [125I]-IGF-I
from both granulosa and thecal cells was IGF-I > IGF-II >Insulin.
The affinity constant (Ka) and binding capacity (Bmax) of IGF-I for the binding
site on granulosa cells were 7.36 ± 17.3 litres/nmol and 215 ± 40.1 fmol/well
respectively; those on thecal cells were 7.7 ± 27.2 litres/nmol and 214 ± 90 fmol/well
respectively (300 ng DNA per well), these were calculated using the LIGAND
statistical program (Munson and Rodbard, 1980). The analysis shows that the
characteristics of the IGF-I binding sites on granulosa and thecal cells are the same
(Figure 6.2). Comparison of one and two binding-site models for the Scatchard
analysis indicated that the one binding site model was most appropriate for the data for
both the granulosa and thecal cell studies. The experiments were confirmed, once for
each cell type.
6.3. Regulation Of Granulosa Cell IGF Receptors ByLH
Granulosa cells were prepared and cultured as described above. After the
restriction period of culture, cells were treated with 50 ng/ml oLH in medium M199
with 0.1% FCS or left untreated in medium. A treatment period of 6 hours was
followed by incubation with labelled and unlabelled peptides as described above.
Treatment of granulosa cells with LH appears to have no appreciable effect on
the order of affinity of IGF-I, -II and insulin for IGF-I binding sites (Figure 6.3).
Scatchard analysis of the data produced Ka and Bmax values for IGF-I of 7.511/nmol,
220 fmol/well and 9.98 1/nmol, 383 fmol/well for the control and LH treated cells,
respectively. These estimates are essentially the same as observed for cells treated with
IGF-I and suggest that treatment of granulosa cells with LH does not affect the affinity
of IGF-I for its receptor or the number of IGF receptors on granulosa cells. However,
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Figure 6.3. Binding of [125I]-IGF-I to granulosa cells in the presence of
increasing concentrations of unlabelled IGF-I, IGF-II or insulin. Cells
were cultured a) untreated or b) treated with 50 ng/ml LH. Values are
the means of triplicate cultures, standard deviations are shown as
vertical bars.
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were estimates produced from an eqilibrium binding data analysis (EBDA) program
which is not as accurate as LIGAND.
6.4. Summary And Discussion
Cultured granulosa and thecal cells were shown to have binding sites for IGF-I
and that IGF-I, IGF-II and insulin displace labelled IGF-I from these sites with relative
potencies similar to those described by Rechler et al. (1980) for human fibroblasts and
BRL 3A2 cells. This indicates that the binding sites for IGF-I on chicken granulosa and
thecal cells are type I IGF receptors. The data were consistent with a one binding site
model, which supports other work showing that there is only one IGF receptor type in
chicken cells (Bassas et al., 1988; Canfield and Komfeld, 1989; Duclos and Goddard,
1990). In this respect, chicken granulosa cells appear to differ from rat granulosa cells
which have been shown to posses two IGF receptor types (Davoren et al., 1986).
There were no significant differences of receptor affinities or binding capacities for
IGF-I between granulosa and thecal cells. Thus there is no evidence to suggest that the
differences observed in the growth response of these cells, as described in Sections
4.4.1. and 4.4.3., are due to differences in their IGF receptors.
The experiment described in Section 6.3 explored the possible regulatory effects
of LH treatment on the IGF receptors of granulosa cells and showed that LH had no
effect on either receptor number or affinity. Thus, the synergistic effects of IGF-I and
LH on [3H]-thymidine uptake (Chapter 4) does not appear to be modulated through an
effect on the IGF receptor. However, the data did not support detailed analysis due to
the small scale of the experiment (which was not repeated). Thus no great significance
should be attached to these findings
The experiments in this chapter showed that insulin displaced IGF-I from its
receptors in chicken granulosa cells and therefore possibly act through them. However,
its potency was much lower than IGF-I or IGF-II suggesting that in vivo, the IGF
receptor mediates the effects of IGF-I and IGF-II but not insulin. Insulin is more likely
to mediate its effects on granulosa cells via its own receptor. In support of this view,
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Webb and McBride (1991) working with mammalian (ovine) granulosa cells showed
that insulin and IGF-I have dose-dependent effects on [3H]-thymidine incorporation by
these cells with ED50S of 6.8 and 3.8 nM respectively, supporting the hypothesis that
these peptides act through separate receptors.
In conclusion, chicken granulosa and thecal cells posses IGF receptors with
characteristics similar to those described for type I IGF receptors in previous studies,
and that there are no differences in these characteristics between granulosa and thecal
cells in vitro.
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CHAPTER 7: GENERAL DISCUSSION
It is well established that IGF-I has both mitogenic and steroidogenic properties
in the mammalian ovary (see Chapter 1 for references). This study investigated the
nature and some of the actions of IGF-I in the ovary of the domestic hen. It was
established that the IGF-I gene is expressed in the granulosa and thecal cells of the four
largest pre-ovulatory follicles and that IGF-I is present in both these tissues in vivo and
in vitro. Secondly it was shown that IGF-I stimulates DNA synthesis in a dose-
dependent manner in granulosa and thecal cells in vitro; and that the gonadotropin, LH
has a similar effect on granulosa cells but not thecal cells. Further, LH and IGF-I act
synergistically to stimulate DNA synthesis in granulosa cells. Thirdly, it was found that
granulosa and thecal cells produce IGF-I binding proteins in vitro, which in granulosa
cells are regulated by IGF-I. Finally, it was demonstrated that IGF-I binding sites are
present on granulosa and thecal cells in vitro and that these are characteristic of IGF
type-I receptors.
In the original somatomedin hypothesis, IGF-I (somatomedin-C) was
considered to be a growth hormone-dependent factor which was synthesised primarily
in the liver and then circulated around the body where it mediated the actions of growth
hormone on skeletal growth (Van Wyk et al., 1974; Van Wyk, 1984; Froesch et al„
1985). However, since this hypothesis was proposed, it has been established that IGF-
I is synthesised in many diverse extra-hepatic tissues. This indicates that it also has an
autocrine or paracrine role.
The known interactions of IGF-I in chicken thecal and granulosa cells with
respect to mitogenesis are shown in the summary diagram in Figure 7.1. Most of the
information represented was elucidated by the studies described in this Thesis.
This work has shown that the IGF-I gene is expressed in chicken ovarian cells,
that the peptide itself and IGF receptors are present in the same cells and that IGF-I
affects the growth of these cells. This indicates that IGF-I is synthesised locally in the
chicken ovary and that it may act in a paracrine/autocrine manner. Since both granulosa
1 50
and thecal cells were shown to produce IGF-I and posses IGF-I receptors, it seems that
the growth factor has autocrine/paracrine actions in either or both cell types.
A system of local control of IGF-I is implicit in an autocrine/paracrine model.
One of the factors which has been found to regulate the effects of IGFs locally are the
IGFBPs. The pattern of IGFBP occurrence in human tissues is similar to that of the
IGF peptides (Hill etal., 1989(b)), This led to suggestions by these and other workers
that IGFs and IGFBPs are mutually regulated. More recently, several studies have
shown that administration of IGFs increases IGFBP production from cells both in vitro
and in vivo (e.g. Zapf et al., 1989; Froger-Gaillard et al., 1989). When this
information is coupled with earlier work which showed that IGFBPs inhibit the effects
of IGF-I on cells (Knauer and Smith, 1980; Blat et al., 1988), the basis for a local
mechanism regulating IGF-I actions by IGFBPs emerges. Simply, this would involve
cells responding to increased IGF-I concentrations by increasing IGFBP synthesis,
which then attenuate the effects of the peptide by forming complexes with it (Figure
7.1). Modification of IGFBPs by proteases may inhibit the formation of these
complexes (Hossenlopp et al., 1990; Schmid et al., 1991) and thus regulate the
availibility of free IGF-I to cells, introducing a further level of control on IGF-I
activity.
The work presented in this Thesis shows that IGFBP production by chicken
granulosa cells is stimulated by the administration of IGF-I and is consistent with the
mechanism described above. As further evidence of this mechanism operating in the
ovary, IGFBPs are produced by mammalian ovarian cells (Suikkari et. al., 1989;
Nakatani et al., 1991; Erickson et al., 1992) and have been shown to inhibit the
stimulatory effects of IGF-I on FSH-induced oestradiol synthesis by rat granulosa cells
(Shimasaki et al., 1990(a)). Also, IGF-I was recently shown to stimulate the
production of 2 IGFBPs by porcine granulosa cells in a dose-dependent manner
(Grimes and Hammond, 1992). A stimulatory role of IGFBPs in the ovary can not be
ruled out since they increase cell proliferation in porcine muscle cells, human and chick
fibroblasts and baby hamster kidney cells (Clemmons et al., 1986; Elgin et al., 1987;
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Blum et al., 1989). However, the other reports of IGFBP actions in the ovary have
shown them to be inhibitory (Bicsak et al., 1990; 1991). Further evidence of the
importance of IGFBPs in regulating ovarian follicular development was provided by
Nakatani et al. (1991), who showed that the IGFBP-4 gene is expressed exclusively in
the granulosa cells of atretic follicles in rats. Thus evidence is shown in this Thesis
which is consistent with the ovarian actions of IGF-I being regulated by IGFBPs by
means of a negative feedback loop in the domestic hen (see Figure 7.1); this is
supported by similar work in mammalian species.
The gonadotrophin, LH, was shown in these studies to be mitogenic for
granulosa cells and therefore acts in a similar manner to IGF-I. When LH and IGF-I
were added together to cultured granulosa cells, there was a synergistic effect on DNA
synthesis. Further experiments are necessary in order to determine the nature of the
synergistic relationship between IGF-I and LH with respect to cell growth. One
possible area of investigation suggested by other studies is the role of cAMP. The
steroidogenic effects of FSH on rat granulosa cells are mediated by cAMP, which is
also involved in mitogenic actions of both FSH and LH on chicken granulosa cells
(Yoshimura and Tamura 1988; 1991; Adashi et al., 1991b). Additionally, treatment of
rat granulosa cells with IGF-I and FSH results in an increase in accumulation of cAMP
in conditioned media which is greater than that seen after treatment with FSH alone
(Adashi et al., 1986b). Thus, it is possible that cAMP is involved in the synergistic
effects of IGF-I and LH shown here.
In the light of evidence showing that another gonadotrophin, FSH, regulates
IGFBP release from rat granulosa cells (Adashi et al., 1991c), it seems possible that
LH could exert its mitogenic effects on granulosa cells by reducing IGFBP production
and thus reducing the inhibitoty effects on IGF-I due to these binding proteins. The
possible regulatory effects of LH on IGFBP release from chicken granulosa cells were
therefore investigated. However, the results showed no such effects, suggesting that
LH does not regulate mitogenic activity of IGF-I via an IGFBP system. A further
experiment to examine the effects of LH on granulosa IGF receptor number and
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affinity, showed that there was no effect. Thus LH does not appear to regulate the
mitogenic actions of IGF-I via the IGF receptor.
IGF-I, is likely to be one of several growth factors involved in the growth of
follicles, two more are likely to be epidermal growth factor (EGF) and platelet-derived
growth factor (PDGF) which together with IGF-I have been identified as being
important to the control of the cell cycle (Pledger et al., 1978; Leof et al., 1982). Recent
reports have shown that EGF has steroidogenic and mitogenic effects on the cells of
chicken pre-ovulatory follicles (Onagbesan et al., 1990; Peddie et al., 1991; Peddie,
1992). EGF also acts synergistically with IGF-I to induce mitogenesis in porcine
granulosa cell (May et al., 1988). Other factors, most notably gonadotrophins have
been shown to act synergistically with IGF-I to stimulate steroidogenesis in granulosa
cells (e.g. Adashi et al., 1985b; Veldhuis et al., 1987). In this study, a synergistic
effect of LH and IGF-I on mitogenesis was observed and the observation that IGF-I
and low concentrations of serum are mutually synergistic in the same way, suggests
that serum contains additional factors which act synergistically with IGF-I.
The synthesis of IGF-I is known to be influenced by many factors, depending
on tissue or cell type. For example, IGF-I production by porcine granulosa cells is
stimulated by LH, FSH, GH, oestradiol, EGF and TGF-a (Hsu and Hammond, 1987;
Mondschein and Hammond, 1988). Thus it is probable that in an autocrine/paracrine
system as described above IGF-I activity would be regulated by proximal factors such
as the pituitary hormones. One such hormone, GH, has been shown to increase IGF-I
gene expression in cultured rat hepatocytes (Johnson et al., 1989) and to elevate IGF-I
levels in rat ovarian tissues (Davoren and Hsueh, 1986). A recent report showed that
GH stimulates the development of ovarian follicles in the domestic hen, and that it is
associated with an increase in plasma IGF-I concentrations (Williams et al., 1992).
Thus GH may be a candidate for proximal regulation of IGF-I action in the avian
ovary.
The studies of IGF-I stimulation of IGFBP synthesis and LH stimulation of
DNA synthesis showed that granulosa and thecal cells behave differently. The
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granulosa cells were responsive to both treatments, but no effects were observed in
thecal cells. The conclusions drawn from this is that the granulosa layer of cells is more
sensitive to the effects of IGF-I (both alone or combined with LH) than the adjacent
thecal layer in the follicles of domestic hens. Since the IGF-I gene was shown to be
expressed in both tissues, it is possible that IGF-I synthesised in thecal cells could exert
effects on the adjacent granulosa cells and thus act in a paracrine manner. However,
further studies involving co-culture of both cell types are required before further
conclusions can be drawn.
This study clearly shows that IGF-I affects the growth of avian granulosa and
thecal cells. The involvement of IGF-I with ovarian growth and development was
originally indicated by studies showing that IGFs are present in mammalian follicular
fluid in vivo (Hammond et al., 1982). This was reinforced by studies showing
production by cells in vitro and further showing that IGF-I has mitogenic and
steroidogenic roles in mammalian granulosa cells (Baranao and Hammond, 1984;
Adashi et al., 1985b). Thus IGF-I is involved in the development of the avian pre¬
ovulatory ovarian follicle. The nature of the involvement of IGF-I in the ovary of the
domestic hen appears to be complex, with an autocrine/paracrine IGF-I system
complete with ligands, receptors and binding proteins which interact with at one factor
(LH) and possibly others. The role of IGF-I in the ovary of the domestic hen, as
















Figure 7.1 Summary of the interactions of IGF-I in granulosa and thecal cells of the
domestic hen. Elements in red are described in this thesis, elements in grey
are speculation based on mammalian studies. Elements in pink were
elucidated by other studies.
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